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Abstract
Whoever is not “green” is not “in”. That’s the latest trend of the market. This environmental move-
ment pushes the companies to review their policies and assure a sustainable development by
reducing their Carbon Dioxide (CO2) emissions and use of natural resources or in general show an
eco-friendly behaviour.
The objective of our work is to assess the pertinence of green policy introduction at the business
level. For our analysis, we are using unique data sets of the firm’s CO2 emissions. We built our
data by adding several firms’ characteristics to an initial database provided by South Pole Group.
Based on particular companies’ specificities we were then able to select the suitable treated and
control groups.
Carbon Disclosure Project (CDP) is a non-profit organisation allowing companies to report and
manage their emissions, climate risk and reduction goals. And in our study, we intend to evaluate
whether signing up to the CDP has a positive effect on the firms’ emissions.
It is a typical causal effect evaluation problem that we solve using a relatively new approach
called “Synthetic Control Method (SCM)” introduced by Abadie and Gardeazabal (2003). The ob-
jective of this method is to build the synthetic control unit, which is the weighted combinations of
available control units that most closely resemble the treated unit before the treatment in term of
different characteristics. This synthetic control unit allows us to define the counterfactual outcome,
that is then compared to the actual outcome to evaluate the treatment effect. We chose the syn-
thetic control method because it allows researchers to analyse phenomena that occur in a limited
population or that apply to only a small number of firms, which is ideally suited to our problematic.
Almer and Winkler (2013) used this method in environmental problematic, but to our knowledge,
it has never been applied to evaluate firms’ politics, and indeed we will use this approach to analyse
the environmental programme at a company level.
To complete the investigation of the general impact of this program on firms’ emissions, we also
focus on three geographic regions: the United States (US), the United Kingdom (UK), and the rest
of European Union (EU). Moreover, the study also covers the comparison of results between all
sectors of activities.
xvii

Introduction
Nowadays, most of the world is aware of the irreversible climate change and the impact of this in-
stance on the entire planet. As covered in the Stern Review (Stern (2006)), even the most powerful
economies, who are the biggest greenhouse gas emitters, are not prevented from the effect of the
raising temperature. This phenomenon increases the need of “green” and sustainable economies
to mitigate the climate change and assure the future. Consequently, the companies are pushed to
quickly and significantly cut down their greenhouse gas emissions and revise their actions in this
direction.
Many policies, international agreements and regulations, that are also introduced in this work
exist to control the greenhouse gas emissions and mitigate the climate change. The question that
naturally arises is “how do we evaluate the pro-environmental behaviour?”
To answer that, numerous studies assessing the introduction of climate agreements were con-
ducted on the macro scale. For example, we can cite work of Aichele and Felbermayr (2012) or
Almer and Winkler (2013), who evaluated the Kyoto Protocol. Almer and Winkler (2013) used the
synthetic control method in environmental problematic, but to our knowledge, it has not been ap-
plied to assess a firm’s policy such as environmental programmes at the company level. This lack
in the application of the synthetic control method catches our attention.
The primary objective of our study is to assess the pertinence of green policy introduction at the
business level. More precisely, we intend to evaluate whether participating to the Carbon Disclosure
Project1, as one of the binding reporting standards, has a positive effect on the firm’s emissions.
This is a typical causal effect problem that we solve by using a relatively new method, that is the
synthetic control approach.
The synthetic control method is one of many program evaluations’ approaches that seeks the
estimation of the treatment effect of particular program or treatment. Introduced by Abadie and
Gardeazabal (2003), this approach provides a data-driven procedure to estimate synthetic control
units based on a weighted combination of control units that approximates the characteristics of the
unit exposed to the treatment. Moreover, with this approach, we can estimate the treatment effect
in settings where a single unit is exposed to treatment, or where we dispose few historical data. We
1CDP is a not-for-profit organisation that runs the global disclosure system for investors, companies, cities, states
and regions to manage their environmental impacts. Founded in 2003 and based in the United Kingdom. Its primary
goal is to help the corporations and cities to disclose the greenhouse gas emissions and assist them to manage the
environmental risk.
1
2 Chapter 0. Introduction
start from the principle that a combination of comparison units often provides a better comparison
for the unit exposed to the intervention than any comparison unit alone. By its characteristics, the
synthetic control method allows us to generate treatment effects for each of the studied companies,
and perform statistical inferences.
Furthermore, our work covers several research questions. The first general question asks if
there is a positive impact of the Carbon Disclosure Project on the participating companies’ emis-
sions. The second research question is focussed on the comparison of the results between three
different geographic regions, which are the EU, the UK, and the US. Note that it was the similar-
ity in the economic development and the environmental strategies that lead us to the choice of
these regions. Last research question inquires whether there is one of the nine sectors of activities
(Financials (FINA), Health Care (HC), Information Technology and Telecommunication (ITTE), Con-
sumer Discretionary (CD), Consumer Staples (CS), Industrials (INDU), Energy (ENGY), Materials
(MATR), Utilities (UTIL)), or any of three emitter groups (light, medium, or heavy carbon dioxide
emitters), that would be more successful in the program participation than the others.
Another objective of our work is to do a complete and detailed review of the synthetic control
approach. Note that this method is covered in four papers by Abadie and al. (Abadie and Gardeaz-
abal (2003); Abadie et al. (2010, 2011, 2015)), where the authors assess different political problems
and develop the synthetic control method, as well as the tests used to evaluate the significance of
the results. In our work, we do review all the papers and present the main elements of the method,
the way of showing the results, and all different statistical inferences that the approach allows.
Moreover, we also cover the application of the synthetic control method in the statistical program R
Core Team (2013) and present how we used the package “Synth” developed by Hainmueller and
Diamond (2015).
An essential element to mention is the quality and uniqueness of our database. Collecting the
historical data on the carbon dioxide emissions on the firm’s level is still quite a challenging task,
as the companies are not usually holding the historical data. With the contribution of the South
Pole Group, we were able to collect the data for a total of 139 companies between the years 2005
to 2013. This data contains carbon dioxide emissions and other characteristics of the firms that
do or do not participate in the Carbon Disclosure Project. Moreover, the data covers nine different
sectors and three geographic regions.
We structured our work in two parts. The first one gives a theoretical overview of the program
evaluation methods and the synthetic control method in particular. Moreover, we also introduce
the environmental problematics at the international and firm’s level, and we present the Carbon
Disclosure Project into more details. The second part presents the empirical application of the
synthetic control method on the environmental problematic, more specifically, the evaluation of the
Carbon Disclosure Project. We introduce the research questions, data and model implementation,
as well as the estimations and the results of the study.
Chapter 1 introduces the problematic of treatment effect estimation in political and economic
sciences. We review the historical development of the program evaluation methods. These tech-
niques assess the effect of the exposure of a set of units to a program or treatment on some
outcome in two different backgrounds, the randomised experiment or the observational studies. In
3the randomised experiment, all is under the control of the investigator, and in the observational
studies, the system under study is outside his control. To estimate a treatment effect there exists
different techniques as the social experiment, the regression model, the matching estimators, or the
instrumental variables. These methods, covered in various articles of scientists as Neyman, Rubin,
LaLonde, Holland, and many others, are also briefly reviewed in the first chapter. Also, we intro-
duce the main elements of program evaluation methods as the potential outcome, the treatment
effect, as well as different estimators and assumptions.
Chapter 2 goes further in the problematic of the treatment effect estimation and presents a
relatively new approach, the so-called synthetic control method, which estimates the impact of
interventions. The synthetic control method is the primary approach used in our work to evaluate
the treatment effect. The first section of this chapter presents the series of main articles on the
synthetic control method. The second section introduces the methodology of the synthetic control
method. In this part, we introduce the basic notations and definitions, the driving model and its
application, the optimisation problem, the way of presenting the results of the analysis, and we finish
with a short review of the advantages and limitations of the synthetic control method in comparison
to the standard regression method. The final section describes the statistical inferences’ tools as
the placebo tests, and the root mean squared prediction error or the robustness analysis.
Chapter 3 introduces the problematic of the climate change, the necessity of the reduction
of carbon emissions and how this is regulated on the international and firm’s level. In the first
section, we present the leading organisations and regulations related to the climate change, as the
contributions of the United Nation, or the Kyoto Protocol. The second section overview the main
disclosing programs on the firm’s level. Moreover, we present some initiatives and regulations
promoting the low carbon economy in the European Union, the United Kingdom, and the United
States (as these regions are studied in our work). The last section of this chapter presents the
Carbon Disclosure Program, one of the binding reporting standards that are evaluated in our study.
Chapter 4 primary objective is to introduce the research questions, data and model implemen-
tations. We start with a brief literature review of firm’s environmental studies, and open to the
section that develops our frame of hypothesis and three research questions for the study. As the
next step, we present the creation of the database, the variables and provide the descriptive statis-
tics. The third section is dedicated to the methodological part of our study, where we present the
model, the application of the synthetic control method, and the statistical inference tests. The final
section introduces the implementation of the model with the statistical program R. We introduce the
library “Synth”, the R package developed by Hainmueller and Diamond (2015) for synthetic control
methods in comparative case studies. Moreover, we present the library “Mylib”, a package we built,
that contains different functions created to adapt the package “Synth” on our case. We also present
the “Jobs” that produce the synthetic control analysis and show the outcomes of the most important
functions.
Chapter 5 is focussed on estimations, presentation of the results and gives the answers to the
three research questions. The first section presents the results of the analysis regardless of the
sector or the geographic region of the firms. The second section compares the results between the
regions. The third section analysis the results in different areas of activities. And the last section
presents a short conclusion of the study.

Part I
Theoretical part

Chapter 1
Historical review and introduction to the
program evaluation methods
In economics or other social sciences, in particular, many empirical questions are about evaluating
the effect of exposure to a set of units to a program or treatment on some outcome. We mean
by term “units” the “economic agents” such as individuals, households, schools, firms, countries.
The term “treatment”, also known as exposure to program, experiment, or intervention, refers for
example to job search assistance programs, laws or regulations, environmental or technology ex-
posures.
To assess the causal effect of particular program or policies we make use of the program evalu-
ation methods. The term “causal effect” refers to the comparisons of so-called potential outcomes,
pairs of outcomes defined for the same unit given different levels of exposure to the treatment. In
this work, we are limited to settings with binary treatments, and we are interested in the evalua-
tion of the “treatment effect”, comparison of the two outcomes for one unit that would result from
exposure to alternative causal state when exposed and not exposed to the treatment. As we can-
not observe the same unit exposed and not exposed to the treatment, only one of the potential
outcomes is realisable. And to evaluate the treatment effect we make use of the counterfactual
outcome, which is the not realised potential outcome that has to be estimated.
While estimating the treatment effect the researcher faces two kinds of backgrounds: ran-
domised experiment or observational studies. In the randomised experiment, the system under
study is under the control of the investigator. This means that the researcher selects the assignment
to the treatment, nature and the measurement procedures used. By contrast in an observational
study these features, in particular, the allocation to the treatment, are outside the investigator’s
control.
The treatment effects can be estimated by using, for example, social experiments, regression
models, matching estimators, or instrumental variables. A standard to estimate the treatment effect
is the potential outcome model of causal inference published by Rubin (1974) in his revolutionary
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article on the counterfactual model for causal analysis of observational data. Rubin’s model be-
comes the basis of the program evaluation method, and in all our work we also think of the causal
relationship in term of the potential outcome framework.
In this chapter, first, we make a short historical review of program evaluation methods. In the
second section, we present the basic notions, definitions, estimators and assumptions used in the
evaluation methods. Note that as we cannot cover all the methods, for more detailed review, see
Imbens and Wooldridge (2008) which is an excellent document offering an in-depth overview of
the research made in the previous two decades on the econometric and statistical analyses of the
effects of programs or treatments. Another good review, focusing more on technical detail of the
analysis is Angrist and Pischke (2008). Moreover, in annex A.1 we present a section covering the
basic ideas behind matching and Difference-in-differences (DID) methods.
1.1 Historical review of program evaluation methods
In the introduction, we mentioned that the central problem in program evaluation methods is the
assessment of the causal effect. This problematic does have a long history both in statistics and
econometrics. In this chapter we review the main research done in program evaluation, starting with
the introduction of potential outcome framework and following by three subchapters developing the
randomised and observational studies methods.
Historically, potential outcomes were first approached in 1923 by Neyman (Splawa-Neyman
et al. (1990)). Rubin notes on Neyman’s work: “The most important contribution of Neyman is its
explicit use of notation Uik to indicate the yield of plot k if exposed to variety i drawn accordingly to
the urn schema. The Uik is a potential yield, not an observed yield because i indexes all varieties
and k indexes all plots, and each plot is exposed to only one variety. This notation become the
standard for describing possible outcomes of randomised experiment, and allows for causal effect
and causal estimates to be defined without any probability model for the data” (Rubin (1990a,
pp. 473-474)).
In the first half of century, the potential outcome framework was sowing its seeds. Neyman’s
work was followed by Fisher (1935), Cochran and Cox (1950), Kempthorne (1952), Cox (1958)
and other articles focusing on random experiments. The potential outcomes were also used in
economics, by Haavelmo (1943) in the simultaneous equations models, and in the econometric
analyses of production functions, or in labour market settings in Roy’s model (Roy (1951)).
But it is only in the second half of the past century that the potential outcome model was officially
founded. In 1974 Rubin pioneered the statistical framework for the problem of potential outcome
and extended it to the analysis of observational studies, where the units are not randomly assigned
to the treatments (see Rubin (1974)). Rubin continued to develop and formalise the model in series
of papers1. Holland (1986) overviewed his work and labelled the Rubin’s formulation as Rubin’s
Causal Model. By means of this model, we can formalise basic intuitions concerning cause and
effect and above all, analyse the causal effect.
1Rubin (1977, 1978, 1980, 1981, 1990b).
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Apart of Rubin, an important contribution to the development of the evaluation methods was
in the 90’s and is due to the researchers as Ashenfelter (1978), Heckman and Robb (1985a),
LaLonde (1986), or Manski (1990), and their focus on the evaluations of labour market programs in
observational settings.
Resulting from Rubin’s model, the program evaluation methods can be divided into two groups
on the relationship between treatment assignment and the potential outcome. The first class of
methods covers all the approaches with the randomised assignment to treatment. The second
class of evaluation methods includes all methods, more common in economics, with the data from
observational studies. In the observational setting itself, we distinguish two other subclasses. The
first one holds the assumption of unconfoundedness2, and the other one relaxes the unconfound-
edness assumption. We present different classes of methods to estimate the treatment in the
following sections.
1.1.1 Treatment effect in randomised experiments
The core characteristic of non-observational studies on the program evaluation is the indepen-
dence between the treatment assignment and the covariates as well as the potential outcome. The
randomised selection of individuals to a program presents ethics problem, so these methods are
rather rare in economics. Note that it has been used in the case of some labor market evaluations
(e.g., LaLonde (1986), Ashenfelter (1978)), and recently, there has been a significant number of
experiments in development economics (e.g., Duflo (2001), Banerjee et al. (2007)), or behavioural
economics (e.g., Bertrand and Mullainathan (2004)).
In general, using experimental data makes the statistical analysis straightforward, as we can
obtain an unbiased estimator for the average effect of the treatment and improve the precision of the
estimation by adding some covariates in the regression function. On the one hand, in economics,
randomisation has never been regarded as the exclusive method for establishing causality. But on
the other hand, LaLonde (1986) suggested that widely used econometric methods were unable to
replicate the results from experimental evaluation. It was this point that encouraged governments
to include the experimental evaluation of job training programs, but it has not had a long-lasting
success. As previously mentioned, there has been the recent progression in the experimental
studies for development economics. The majority concerned educational issues, and from the
inception, economists have been heavily involved in the construction of optimal design.
2Unconfoundedness assumes that beyond the observed covariates there are not (unobserved) characteristics of the
individual associated both with potential outcomes and treatment.
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1.1.2 Treatment effect under unconfoundedness
The first class of program evaluation methods in observational studies concerns the methods that
keep the assumptions of unconfoundedness, or overlap3 or the combinations the two assumptions
referred by Rosenbaum and Rubin (1983) as the strong ignorability assumption. Many different
semi-parametric estimators exist, and they are classed in three groups of estimation methods pre-
sented in this section: regression methods, methods relying on propensity score and matching
methods.
The regression methods for estimating average treatment effects went far beyond the simple
parametric models, and two general directions have been explored. The first direction concerns the
local smoothing, where Heckman et al. (1997) and Heckman et al. (1998) consider this method for
estimating kernel and local linear regression functions. The second direction is the flexible global
approximation, such as series or sieve estimators studied in Hahn (1998) or Chen et al. (2008).
The second group of methods to estimate different classes of estimators is based on the
propensity score. These methods are founded on the results from Rosenbaum and Rubin (1983),
and different methods are proposed. The first one uses the propensity score in place of the covari-
ates in regression analysis (see Heckman et al. (1998)). The second one, stratification, adjusts
for differences in the propensity score. The idea comes from Rosenbaum and Rubin (1983), and it
is to partition the sample into strata by values of the propensity score, and then analyse the data
within each stratum as if the propensity score was constant. In this case, the observations in the
strata could be interpreted as coming from a completely randomised experiment. The third method
is based on weighting, as the weighted estimator or the inverse probability weighting estimator (see
Hirano et al. (2003)).
The last method to estimate different classes of estimators is matching. Matching estimators,
widely used in practice because of their simplicity, use the closest neighbours from the opposite
group. Given the matched pairs, the treatment effect within a pair is estimated as the difference
in outcomes, and the overall average as the average of the within-pair differences. The matching
estimator has been widely studied by Rosenbaum, Rubin, Heckman or Abadie4. Because matching
is a component of the SCM used for our analysis, we present basics of the matching method in the
annexe .
Imbens and Wooldridge (2008, pp. 20) states that: “Although still widely used in practice, we
do not recommend the basic methods, relying on the regression, propensity score methods, and
matching, in practice.” They proposed the use of several mixed methods. The first combines
regression and propensity score weighting but is not widely used in economic applications. The
second combines the sub-classification and regression and is one of the most attractive estimation
methods in practice. The last method merges matching with regression and is also supposed to be
a very good technique to estimate the treatment effect.
3Overlap assumption implies that the support of the conditional distribution of the covariates given the non-
participation to the treatment overlaps completely with that of the conditional distribution of the same covariate given
the participation to the program.
4Rosenbaum (1989, 1995, 2002); Rubin (1973b, 1979); Heckman et al. (1998); Abadie and Imbens (2006).
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1.1.3 Treatment effect without unconfoundedness
The third class of methods based on the assignment mechanism contains all other assignment
mechanisms in observational studies with some dependencies on potential outcomes. These
methods relax or completely drop the hypothesis of unconfoundedness and either replace it with
another assumption or do not. There exist the multitude of methods, but the most prominent ones
are: bounds analyses, sensitivity analyses, instrumental variables, regression discontinuity and
difference-in-differences.
Bounds analyses were developed in series of papers and books by Manski5. This method
simply drops the unconfoundedness assumption. Moreover, it supposes that the parameters of
interest are not identified and can be bounded between two values and researcher may add some
assumptions regarding the estimands.
Approaches based on the sensitivity analyses partially relax the unconfoundedness assump-
tion. They include two main methods which are Rosenbaum’s method to sensitivity analysis
(Rosenbaum and Rubin (1983)) and the Rosenbaum-Rubin approach to sensitivity analysis (Rosen-
baum (1995)). By sensitivity analyses, we examine the robustness of the results by the modest
violation of the unconfoundedness assumption, which introduces a presence of unobserved co-
variates that are correlated, both with the potential outcomes and with the treatment indicator.
Instrumental variables method relies on the presence of additional treatments, so-called in-
struments, which satisfy specific exogeneity and exclusion restriction6. The formulation of these
methods in the context of potential outcome framework is presented in Imbens and Angrist (1994),
Angrist et al. (1996), where they focus on binary or multi-valued instruments and local average
treatment effects.
Regression discontinuity methods have a long tradition in psychology and applied statistics, but
it is only recently that these methods attracted more attention in economic research. These meth-
ods have two general settings: the sharp and the fuzzy regression discontinuity design7. Hahn et al.
(2001, pp. 201) specifies: “The regression discontinuity data design is a quasi-experimental design
with the defining characteristic that the probability of receiving treatment changes discontinuously
as a function of one or more underlying variables.”
Difference-in-differences is one of the most popular tools for applied research in economics to
evaluate the treatment of some programs or politics. DID relies on the presence of additional data
in the form of samples of treated or control units before and after treatment. Some applications
were done by Ashenfelter and Card (1985) and recent theoretical work includes Abadie (2005) and
others8. As the matching, the difference-in-differences is a base method to extend the synthetic
control approach, and so we present them with more details in the annex A.1.1.
5Manski (1990, 2003, 2007).
6Exclusion restriction means that the instrument, Z, should not affect outcome variable, Y , when the covariate, C, is
held constant.
7VanderKlaauw (2002), Hahn et al. (2001), Lee (2001), Porter (2003).
8Bertrand et al. (2004), Donald and Lang (2007), Athey and Imbens (2006).
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1.2 Introduction to the program evaluation methods
The main point of the research in program evaluation is how to evaluate the causal effect of the
units’ exposure to one or more levels of treatment. As already mentioned, we are limited to settings
with binary treatments, and we are interested in a comparison of two outcomes for the same unit
depending on exposure to an experiment. The main problem is that we cannot observe more
than one of the outcomes because the unit can be exposed to only one level of the treatment at a
time. This problem is known as the “fundamental problem of causal inferences” covered in Holland
(1986). Therefore to evaluate the treatment effect we need to compare distinct units being exposed
to different experiments, these units are so-called “counterfactuals”. Because of it, we encounter
so-called selection bias. Selection bias is due to the individuals who choose to enrol in a program
are by definition different from those who choose not to enrol.
The link between the selection bias, causality and treatment effect can be seen most clearly
by using the potential outcomes framework. As we alluded before, one of the most common ap-
proaches to program evaluation is based on Rubin’s work, in particularly it is the model for causal
inference that Holland (1986) refers to as “Rubin’s Causal Model”.
In this section, we introduce the foundation of Rubin’s model and describe different notions,
notations and definitions used in the program evaluation methods. We start with the definition of
the potential and realised outcomes, and we list main advantages of the potential outcome setup.
We follow by main estimands for average treatment effect, and we finish this section with the most
important assumption in causal effect modelling.
1.2.1 Potential outcome versus observed outcome
Before we define what the potential outcome is, we have to give some other notations and defi-
nitions. Let i = 1, . . . ,n be an individual, who decides whether to participate in the program. The
unit that would receive the treatment is called treated unit, and the unit that does not receive the
treatment is called control unit. We denote by g the participation to the program, respectively g= I
(I as intervention) is the exposure to the treatment, and g = N (N as non-intervention) is the non-
exposure to the treatment. The symbols nI and nN are the numbers of individuals that are in the
program and those that are not, respectively.
Before the individuals decide to enrol in the program, there is the existence of two potential
outcomes, Y Ii and Y
N
i for each individual. Where Y
I
i indicates the outcome of individual i who
decided to participate in the program, whereas YNi indicates the outcome of non-participation. Both
outcomes are potentially realisable, but only one of them is observable. The important concept
to mention here is the counterfactual outcome. If the individual i attends the program then Y Ii will
be realised and YNi will ex-post be a counterfactual outcome. On the other hand, if the individual
i does not attend the program, then YNi will be realised, and Y
I
i will ex-post be a counterfactual
outcome. The causal effect in this context is based on comparisons of outcomes that would result
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from exposure to alternative causal state. The unit level causal effect of the treatment is defined
as:
ai = Y Ii  YNi . (1.1)
The decision to participate to the program is described by causal exposure variable, Di, which is
a dummy variable. Di takes two values, respectively Di = 0 for members of the population who
are exposed to the control state or Di = 1 for members of the population who are exposed to the
treatment state. With respect to the exposure variable the realised outcome is defined as:
Yi = YNi +ai ·Di =
8<:YNi if Di = 0,Y Ii if Di = 1.
Advantages of the potential outcome setup
There are several main advantages of the potential outcome setup over a framework based directly
on realised outcome. First, it allows defining the causal effect before specifying the assignment
mechanism, and without considering probabilistic properties of the outcomes or assignment. Sec-
ond, it allows for heterogeneity in the effects of the treatment. Third, it allows formulating proba-
bilistic assumptions in terms of potentially observable variables, rather than in terms of unobserved
components. And finally, it clarifies where the uncertainty in the estimators comes from.
1.2.2 Estimands
Typically it is impossible to calculate individual causal effect, defined in equation (1.1), and we
usually estimate the aggregate causal effect. There are several estimands commonly used. The
first one is the population average treatment effect. And the population expectation of the unit-level
causal effect is:
E[ai] = E[Y Ii  YNi ]
= E[Y Ii ] E[YNi ],
where Y Ii and Y
N
i are individual level potential outcomes, that is the potential outcome random
variable for treated and control group.
Another estimand of the causal effect is the conditional average treatment effect. We define dif-
ferent conditional average treatment effects depending whether we are conditioning on the causal
exposure variable, D, or on the covariates9, C, or both of them. Here is the list of different esti-
mands:
9Covariates define the characteristics of the units.
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1. The conditional average treatment effect on the treated or the controlled is defined as:
E[t | D= 1] = E[Y Ii  YNi | Di = 1]
= E[Y Ii | Di = 1] E[YNi | Di = 1],
E[t | D= 0] = E[Y Ii  YNi | Di = 0]
= E[Y Ii | Di = 0] E[YNi | Di = 0].
2. The average causal effect conditional on the covariates in the sample is defined as:
E[t |C] = 1
n
n
Â
i=1
E
⇥
Y Ii  YNi |Ci
⇤
.
3. The average over the subsample of treated or control units are:
E[t | D= 1,C] = 1
nI Âi;Di=1
E
⇥
Y Ii  YNi |Ci
⇤
,
E[t | D= 0,C] = 1
nN Âi;Di=0
E
⇥
Y Ii  YNi |Ci
⇤
.
As above, this is simply the average across the treated or control units in the subsample.
The four kinds of estimands presented in this sections are similar if the treatment effect t is
constant. The disparity between them depends on the degree of heterogeneity in the effect of the
treatment. The big difference is not at the estimation stage, but there is an important divergence
between the population and conditional estimates at the inference stage. If there is heterogene-
ity in the treatment effect, that sample average treatment effect is usually more precise than the
population one.
Additionally to the previous estimands, there is another more general class of estimands, which
includes the average causal effects for sub-populations and weighted average. This estimand is
presented as:
E[t | A] = 1
nA Âi:Ci2A
E
⇥
Y Ii  YNi |Ci
⇤
,
where nA is the number of units which belong to a class with certain characteristics that is Ci 2 A.
This kind of estimator may be easier to estimate than the previous ones, and although it does not
have as much external validity as estimates for the overall population, they may be much more
informative for the sample at hand.
An other alternative class of estimands is the quantile treatment, which is fairly recent in eco-
nomic literature, and is defined as:
tq = F 1Y I (q) F 1YN (q).
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This estimand tq is the difference between quantiles of the two marginal potential outcome distri-
butions. Note that it differs from the following quantile of the unit level effect defined as:
t˜q = F 1Y I YN (q).
To finish this short presentation of the estimators, we conclude by the following statement from
Imbens and Wooldridge (2008, pp. 20): “Most estimators currently in use can be written as the
difference of a weighted average of the treated and control outcomes, with the weight in both
groups adding to one:
tˆ =
N
Â
i=1
wi ·Yi, with Â
i:Di=1
wi = 1, Â
i:Di=0
wi = 1,
where the wi is the weight depending on the full vector of assignments and matrix of covariates.”
1.2.3 Assumptions
In this section, we present the main assumptions used in the causal effect modelling, which are:
Stable Unit Treatment Value Assumption (SUTVA), ignorable treatment assignment, unconfound-
edness, overlap and strong ignorability assumption. Furthermore, we also introduce the concept of
confounding variable.
Stable unit treatment value assumption
The first assumption, resulting from Rubin’s model, concerns the problematic of interactions be-
tween the individuals. This assumption, widely used in the literature, is the stable unit treatment
value assumption, and has the following definition:
Assumption 1 (Stable unit treatment value assumption).
By SUTVA assumption we suppose that treatments received by one unit do not affect outcomes
for another unit. Only the level of the treatment applied to the specific individual is assumed to
potentially affect outcomes for that particular individual.
This assumption seems plausible in most of the cases. But in some situations where the interaction
exists10 and may be a serious problem, we could use the no-interaction assumption, or we firmly
model the interaction between the individuals.
10For example direct interaction between individuals or interaction via the market.
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Ignorable treatment assignment
The second assumption concerns the treatment assignment, which is different in the experimental
or observational context.
In randomised studies the assignment process is completely random and so the probability of
being assigned to the treatment is independent of the potential outcome, that is:
P[Di = di | YNi ,Y Ii ] = P[Di = di].
As defined in Rubin (1978), ignorability of treatment assignment holds when the potential outcomes
are independent of the causal exposure variable. For this case all variation in D is random, that is:
(YNi ,Y
I
i )? Di,
where ? is the independence symbol. In this case the expected potential outcomes for treated and
for control group are defined as follow:
E[Y Ii | Di = 1] = E[Y Ii | Di = 0] = E[Y Ii ],
E[YNi | Di = 1] = E[YNi | Di = 0] = E[YNi ].
On the other side, in observational studies, to keep the treatment assignment ignorable we
resort to the confounding variable defined as:
Definition 1.1 (Confounding variable).
We call “Confounding variable” all variables which denote individual characteristics and all vari-
ables that systematically determine all treatment assignment patterns and the potential outcomes.
And we designed by C a vector of so-called confounding variables.
These variables help us to build the groups of similar characteristics (e.g. region, industry, revenue).
Complete observation of C allows asserting that treatment assignment is “ignorable”, as we now
explain, and then consistently estimate the average treatment effect.
Assumption 2 (Ignorable treatment assignment (Unconfoundedness)).
The treatment assignment mechanism is ignorable when the potential outcomes, and any func-
tions of them, are independent of the treatment variables. Ignorable treatment assignment, also
known as unconfoundedness, selection on observables or conditional independence assumption,
is approved in randomised studies, and in observational studies depends on other variables. Un-
confoundedness assumes that beyond the observed covariates there are not (unobserved) char-
acteristics of the individual associated both with potential outcomes and treatment.
The definition of unconfoundedness is summarise by the following formula:
(YNi ,Y
I
i )? Di |Ci. (1.2)
In other words, it means that two individuals are identical if conditionally on C, the probability to
be assigned to the treatment program is independent of the potential outcome. In this case the
expected potential outcomes for treated and for control group are defined as follow:
E[Y Ii |Ci,Di = 1] = E[Y Ii |Ci,Di = 0] = E[Y Ii |Ci],
E[YNi |Ci,Di = 1] = E[YNi |Ci,Di = 0] = E[YNi |Ci].
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Strong ignorability
The unconfoundedness presented above, and the overlap, defined in the following definition, are
the key assumptions underlying an analysis based on unconfoundedness introduced by Rosen-
baum and Rubin (1983).
Assumption 3 (Overlap).
0< P(Di = 1 |Ci = c)< 1.
Overlap assumption implies that the support11 of the conditional distribution of Ci given Di = 1
overlaps completely with that of the conditional distribution of Ci given Di = 0 (see Imbens and
Wooldridge (2008, pp. 21)). In other words, each unit in the defined population has some chance
of being treated and some chance of not being treated.
In other words, it means that in the random experience each unit is assigned to the treatment with
a certain probability.
In a overlap assumption the probability:
e(c) = P(Di = 1 |Ci = c),
represents propensity score that is estimated with a random sample, (Di,Ci)Ni=1, and this provides
some guidance for determining whether the overlap assumption holds.
The combination of the two assumptions, unconfoundedness and overlap, gives us what is
known as strong ignorability (Rosenbaum and Rubin (1983)). And under the strong ignorability
assumption, we estimate the average treatment effect by:
t(x) = E
⇥
Y Ii |Ci = c
⇤ E ⇥YNi |Ci = c⇤
= E
⇥
Y Ii | Di = 1,Ci = c
⇤ E ⇥YNi | Di = 0,Ci = c⇤
= E [Yi | Di = 1,Ci = c] E [Yi | Di = 0,Ci = c] .
11Support of the function is the set of points where the function is not zero value.

Chapter 2
Synthetic control method
In the first chapter, we have introduced the problematic of treatment effect estimation in political
and economic sciences. In this chapter, we go further on this subject and present a relatively new
approach the so-called synthetic control method (SCM) that estimates the impact of interventions.
This method is an extension of the difference-in-differences approach (see annex A.1.1). The syn-
thetic control method was introduced in Abadie and Gardeazabal (2003) and knows an exponential
use since 2010 after the introduction of the second article on SCM (Abadie et al. (2010)).
The main idea behind this method is that a combination of units often provides a better compar-
ison for the unit exposed to the treatment than any single unit alone. SCM provides a systematic
way to estimate the counterfactual unit so-called synthetic control, that is, a convex combination
(weighted average) of available control units that most closely resemble the treated unit before the
treatment in terms of the potential outcome and other relative predictors. The synthetic control
allows us to identify the counterfactual outcome, which is then compared to the actual outcome to
evaluate the treatment effect. Moreover, the SCM makes explicit the relative contribution of each
available control unit and the degree of the similarity prior to the treatment between treated and
control. Thanks to these characteristics, we can run different inferential exercises.
In this chapter, we expose the synthetic control method, which is the main approach used
in our work in order to evaluate the treatment effect. The first section introduces the series of
main articles on the synthetic control method. The second section presents the methodology of
the synthetic control method. In this part, we introduce the basic notations and definitions, the
driving model and its application, the optimisation problem, and we finish with a short review of the
advantages and limitations of the SCM in comparison to the standard regression method. The final
section describes the statistical inferences’ tools as the placebo tests, and the root mean squared
prediction error or the robustness analysis.
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2.1 Synthetic control method in literature
The synthetic control method is a relatively new approach to evaluating the treatment effect in
comparative case studies and was introduced by Abadie and Gardeazabal (2003). In this first
article, the SCM is used to assess the economic effect of conflicts. A few years later, Abadie et al.
(2010) applied the SCM to study the effect of an anti-tobacco legislation and in Abadie et al. (2015)
to examine the economic consequence in case of political integration. Almer and Winkler (2013)
introduced the SCM to deal with the environmental problematic, where they evaluate the effect
of the commitment to the specific greenhouse gas targets under the Kyoto protocol on the CO2
emissions. In this section, we briefly present the evolution of the synthetic control method in the
literature. In particular, we focus on the three main articles written by Abadie et al. that introduce
the synthetic control method and develop the inference tools to evaluate the significance of the
results.
Abadie and Gardeazabal (2003)
The article “The economic costs of conflicts: A case study of Basque country” by Abadie and
Gardeazabal (2003) introduces the synthetic control method and the one-unit placebo test. The
article studies the economic impact of conflict, using the terrorist conflict in the Basque Country as
a study case.
To construct a “synthetic” control country without terrorism, the authors use the other Spanish
regions for which the relevant economic characteristics resemble to the ones of the Basque country
before the outset of Basque political terrorism in the late 60’s. The subsequent economic evolution,
measured by per capita Gross Domestic product (GDP), of this “counterfactual” Basque country
without terrorism is compared to the actual evolution of per capita GDP of the Basque country. The
post-treatment gap between the two outcome variables represents the effect of terrorist activities.
The gap shows negative effects of the terrorist activity on the economic evolution of the Basque
country.
In order to test the relationship between the gap and the terrorist activity Abadie and Gardeaza-
bal (2003) use single-unit placebo test (see section 2.3.1). In this test, the synthetic control method
is applied to one control unit from all possible controls that the most resemble the Basque country
before the terrorist activity. The evolution of the outcome variable of the “placebo-treated”, and
its synthetic control followed almost the same path, which proved the small effect of the terrorist
activity outside of Basque country.
Moreover, in order to check if the terrorism causes the GDP gap, Abadie and Gardeazabal
(2003) look at the relationship between the per capita GDP gap (synthetic versus actual treated)
and the intensity of the terrorism in the Basque country during the sample period. They use, what
they call, the “impulse-response function” to construct confidence intervals and they prove by this
test that the terrorist activity explains the GDP gap almost perfectly.
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Abadie et al. (2010)
The article “Synthetic control methods for comparative case studies: Estimating the effect of Cal-
ifornia’s tobacco control program” by Abadie et al. (2010) is the second paper from the series on
SCM. This article is built on the first article Abadie and Gardeazabal (2003) and examines the ad-
vantages of utilisation of SCM over traditional methods in comparative case studies. The authors
propose a simple econometric model that also points out the preferences over traditional panel
data or difference-in-differences estimators.
Moreover, they extend the single-unit placebo study (see Abadie and Gardeazabal (2003)) and
propose a new inferential method to demonstrate the significance of their estimates. They put for-
ward exact inferential techniques, so-called “in-space placebo” test (see section 2.3.1). The new
method provides the ability to perform valid inferences on the effect of treatment independently
from the number of available comparison units, the number of available time periods and whether
aggregate or individual data are used for the analysis. They conclude that the potential applica-
tion of SCM to comparative case studies is very large, especially in situations where traditional
regression methods are not appropriate.
The empirical part of this paper concerns the application of the SCM to study the effect of Cal-
ifornia’s Proposition 99, a large-scale tobacco control program implemented in California in 1988.
They used other states from the United States to construct the synthetic control unit. The results
show a very significant decrease in tobacco consumption following the passing of Proposition 99,
relative to a comparable synthetic control region. Besides, the estimates of Proposition 99 using
synthetic control approach are considerably larger than those obtained by Fichtenberg and Glantz
(2000) using linear regression method for the same study.
Abadie et al. (2015)
The article “Comparative politics and the synthetic control method” by Abadie et al. (2015) is the
last paper in the series on synthetic control methods. The authors use the two previous papers
on SCM1 to discuss how this approach can be applied to complement comparative case studies
in political science, as a way to bridge the qualitative and quantitative approaches to empirical
research.
In particular, they promote the “in-time placebo” test (see section 2.3.1) as an inference mean
in small-sample comparative studies. Beside the presentation of the placebo test, they implement
the use of the root mean squared prediction error (see section 2.3.2) to prove the significance of
the result. Finally, they also propose different sensitivity tests to show the robustness of the model
built using the synthetic control method.
As a case study, they use the economic impact of the 1990 German reunification on West
Germany. They use other OECD countries to produce the West Germany synthetic control. The
study finds the negative effect of the reunification on economic growth in West Germany.
1Abadie and Gardeazabal (2003); Abadie et al. (2010).
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Synthetic control method in others reviews
The first study using the synthetic control method was reported in 2003 (Abadie and Gardeazabal
(2003)), but it is only the second article in 2010 (Abadie et al. (2010)), that initiated large expansion
of its use. Since then, many studies employed SCM as a tool to evaluate the treatment effect. We
will not enumerate these studies, but see Craig (2015, pp. 6-8) who presents a short review of
synthetic control studies between 2003 to 2015.
2.2 Synthetic control methodology
In this section, we first introduce basics of the synthetic control method, as the notations, the driving
model and its implementation. We follow by presenting different techniques to choose the optimal
weights defining the synthetic control unit. And in the last part, we show few ways how to present
the results of the analysis before running statistical inferences that are presented in chapter 2.3.
2.2.1 Basics
In order to run synthetic control method we suppose to collect the data on J+ 1 units indexed
by j = 1, . . . ,J+ 1. The data forms a balanced panel sample S, that is, no missing observations
are present. Without loss of generality, we define that only the first unit j = 1 is exposed to the
treatment and is uninterruptedly exposed to the intervention of interest after some initial treatment
period. This unit is described as treated (I)2. The rest of the units are the J potential controls (N)3
that are not participating in the treatment and all of them constitute so-called “donor pool”4. Table
2.1 contains typical data set needed for the SCM analysis.
All the J+ 1 units are observed over T periods, indexed by t = 1, . . . ,T . The time period is
divided in two subsequent periods. We suppose a positive number of pre-treatment periods T0,
for t = 1, . . . ,T0, and a positive number of post-treatment periods T1, for t = T0 + 1, . . . ,T , with
T = T0+T1 and 1  T0 < T . This means that we do not have any interruption in observation and
that there is at least one pre-treatment and one post-treatment period.
As already presented in section 1.2.1, the variable Yjt is the potential outcome and measures
the impact of the treatment. YNjt is the outcome that would be observed for the unit j at time t in the
absence of the treatment. Y Ijt is the outcome that would be observed for unit j at time t if the unit is
exposed to the treatment in period T0+1 to T .
In addition to the outcome variable, we observe for each unit the confounding variables Cl ,
l = 1, . . . ,m. The (m⇥T ) matrix C j contains m confounding variablesCl . As we will see later in this
section, we use the confounding variables to build the vector of observed covariates Z.
2The index I as intervention.
3The index N as non-intervention.
4The term donor pool is borrowed from medical terminology where it does describe the potential donors of the organs.
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Unit Identificator Time Outcome Confounders
j NAME t Y C1 · · · Cm
1 Treated
1
...
T0
T0+1
...
T
9>>=>>;pre-treatment9>>=>>;post-treatment
Y11
...
Y1T0
Y1T0+1
...
Y1T
9>>>>>>>>>>>>=>>>>>>>>>>>>;
Y1
C111
...
C11T0
C11T0+1
...
C11T
· · ·
Cm11
...
Cm1T0
Cm1T0+1
...
Cm1T
2 Control 1
1
...
T
Y21
...
Y2T
9>>>=>>>;Y2
C121
...
C12T
· · ·
Cm21
...
Cm2T
...
...
...
...
...
...
...
J+1 Control J
1
...
T
YJ+11
...
YJ+1T
9>>>=>>>;YJ+1
C1J+11
...
C1J+1T
· · ·
CmJ+11
...
CmJ+1T
Source: Author’s elaboration.
Table 2.1: Data set
Assumptions
As most of the program evaluation methods, the SCM is not an exception and is based on a couple
of assumptions. The first assumption is defined as:
Assumption 4 (First SCM assumption).
We presume that the intervention does not have any effect on pre-treatment outcome and so
we have YNjt = Y
I
jt for all t 2 {1, . . . ,T0} and j 2 {1, . . . ,J+ 1}. Note that in practice the treatment
may have been anticipated and the impact on the outcome is visible before the selected treatment
period. In this case, we can eventually redefine T0 as the first period in which the outcome may
possible react to the treatment.
Furthermore, the second assumption on which is based the synthetic control method is defined
as:
Assumption 5 (Second SCM assumption).
We assume no interference between units (described in previous chapter by assumption 1 as
SUTVA). That is, we suppose that the control units’ outcomes are not affected by the treatment.
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Treatment effect
We define by a jt = Y Ijt  YNjt the effect of the treatment for unit j at time t. The treatment effect for
any unit and time period is represented by the figure 2.1. Moreover, let Djt be the causal exposure
variable described in section 1.2.1. We know that only the first unit is exposed to the treatment
after period T0, consequently, the causal exposure variable is redefined as:
Djt =
8<:1 if j = 1 and t > T0,0 otherwise. (2.1)
Therefore the observed outcome for unit j at time t is:
Yjt = YNjt +a jt ·Djt . (2.2)
As a result of equations (2.1) and (2.2), the treatment effect for unit j = 1 at time t > T0 is defined
as:
a1t = Y1t  YN1t . (2.3)
Note that only the YN1t is unobserved. The goal of the synthetic control method is to construct a
synthetic control group providing an estimate for this missing potential outcome.
Source: Author’s elaboration.
Figure 2.1: Treatment effect
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Driving model
Synthetic control approach belongs to the class of difference-in-differences methods (for more
details on the method see annexe A.1.1). It is a generalised DID (fixed-effect) model that allows
the effect of confounding unobserved characteristics to vary over time. In order to estimate the
potential outcome of non-treated unit, YNjt , based on a specific factor model
5, Abadie et al. (2010)
propose to use the weighted value of the outcome variable for each control from the donor pool
that is:
J+1
Â
j=2
wjYjt ,
where wj is a value of the (J⇥1) vector of weightsW= (w2, . . . ,wJ+1)0 , s.t wj   0 and ÂJ+1j=2wj = 1.
Each scalar wj represents the weight of unit j in the synthetic control. Each particular vector W
generates one particular weighted average of control units, therefore one potential synthetic control.
Ideally, we would like to choose among the set of all possibleW a vectorW⇤ = (w⇤2, . . . ,w⇤J+1)0 such
that:
J+1
Â
j=2
w⇤jYjt = Y1t and
J+1
Â
j=2
w⇤jZ j = Z1, 8t  T0. (2.4)
Note that these conditions have to be true for all t  T0, i.e. for all t in pre-treatment period.
Moreover, if we ignore, for this moment, the mathematical optimisation procedure described in
section 2.2.2, we can imagine the synthetic control matching procedure as a black box, and the
results of it should be the set of weights W⇤. We represent the matching procedure graphically
by figure 2.2. During the pre-treatment period, the treated unit j = 1 is looking for the units in the
donor pool that has similar characteristics. The results of the matching are the combination of the
control units that the most resembles the treated unit before the treatment. For more details about
the matching see annexe A.1.1.
If we suppose that there is such W⇤ satisfying equations in (2.4), then under condition of no
extrapolation outside the convex hull of the data6, Abadie et al. (2010) suggest an estimator of
treatment effect (see equation (2.3)), defined as:
aˆ1t = Y1t  
J+1
Â
j=2
w⇤jYjt , 8t > T0. (2.5)
Note that equations in (2.4) hold exactly if (Z01,Y11, . . . ,Y1T0) belongs to convex hull of {(Z02,Y21, . . . ,
Y2T0), . . . ,(Z0J+1,YJ+11, . . . ,YJ+1T0)}. In practice, these equalities often do not hold, hence we have
to make sure that the synthetic control is selected such that the equations in (2.4) hold approxima-
tively7.
5For more explanation see Abadie et al. (2010, pp. 496).
6For the proof see Abadie et al. (2010, p. 504).
7In addition, if our treated unit is an outlier (extreme value), the (Z01,Y11, . . . ,Y1T0) is to far of the convex hull of
{(Z02,Y21, . . . ,Y2T0), . . . , (Z0J+1,YJ+11, . . . ,YJ+1T0)} so in this case the synthetic control would not provide a good matching.
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Source: Author’s elaboration.
Figure 2.2: Synthetic control matching
Abadie et al. (2010) argue that synthetic control can provide useful estimates also in more
general context, for example, in the case of the autoregressive model with time-varying coefficients:
YNjt+1 = atYNjt +b t+1Z jt+1+u jt+1,
Z jt+1 = gtYNjt +PtZ jt +n jt+1,
where u jt+1 and n jt+1 have mean zero conditional onFt =
 
Yjs,Z js
 
1 jJ+1,st . If we suppose that
we can choose {w⇤j}2 jJ+1 such that ÂJ+1j=2w⇤jYjT0 =Y1T0 and ÂJ+1j=2w⇤jZ jT0 = Z1T0 , then we can prove
that the synthetic control estimator is unbiased even if only one pre-treatment period is available8.
Implementation of the driving model
Ideally, we would like to construct a synthetic control that most closely resembles the treated unit
in all relevant pre-treatment characteristics. To do so, Abadie and Gardeazabal (2003) propose to
make use of the observed characteristics of the units from the donor pool. They also propose to
weight the pre-treatment outcomes and form linear combinations of these outcomes to control for
unobserved common factors whose effects vary over time. Abadie and Gardeazabal (2003), and
Abadie et al. (2010) argue that if the pre-treatment period is large, then matching on pre-treatment
outcomes helps control for unobserved factor and the heterogeneity of the effect of the observed
and unobserved factors on the outcome of interest. Moreover, they specify that only units that are
alike in both observed and unobserved determinants of the outcome variables as well as in the
8For the proof see Abadie et al. (2010, p. 504).
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effect of those determinants on the outcome variables should produce similar trajectories of the
outcome variable over an extended period.
In order to construct the synthetic control, we define the variables described in following para-
graphs. Let Z j = (ZL1j , . . . ,Z
Li
j , . . . ,Z
Lr
j )
0
be a vector of predictors of the outcome variables that are
not affected by the treatment. To be more specific, let C j be (m⇥T )matrix containing observations
of confounding variables Cl , l = 1, . . . ,m, for T periods. Each ZLij is a linear combination of some
confounding variable Cl9.
We also define K = (k1, . . . ,kT0)0, a (T0⇥ 1) vector that denotes some linear combination of
pre-treatment outcomes, YKj = Â
T0
s=1 ksYjs
10. We consider till maximum M  T0 of such linear com-
binations defined by the vectors K1, . . . ,KM11.
In addition, let X1 = (Z01,Y
K1
1 , . . . ,Y
KM
1 )
0 be a vector of pre-treatment characteristics for the unaf-
fected unit, with k= r+M column. And X0, (k⇥J) matrix of pre-treatment values predictors for the
J control units with j-th column equals to (Z0j,Y
K1
j , . . . ,Y
KM
j )
0. The values of the predictor variables
reflect the heterogeneity between the units. The vector X1 and the matrix X0 are presented as
follow:
X1 =
26666666666664
ZL11
...
ZLr1
YK11
...
YKM1
37777777777775
; X0 =
26666666666664
ZL12 · · · ZL1j · · · ZL1J+1
... · · · ... · · · ...
ZLr2 · · · ZLrj · · · ZLrJ+1
YK12 · · · YK1j · · · YK1J+1
... · · · ... · · · ...
YKM2 · · · YKMj · · · YKMJ+1
37777777777775
. (2.6)
Note that the choice of the predictor variables in X is very important. The values of the predictor
variables reflect the heterogeneity between the units. We should make sure that we chose the
variables that have a good predictive power of the potential outcome variable, but that they are
not affected by the treatment. Moreover, it is crucial that synthetic control closely reproduces the
values of the variables with a large predictive power on the outcome of interest.
Final step before the estimation process is to define a (J⇥1) vector of weightsW=(w2, . . . ,wJ+1)0
such that 0 wj  1, for j = 2, . . . ,J+1, and ÂJ+1j=2wj = 1.
9We define L = (l1, . . . , lT0)0,a (T0 ⇥ 1) vector that denotes some linear combination of pre-treatment confounding
covariates, ZLj = Â
T0
s=1 lsCjs. Natural choice is to take average of all pre-treatment observations, but other choices are
also possible.
10Abadie et al. (2010) propose different possibilities to choose YKj . First choice is to take the value of the outcome
variable in the period immediately prior to the treatment, that is k1 = k2 = . . .= kT0 1 = 0, kT0 = 1 and YKj =YjT0 . Second
option is to take simple average of the outcome variable for the pre-treatment periods, that is k1 = k2 = . . .= kT0 = 1/T0
and YKj = T
 1
0 Â
T0
s=1Yjs.
11One intuitive choice for M linear combinations of pre-treatment outcomes is to take all available pre-treatment peri-
ods, that is YK1j = Yj1, . . . ,Y
KM
j = YjT0 . In practice we consider only few linear combinations of pre-treatment outcomes
and check whether equation (2.4) holds approximatively.
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Source: Author’s elaboration.
Figure 2.3: Treatment effect estimation
The estimate of the treatment effect, aˆit , was defined in equation (2.5), where ÂJ+1j=2w⇤jY jt esti-
mates the unobserved counterfactual outcome YN1t . The treatment effect estimation is represented
by figure 2.3. In order to find the estimate of YN1t , we choose a vectorW⇤ = (w⇤2, . . . ,w⇤J+1)0 such that
the resulting synthetic control best approximates the unit exposed to the intervention with respect
to the outcome predictors Z and M linear combinations of pre-treatment outcome YK1j , . . . ,Y
KM
j . In
other words, we seekW⇤ that satisfy the following equations:
J+1
Â
j=2
w⇤jY
K
j = Y
K
1 and
J+1
Â
j=2
w⇤jZ j = Z1. (2.7)
In general, we cannot findW⇤ such that the equations in (2.7) hold exactly. Thus, we try to make
the difference between the characteristics of the treated unit and its synthetic control as small as
possible. Note that this difference is given by X1 X0W. Following Abadie et al. (2010) we select
the synthetic control,W⇤, that minimise the distance:
kX1 X0WkV =
p
(X1 X0W)0V(X1 X0W), (2.8)
subject to 0  wj  1, j = 2, . . . ,J+ 1 and ÂJ+1j=2wj = 1, where V is some (k⇥ k) symmetric and
positive semidefinite matrix (other choices are also possible). The diagonal elements in V are
weights which reflect the relative importance of the variables in X0 and X1.
A couple of remarks has to be done. The first one is that even though the synthetic control is
defined as convex combinations of control units, negative weight or weights larger than one can
be used at the cost of allowing extrapolation. The second one concerns a penalty terms included
in the estimation to reduce the interpolation bias. On that problematic Abadie et al. (2010, p. 496)
specify: “If the relationship between the outcome variable and the explanatory variables in X1 and
X0 is highly nonlinear and the support of the explanatory variables is large, interpolation bias may
be severe. In that case, W⇤ can be chosen to minimise the distance kX1 X0Wk plus a set of
2.2. Synthetic control methodology 29
penalty terms specified as increasing function of the distance between X1 and the corresponding
value for the units with positive weights in W. Alternatively, interpolation bias can be reduced by
restricting the comparison group to units that are similar to the exposed units in term of the values
of X1.” Though, it is recommended to restrict the donor pool to units with outcomes that are thought
to be driven by the same structural process as the treated unit.
Note that the weight for the synthetic control W⇤ is a function of V. Hence the optimal choice
ofW is dependent on the weighting matrix V. Abadie and Gardeazabal (2003), and Abadie et al.
(2010) propose different option of choosing V, described in the following section 2.2.2.
2.2.2 Optimal choice of V
The matrix V is introduced to the model in order to allow different weights to the variables in X0 and
X1 depending on their predictive power on the outcome. There are different possibilities of choosing
V. The first one is base on subjective assessments of the predictive power of the variables in X.
More the variable has the influence on the path of the outcome variable, bigger is its weight in the
matrix. The second one is data-driven procedure12. In this method, we choose V such that the
difference of pre-treatment outcome of the treated unit and its synthetic counterpart is minimised.
The last method is cross-validation. This method is based on the data-driven procedure but uses
two pre-treatment periods to find V. The data-driven and cross-validation procedures are explained
in the following sections.
Data-driven procedure
The choice of V = diag(v1, . . . ,vk) influences the mean squared error of the synthetic control esti-
mator. Abadie and Gardeazabal (2003), and Abadie et al. (2010) argue that the optimal choice of V
assigns weights that minimise the mean squared error of the estimator. In other words, we choose
V⇤ among all positive definite and diagonal matrices such that the mean squared prediction error of
the outcome variable is minimised over some set of pre-treatment periods, Tp13 with (1 Tp  T0).
The minimisation problem translates to the following equation:
arg min
V2V(U1 U0W
⇤(V))0(U1 U0W⇤(V)), (2.9)
where U1 is a (Tp⇥ 1) vector containing values of Y1 for some set of pre-treatment periods, U0
is a (Tp⇥ J) matrix with values of Y0 for some set of pre-treatment periods, V is the set of all
nonnegative diagonal (k⇥ k) matrices and W⇤ =W⇤(V) are weights for some possible synthetic
control. The objective is to findW⇤ =W⇤(V⇤), that is the optimal weights for the synthetic control,
that we can obtain by classical nested optimisation problem14 where we minimise equation (2.9),
12The three articles, Abadie and Gardeazabal (2003); Abadie et al. (2010, 2015), defend the use of the data-driven
procedure to produce the comparison unit.
13Natural choice is Tp = T0, so the V⇤ minimises the mean squared prediction error over the entire pre-treatment
period. Often it is sufficient to chose Tp < T0 to achieve a low MSPE over the entire pre-treatment period.
14Nested optimisation is special kind of optimisation when one problem is embedded (nested) within another.
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forW⇤ resulting from the minimal distance given in equation (2.8). Moreover, note that Abadie and
Gardeazabal (2003) recommend to normalise the Euclidean norm of V⇤ (i.e. diag(V⇤) to one, as
there are infinitely many equivalent solutions for V⇤.
Alternatively to this nested optimisation, the synthetic control could take into consideration only
the pre-treatment outcome, and so we try to findW⇤ such that:
arg min
W2W(U1 U0W
⇤)0(U1 U0W⇤), (2.10)
whereW= {(w1, . . . ,wJ)0 subject to 0 wj  1, j = 2, . . . ,J+1 and ÂJ+1j=2wj = 1}.
It is often the case that the synthetic control derived by equation (2.10) produces larger treat-
ment effect than the one taking into account also the potential outcome predictors (the first optimi-
sation problem). This alternative optimisation does not take into account different characteristics
of each unit. Thus the respective synthetic control may not be fully representative of the treated
unit. Consequently, if we possessed data containing predictors with good predictive power, the first
optimisation that we presented in this section would be a preferable option in order to find optimal
weights.
Cross-validation method
If the number of available pre-treatment periods in the sample is large enough, we may use the
cross-validation method to find the matrix V. In this approach we divide the pre-treatment period
into an initial training periods, TP1 , and a subsequent validation period, TV , with 1 TP1 < TV  T0.
Given a V, we compute W⇤(V) using data from the training period. Then, the matrix V can
be chosen to minimise the mean squared prediction error ofW⇤(V) from the validation period. In
certain way, the cross-validation method is an alternative application of data-driven procedure. In
other words, we minimise equation (2.9) over the validation period, TV , forW⇤(V) given in equation
(2.8) minimised over the training period, TP1 .
Note that, this method requires a substantial number of pre-treatment periods. Abadie et al.
(2015) do not recommend using this method when the pre-treatment fit is poor (see section 2.3.2)
or the number of pre-treatment periods is small.
2.2.3 How to present some analysis’ results
The results of the synthetic control analysis can be presented as tables (see tables 2.2-2.5) or
graphs (see figure 2.4). Note that in this section we present only a generic pattern of results for the
treated unit. The inference tests are presented in the following chapter 2.3.
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Quantitative results
The first aspect of the analysis we might want to check is the relative contribution of each control
unit to the synthetic control. The table 2.2 shows the values of the optimal weight for the synthetic
control. The control unit j from the donor pool is weighted by the weight w⇤j . Remind that all the
weights should be positive, and the sum of the weights is equal to one. Bigger is the w⇤j , more
important is the respective control unit in the synthetic control.
Another element to examine could be the relative contribution of each predictor to the synthetic
control. Table 2.3 presents the weights vi reflecting the relative importance of the variables in X0
and X1. We apply the same condition as for the control units of no extrapolation outside of the
convex hull, that is 0  vi  1, i = 1, . . . ,k and Âki=1 vi = 1. At the optimum, we note vi by v⇤i . As
previously, the bigger is the v⇤i , the more influence has the respective predictor. Note that it could
be that some predictors have very small contribution in the synthetic control. There are three
reasons for that. It is either because the treated and control units are very similar with respect
to the specific characteristic. The second reason could be that the treated unit outperforms the
control units regarding the relative predictor15. And the last reason is that other predictors have
simply much bigger predictive power than the one with a small contribution. Closer analysis of the
respective weights is always very important.
Third table 2.4 shows the treatment effects aˆ1t defined in equation (2.5). Note that in this table
the treatment effect is defined for all periods and not only for the post-treatment period as defined
in the equation (2.5). The treatment effects between the treated and its synthetic control should be
close to zero during the pre-treatment period, that is, there is no difference between the treated unit
and its synthetic control. On the other side, if we expect a positive or negative treatment effect, the
treatment effect should be different from zero in the post-treatment period. The size of the effect is
very arbitrary and depends on each case individually. Alternatively, we might want to calculate the
average treatment effect for a set of periods by:
ˆ¯a = 1
nt
t2
Â
t=t1
aˆ1t , (2.11)
where t1 and t2 are the periods for which we want to calculate the average treatment effect, and
nt is the number of the respective periods. Eventually, we can also associate different weights to
each period if we judge that distinct years do have non-identical importance in the estimation (e.g.,
first years of the program might have more importance for the treatment effect that the last years).
Similar to the matching estimators, the synthetic control method demonstrates the affinity be-
tween the treated unit and its synthetic counterpart. These affinities are shown in table 2.5. The
second column represents the value of the predictor for the treated units, respectively the values
of YK1 and Z1 from equations (2.7). The third column of the table presents values of the synthetic
control unit predictors, that is the values of X0W⇤ (respectively ÂJ+1j=2w⇤jYKj and Â
J+1
j=2w
⇤
jZ j). By
comparing these two columns, we check how well the weighted combination of the control units
reproduces the values of outcome predictors before the treatment. In other words, we verify the
15For example, one company that participates in the certain program has extremely big revenue with respect to the
other companies, which do not participate to the program.
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equality of the equations in (2.7). Additionally, we can also compare the results to the last column of
the table which contains the values of the sample means for the predictors, respectively 1J Â
J+1
j=2Z j
and 1J Â
J+1
j=2Y
K
j . The comparison of all columns would give an idea how well the synthetic control
outperforms the averages, as we have seen in the first chapter that the simple comparison of the
expected values is a common way to set and evaluate the treatment effect.
Table 2.2: Control units’ weights
Unit name w weight
Control 1 w⇤2
...
...
Control i w⇤i
...
...
Control J w⇤J+1
Table 2.3: Predictors’ weights
Predictor v weight
Z1 v⇤1
...
...
Zr v⇤r
9>>=>>;predictors
YK1 v⇤r+1
...
...
YKM v⇤k
9>>=>>;special predictors
Table 2.4: Treatment effects
Period Gaps
1 g11
...
...
T0 g1T0
9>>=>>;pre-treatment
T0+1 g1T0+1
...
...
T g1T
9>>=>>;post-treatment
Table 2.5: Predictors
Predictor Treated Synthetic Mean
Z1 Z11 Z
1⇤ Z¯1
...
...
...
...
Zr Zr1 Z
r⇤ Z¯r
YK1 YK11 Y
K1⇤ Y¯K1
...
...
...
...
YKr YKr1 Y
Kr⇤ Y¯Kr
Source: Author’s elaboration.
Table 2.6: Different synthetic control method results representations
Graphics
Note that the treatment effect can also be represented by the path plot or gaps plot (e.g., figure
2.4). The path plot, which is always the first plot in each quadrant, shows the values of the outcome
variable for the treated unit Y1t , represented by a black line and its synthetic control, ÂJ+1j=2w⇤jYjt
represented by the dotted line. Gaps plot, the second graph in each quadrant, shows the values of
the treatment effect reported from table 2.4. The horizontal dotted line in the gaps plot represent
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the zero treatment effect, and the vertical dotted line on both path’ and gaps plots, represents
the period when the treatment started. Figure 2.4 represents four different possible results of the
analysis. In the following paragraphs, we have a closer look on each of the four figures.
The path and gaps plots on the figure 2.4a and 2.4b show treatment effect with negative values
and treatment effect with positive values respectively. Before the treatment, during all pre-treatment
period, there is the almost parallel evolution of treated unit and its synthetic control on the path plot.
On the gaps plot, this is represented by the gaps line being as close as possible to the zero gap line.
After the treatment, the both path plots show the deviation between the treated unit and its synthetic
control. The figure 2.4a shows negative values of the treatment effect, so that the synthetic control
lays above the treated unit on the path plot which is represented by a negative gap on the gaps plot.
The opposite is true for the figure representing the positive values of the treatment effect. Note that
positive values might mean a negative treatment effect and vice-versa (e.g. the increasing cost of
goods sold after the introduction of cost reducing politics could be perceived as negative treatment
effect or respectively no-effect).
The path and gaps plot on the figure 2.4c shows a good match between the treated and control
units during the pre-treatment period, which is a needed result after running the SCM. We explained
the notion of a good match in the previous paragraph. The almost parallel evolution between
the treated and synthetic control after the treatment (respectively no gap on the gaps plot), is
representative for no treatment effect.
An example of a bad match between the treated unit and its synthetic control is shown on the
path and gaps plot on the figure 2.4d. This is represented by no parallel path of the treated unit
and its synthetic control on the path plot and unevenly distributed gaps around the zero gap line
on the gaps plot. If there is no good match in the pre-treatment period, it is very likely that the no
match continues in the post-treatment period too, as we represented it on the figures. In this case,
the synthetic control does not provide good tools to find the treatment effect and the treated unit
should not have to be considered in the analysis.
The figure 2.5 summarises the previous results of all graphs from the figure 2.4 with respect to
the treatment effect and its graphical representation on the path plot. The green line that contours
the zero gap line during the pre-treatment period signalise a good match between the treated unit
and its synthetic control. On the other side, the red line in the pre-treatment period shows no match
between the treatment and synthetic control. If we check the post-treatment period, the green
line that goes up shows positive values treatment effect and the decreasing green line represents
negative values treatment effect. The red line that contour the zero treatment effect line is this time
signalling no treatment effect, as the gap between the treated and synthetic control unit is almost
zero.
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Source: Author’s elaboration.
Figure 2.4: Different examples of path and gaps plots
2.2. Synthetic control methodology 35
Source: Author’s elaboration.
Figure 2.5: Gaps graph
2.2.4 Advantages and limitations of the synthetic control method
The SCMmodel has several advantages over the traditional regression and difference-in-differences
methods. They are reviewed in Abadie et al. (2010). In this model we can minimise the biases
caused by interpolating across units with very different characteristics by restricting the sample of
units with (Y¯ Kj ,Z j) sufficiently close to (Y¯ K1 ,Z1) under some distance metric. That is, the control
units we choose to put in a donor pool should be relatively similar to the treated unit. Inter alia, in
contrast with the traditional DID this model allows the effect of confounding unobserved character-
istics to vary over time. We should also add the transparency and safeguard against extrapolation.
That is, we can see the relative contribution of each control unit to the synthetic control and the
similarities between synthetic control and treated units in term of predictors and outcome. In addi-
tion, because the choice of synthetic control does not require access to post-treatment outcomes,
the SCM allows deciding on study design without knowing how those decisions will affect the con-
clusions of their studies. In addition the SCM deals with the Omitted Variable Bias (OVB)16 and the
so-called “bad control”17.
16See definition A.1.
17Angrist and Pischke (2008, pp. 47-51) elaborate the notion of bad control: “Some variables are bad controls and
should not be included in a regression model even when their inclusion might be expected to change the short regression
coefficients. Bad controls are variables that are themselves outcome variables in the national experiment at hand. That
is, bad controls might just as well be dependent variables too.”
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A couple of limitations have to be mentioned. Abadie et al. (2015) argue different limits of the
SCM. First, the credibility of the synthetic control depends upon how well it tracks the treated unit’s
characteristics and outcomes over an extended period of time prior to the treatment. They point
out that as long as the synthetic control cannot reproduce exactly the characteristics of the treated
unit before the treatment, the gap may have been created by differences in predictors between the
treated unit and its synthetic control before the treatment, or by other differences not reflected by
the data. Second, a substantial number of post-treatment periods may also be required in case
when the effect of the intervention emerge gradually after the intervention or changes over time.
2.3 Statistical inferences
The use of statistical inference in comparative case studies is difficult because of the small sam-
ple nature of the data, the absence of randomisation or lack of a probabilistic sampling to select
sample units. These limitations complicate the application of traditional approaches to statistical
inference18. In addition, Abadie et al. (2010, pp. 496-497) say about the uncertainty in the com-
parative case studies: “The standard error commonly used in regression-based comparative case
studies measures uncertainty about aggregate data. However, perfect knowledge of aggregate
data does not eliminate all uncertainty about the parameters of interest. In comparative case stud-
ies, an additional source of uncertainty derives from ignorance about the ability of the control group
to reproduce the counterfactual of how the treated unit would have evolved in the absence of the
treatment. This type of uncertainty is present regardless of whether aggregate data are used for
estimation or not. The use of the individual data only increases the amount of uncertainty.”
Synthetic control method provides a way for an alternative mode of qualitative and quantitative
inference. The synthetic control method systemises the process of estimating the counterfactuals
and enables us not only to conduct falsification exercises, so-called “placebo studies”, but also
measure and test the misspecification of the model by the use of the root mean squared prediction
error (Root Mean Squared Prediction Error (RMSPE)). Moreover, we can also carry out sensitivity
analyses and robustness tests to amplify the veracity of our results. The use of the tests depends
on the context, the number of the control units and the size of the observation period.
What do we test? The main question is about the gap between the observed outcome of the
treated unit and estimated outcome of its synthetic control. We need to explain whether the gap
accounts for the treatment, or is produced by different factors other than the treatment. Other im-
portant questions may arise during the analysis. For example, we may want to test the predictive
power of the covariates on the outcome path. Besides, we may be interested in the matching good-
ness between treated unit and its synthetic control. Or we may be concerned by the robustness of
our model to the number of units or variables. Next three sections describe different possibilities of
running inferences in the synthetic control context. We explain the implementation of placebo tests,
the use of the root mean squared prediction error, and introduce some possible robustness tests.
18Rubin (1990b) describes different modes of inferential statistics for causal effect.
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2.3.1 Placebo tests
As already mentioned, the synthetic control method systematises the process of estimating the
counterfactuals and enables to conduct placebo studies. Same as the term “donor pool”, the des-
ignation “placebo” study comes from the medical terminology describing: “a beneficial effect pro-
duced by a placebo drug or treatment, which cannot be attributed to the properties of the placebo
itself, and must therefore be due to the patient’s belief in that treatment [Oxford Dictionaries].” In our
case, the main idea of placebo studies is to predict the counterfactual outcome path for the units in
the donor pool. That is, the units that did not receive the treatment and should not be affected by
it, as described by the second SCM assumption (assumption 5).
This alternative model of inference is supported by the confidence that we have in the treatment
effect produced by the synthetic control estimate. We assume that the treatment effect estimated for
the unit that did or do participate in the program reflects the impact of the intervention. Replication
of synthetic control analysis for the units that are not part of the program should not generate a
significant divergence between synthetic and actual outcomes. This means that for the control
units we should not obtain estimated effects of similar or even greater magnitude compared to the
cases for which the treatment did take place. In this section, we present different variations of
placebo tests, namely single-unit placebo, in-time placebo and in-space placebo tests.
An important remark regarding the placebo test methods is that they do not produce confidence
intervals or posterior distributions, and the inferential exercise, including associated p-values, are
restricted to the question of whether or not the estimated effect of the actual treatment is large
relative to the distribution of placebo effects. Note also, that we can apply an exclusion rule to
select the number of the units included in the calculation of the p-value. This rule is based on the
root mean squared prediction error and is explained in the section 2.3.2.
Single-unit placebo
The first kind of placebo test is the so-called “single-unit placebo”, where we apply the synthetic
control method to one particular control unit from the donor pool. It is particularly helpful if there
is only one or two control units that have a major contribution in the synthetic control. The test is
based on the following recommendation:
Recommendation 1.
In the single-unit placebo test, if the “placebo-treated” unit (control unit being analysed as if it
would have received the treatment) shows similar or even larger treatment effect than the “actual
treated” unit (true treated unit), one has to reconsider the veracity of our results.
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Significant evidence and interpretation
This test is purely visual, and we cannot calculate the p-value as for the in-space placebo one.
In order to validate the significant treatment effect of the treated unit, we would like to observe: 1)
similar plots to ones represented by figure 2.4a or 2.4b for the treated unit – perfect match before
the treatment and positive or negative treatment effect; 2) similar plots to ones represented by
figure 2.4c for the placebo-treated – perfect match before the treatment and no effect observed
after the treatment (note that the synthetic control on the path plot 2.4c represents the placebo-
treated unit). If the single unit placebo test create gaps of a magnitude similar to the one estimated
for the treated, then the analysis does not provide significant evidence of a treatment effect for the
treated unit.
This test can also catch an eventual “artificial” amplification of the treatment effect. That is,
the placebo-treated shows an unusual deviation during a particular period. A good example is in
Abadie and Gardeazabal (2003), where there was an increase in GDP during the Olympic games
in Spain in 1992, and this external shock is not related to the treatment. Though, if we detect
an unexpected behaviour of the outcome path, we need to do the qualitative research in order to
explain this deviation.
The single-unit test can also apprehend the spillover effect (Abadie et al. (2015, p. 504)), that
is the contamination of the donor pool by the treatment. This means that the SUTVA assumption is
violated and that the treatment has an effect on other units than the treated. Notice that the limited
number of units in the synthetic control allows the evaluation of the existence and direction of
potential biases created by spillover effects. Though, if we suspect a potential interaction between
the units, we should make a closer analyse and eventually reconsider the donor pool or introduce
a punishment weight into theW⇤ matrix for the suspected units.
Note that Abadie and Gardeazabal (2003) recommend to keep out the actual treatment unit
from the “placebo” donor pool. This recommendation is especially valid if we know that the treated
and placebo treated units are similar in observed and latent predictor and characteristics.
In-time placebo
In the case of the number of available comparison units is very small, and the pre-treatment time
period is relatively long, covering at least several years, we can use the longitudinal dimension of
the data to produce placebo studies. Abadie et al. (2015) present and apply so-called “in-time
placebo test”. The test is based on the following recommendation:
Recommendation 2.
The validity of the result would be dissipated if the synthetic control method also estimates large
effects when applied to periods when the treatment did not take place.
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Note that this recommendation is based on the first SCM assumption (assumption 4). To build
the test, we process as follows. We select a random period in the pre-treatment period, Tˆ0+1, and
suppose that the treatment started at Tˆ0 instead of the real first treatment period T0+ 1. Then we
analyse if there was or not a treatment effect for the date where the treatment did not take place.
In this way, the in-time placebo is similar to the single-unit placebo, with the difference that we use
the “placebo date” instead of “placebo-treated” unit. The test has a similar interpretation.
Significant evidence and interpretation
In order to validate the significant treatment effect of the treated unit, we would like to observe
similar plots to the ones represented by figure 2.4a or 2.4b for the treated unit when the true post-
treatment period is applied, and the plots on the figure 2.4c for the treated unit when the random
pre-treatment period is selected as the first treatment period (note that the treatment vertical line
on the graph 2.4c represents the beginning of the “placebo treatment” Tˆ0+1). If the in-time placebo
test creates gaps of the magnitude similar to the one estimated for the treated unit when applied to
the right dates, then the analysis does not provide significant evidence of a treatment effect for the
treated unit.
In-space placebo
The third and very powerful test was proposed by Abadie et al. (2010) and is so-called “in-space
placebo”. The idea of this test is related to the permutation inference (see Rosenbaum (1995,
2002)), where the distribution of a test is computed under random permutation of the sample units’
assignments to the treatment and control groups. Contrary to the single-unit placebo we apply the
synthetic control method to every potential control in the sample, and we include the treated unit in
the donor pool too.
In practice, we iteratively apply the synthetic control method used to estimate the treatment
effect to every control unit in the donor pool. The placebo permutation procedure is described by
the figure 2.6. In each iteration, we reassign the treatment to one of the control units shifting treated
unit to the donor pool. That is, we proceed as if one of the controls in the donor pool would have
received a treatment in time T0+1, instead of the treated unit. Each iteration would produce the set
of weights for the respective synthetic control. We then compute the estimated effect associated
with each placebo run. This iterative procedure provides us with a distribution of estimated gaps
for the units where no treatment tooks place. This allows to assess whether the effect estimated
by the synthetic control for the treated unit is large relative to the effect estimated for a randomly
chosen control units.
Note that, regardless of a number of available control units, time periods, and use of individual
or aggregated data it is always possible to calculate the empirical distribution of the estimated
effect of the placebo treatment. The test gives us an informative inference under the following
recommendation:
Recommendation 3.
The recommendation for the in-space placebo test is based on hypothesis of no treatment, that
is, the estimated effect of the treatment is not expected to be abnormal relative to the distribution
of the placebo effects, and vice versa.
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Few examples of the “placebo effect graphs” that report the values of treatment effect for the
treated unit (black line) and the “placebo-treated” units (grey line) are presented in the figure 2.7.
(a) Significant treatment effect with negative values (b) Significant treatment effect with positive values
(c) No-significant treatment effect
Source: Author’s elaboration.
Figure 2.7: Different examples of placebo effect plots
Significant evidence and interpretation
If the placebo studies show that the gap estimated for the treated unit is large relative to the gaps
for most of the control units that did not participate in the treatment program, then the interpretation
is that the analysis provides significant evidence of a treatment effect on the treated unit. The
figures 2.7a and 2.7b show the treated units with significant treatment effect. Note that in these two
cases we imperatively suppose that the treatment effect on the first graph should be of relatively
large negative value and relatively large positive value for the second placebo effect graph. If this
is not the case, then both figures might show no-significant treatment effect as all placebo-treated
units would show larger treatment effect compare to the treated unit itself.
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If, on the other hand, the placebo studies create gaps of the magnitude similar to the one
estimated for the treated unit, then the interpretation is that the analysis does not provide significant
evidence of a treatment effect for a treated unit. This case is represented by figure 2.7c, where the
treated unit, even though it does show treatment effect with negative values, lays in the middle of
the placebo-treated units, and so other “placebo-treated” units have created larger treatment effect
and our estimation for the treated unit is not validated.
Moreover, the placebo effect graphs provide us a tool to calculate a specific p-value, described
in the following definition:
Definition 2.1 (Pseudo p-value).
The pseudo p-value assesses the estimation of the treatment effect by comparing the distri-
bution of placebo effects and the estimated treated unit effect. We assume for each placebo unit
one of the two possibilities: “bad estimation”, which gives similar or larger treatment effect for the
control than the treated unit, or “good estimation”, which means missing or small treatment effect
for the control. The p-value is constructed as the fraction of a number of bad estimations over a
total number of units used in a test sample, given by following formula:
Pseudo p-value=
Number of bad estimations
Number of test units
. (2.12)
We interpret the p-value as the probability of obtaining an estimate at least as large as the one
obtained by the unit of interest when the treatment is reassigned at random in the data set.
If the value of the pseudo p-value is close to zero, there is a small chance to get such a good
estimate as the one obtained by the treated unit, and so we can validate the significant effect of the
treatment on the unit of interest. On the other side, if the pseudo p-value is large, the validation of
the significant treatment effect is quite difficult.
2.3.2 Root mean squared prediction error
Put aside the placebo tests, another important measure to evaluate the estimates is the root mean
squared prediction error (RMSPE), that can be calculated for any unit and any time period. In this
section, we present not only the RMSPE, but also the RMSPE-ratio and its p-value, starting with
the root mean squared prediction error definition:
Definition 2.2 (Root mean squared prediction error).
“RMSPE calculates the lack of fit between the path of the outcome variable for any particular
unit and its synthetic counterpart” (Abadie et al. (2015, p. 502)). A general RMSPE for unit k
calculated between two periods t1 to t2 is defined as:
RMSPE(k,t1,t2) =
0@ 1
nt
t2
Â
t=t1
 
Ykt   Â
l2J\k
w⇤l Ylt
!21A1/2 , (2.13)
where nt is the number of periods for which we calculate the RMSPE, (t1, t2) 2 {1, . . . ,T}, k 6= l and
(k, l) 2 J= {1, . . . ,J+1}.
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Most often, we first calculate the RMSPE for pre-treatment and post-treatment periods of the
treated unit under investigation. That is, the pre-treatment RMSPE for unit k = 1 between t1 = 1,
t2 = T0, and post-treatment RMSPE for the same unit between periods t1 = T0+ 1, t2 = T . With
these two measurements we compute the RMSPE-ratio:
Definition 2.3 (Root mean squared prediction error ratio).
RMSPE-ratio calculate the ratio between pre-treatment RMSPE and post-treatment RMSPE,
that is:
RMSPE-ratio=
Post-treatment RMSPE
Pre-treatment RMSPE
. (2.14)
After running a placebo tests, it is common to calculate the RMSPE and RMSPE-ratio for each
unit in the testing sample, whether it concerns only one unit after the single-unit and in-time placebo
tests, or all units from the donor pool after the in-space placebo test. Note that in order to calculate
the RMSPE for the placebo-treated (meaning the control unit), we use the respective placebo
synthetic control that was generated during the placebo test. In a case of in-space placebo or also
in-time placebo for multiple time periods, we can calculate the RMSPE-ratio p-value, which has the
following definition:
Definition 2.4 (Root mean squared prediction error p-value).
RMSPE-ratio p-value gives us the proportion of units with higher RMSPE-ratio than the treated
unit, that we so-called “bad RMSPE-ratio estimation”, to total number of tested units, that is:
RMSPE-ratio p-value=
Number of RMSPE-ratio bad estimations
Number of tested units
. (2.15)
If the RMSPE-ratio for the treated unit is relatively large compare to the rest of the controls in the
donor pool, it implies that no control unit achieves such a large ratio. We can interpret it as: “if one
were to assign the treatment at random in the data, the probabilities of obtaining a RMSPE-ratio as
large as the treated unit one is 1/(J+1)” (Abadie et al. (2010, p. 503)).
Note that we have to be careful when interpreting the resulting p-value, as we do not always
have a sufficient number of units in the donor pool to validate the significance of the treatment
effect. That is why, it is important to take into account all other measures as the graph analysis,
placebo tests and RMSPE itself.
Interpretation of RMSPE indicators
Table 2.7 gives us an overview, how to interpret the results of RMSPE indicators in case of relatively
large or relatively small values. Note that the RMSPE is a scale-less measure, though the term
“relative” is with respect to the values of the potential outcome, treatment effect and the rest of the
units in the donor pool. Note also that the RMSPE is not a measurement of a significance of the
treatment effect, but helps in its interpretation and justification.
44 Chapter 2. Synthetic control method
Relatively large Relatively small
Pre-treatment
RMSPE
Might indicate that the synthetic control
does not provide a good match to the
treated unit. Very large value eventually
indicates a problem of extreme value ob-
servation. In other words, there is no
combination of units in the sample that
can reproduce the time series of the po-
tential outcome prior to the treatment;
Is a first sign of the good match between
the treated and its synthetic control.
Should be the case for majority of the
control units in the donor pool in order to
indicate that the synthetic control method
is able to provide a good fit for potential
outcome path prior to the treatment;
Post-treatment
RMSPE
Shows potentially large treatment effect,
but is not indicative of large effect of the
intervention if the pre-treatment RMSPE
is also large;
Is not indicative of a large treatment ef-
fect;
RMSPE-ratio Indicates large treatment effect for a
given unit;
Indicates that there is not a significant
improvement with respect to the pre-
treatment period;
RMSPE-ratio
p-value
Does not approve large significant treat-
ment effect.
Approve the significant treatment effect.
Remark: we have to check the pseudo
p-value as well.
Source: Author’s elaboration.
Table 2.7: Interpretation of root mean squared prediction error measures
Excluding observations with respect to RMSPE from the placebo test donor pool
There is one important remark with respect to the placebo test and the RMSPE. Note that RMSPE-
ratio does not imply the cutoff for the exclusion of miss-fitting placebo runs. That is, if the synthetic
control had failed to fit the outcome path in pre-treatment period, then much of the post gap between
the treated and its control was also artificially created by the lack of fit rather than by the treatment
effect. Similarly, placebo runs with poor fit prior to the treatment do not provide information to
measure the relative rarity of estimating a large post-treatment gap for a unit that was well fitted
prior the treatment.
Note that for inference placebo analysis Abadie et al. (2015) suggest to exclude units beyond a
certain level of pre-treatment RMSPE. They recommend to use the units from the donor pool with
RMSPE that are smaller than two to five times RMSPE of the unit of interest. This will provide the
focus exclusively on those units that can fit almost as well as the treated unit in the pre-treatment
period. Nevertheless, the choice of the threshold should stay arbitrary and unique to each study,
as it is dependent on the relative size of the RMSPE.
2.3. Statistical inferences 45
2.3.3 Robustness tests and other analysis
The placebo tests and the RMSPE indicators are mostly measuring the good fit of the matching
and the significance of the results of the analysis. It could be that we are also interested in other
measures of the modelling.
In this section, we briefly present two robustness checks of the model: sensitivity analysis of
a number of controls and sensitivity analysis of a number of variables. Moreover, we also present
two other analyses related to the treatment effect: predictor analyses and evolution test.
Sensitivity analysis of number of controls: “leave one out”
In some cases, while using the synthetic control, we may consider only a small number of controls
in the donor pool in order to closely examine each control’s characteristics and outcome. Reducing
the number of units in the synthetic control group may impact the extent to which the synthetic
control units is able to fit the characteristics of the unit of interest. In this case, one has to examine
a trade-off between sparsity and goodness of fit in the choice of the number of units that contribute
to the synthetic control. In order to test the sensitivity of the results to the changes in the units
weights, W⇤, we can run the robustness tests proposed by Abadie et al. (2015). By the specific
robustness checks we analyse the sparsity of the synthetic controls, that is, synthetic controls that
involve a small number of comparison units.
The point is to iteratively reestimate the baseline model to construct a synthetic control omitting
in each iteration one of the units that received a positive weight in the synthetic control. At each
iteration we take one unit out, going from the unit that has the less weight (effect) in the synthetic
control to the one that has the most influence in the synthetic control. By excluding units that
received a positive weight we sacrifice some goodness of fit, but this sensitivity check allows us to
evaluate to what extend our result are driven by any particular control unit.
First, we can visualise the results on the leave-one-out distribution graph. An example of such
a graph is presented on the figure 2.8, which is the path plot with three other synthetic controls
constructed with less of the controls in the respective donor pool.
In order to verify the robustness, we want the leave-one-out synthetic controls to be as similar
as possible to the primary synthetic control. In a case of large deviation form the original synthetic
control, the model needs a closer verification.
Another way to check the robustness of the results is to build the tables containing the predictors
(see table 2.6) for the treated unit, the synthetic control and all leave-one-out synthetic controls. We
can build as many tables as the number of units in the donor pool.
Abadie et al. (2015) show the potential gain from using combinations of units rather than single
countries as comparison cases in comparative research. Abadie et al. (2015) also show that
usually, the synthetic control is robust to the inclusion of discarded units, if the units did not have
much impact in the synthetic control.
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Source: Author’s elaboration.
Figure 2.8: Leave-one-out distribution of the synthetic control for the treated unit
Sensitivity analysis of number of variables
Another way to check the robustness of the model is to include additional predictors of the outcome
variable used to construct the synthetic control. As for the leave-one-out robustness test, we can
also construct different path plot graphs or tables. But this kind of analysis might be very time and
resources demanding. Though, we would suggest analysing the (v) loss function, that is, the loss
associated with equation 2.9.
A good model should stay unaffected regardless of which and how many predictor variables
we include. And an optimal model will have a small (v) loss function, and so by including other
predictors, the value of the (v) loss function should stay relatively unaffected. If it is not the case,
we might have to consider including the new predictors into the model in order to increase the
quality of the estimation.
Moreover, note that by including confounding variables C into the model, we are naturally in-
creasing the (w) loss function (the loss associated with equation 2.8), but at the same time generally
increasing the quality of the estimation.
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Evolution test
The last test presented in this section analyses whether the treatment explains the gap of the
outcome variable between the treated and the synthetic control. To do so, we can check the
evolution of the gap and another indicator of the intensity of the treatment. Both of the variables
are placed on the same graph. Abadie and Gardeazabal (2003), for example, check the number
of deaths as an indicator of the terrorist activity (treatment) and the per capita GDP gap (treatment
effect)
On the one hand, this test is good in case we have evolution in the intensity of the treatment.
On the other hand, we cannot apply the test if we do not have an intensity indicator. In order to test
the evolution, we can, for example, use an impulse-response function or polynomial distributed lag
models (see Abadie and Gardeazabal (2003) for more details).
Another possibility to use the evolution test is when we need a closer examination of the pre-
dictors. It could be that the gap is explained by another factor than the treatment, and this factor
itself can be explained by one of the predictors. In case we detect a potential “effect” disturbance,
that is the sudden unexpected increase or decrease in the treatment effect, we analyse a predictor
that has an important value in the synthetic control (high value of v⇤ in the predictor matrix V⇤).
We check graphically any gaps of different predictors between the treated unit and its synthetic
control. If we observe the relatively substantial gap between the two paths, then this predictor may
contribute to the explanation of the treatment effect and need closer analysis.

Chapter 3
Environmental problematics at the
international and firm’s level, and
Carbon Disclosure Project
The average temperature has already risen by approximately 0.85°C since 1880.1 This change is
proved to be mostly due to the human activity.2 Besides households, the major contribution to the
climate change is caused by the companies and their non-environmental behaviours. As a result,
there is increasing pressure on the firms and institutions to review their politics.
Since half a century, many countries and regions are taking action to prevent the irreversible
phenomena of the global warming. As an example, we can mention the European Union, California
and China that are among those with the most ambitious policies that will reduce Greenhouse Gas
(GHG)3 emissions. In addition, a basis for international co-operation is provided by, for example,
the United Nations Framework Convention on Climate Change, the Kyoto Protocole, and the Paris
Agreement, along with a range of partnerships and other approaches.4
In this chapter, we first briefly explain the reason why it is so important to reduce the carbon
emissions. And then we introduce different international organisations and regulations related to
the climate change. This first section contains some information about the United Nations Environ-
ment Programme, the United Nations Framework Convention on Climate Change, or the Intergov-
ernmental Panel on Climate Change.
1Source: IPCC 2013: Climate Change 2013: The Physical Science (Working Group I to the Fifth Assessment Report
(2013)).
2Source: IPCC 2014: Climate Change 2014: Synthesis Report (Core Writing Team et al. (2015)).
3Greenhouse gas: A gas that contributes to the greenhouse effect by absorbing infrared radiation. Carbon dioxide
and chlorofluorocarbons are examples of greenhouse gases [Oxford Dictionaries].
4Source: The Economic of Climate Change: The Stern Review (Stern (2006)).
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The second section introduces the problematic of the climate change on the firm’s level. It
overviews the main disclosing programs. With exception of the Carbon Disclosure Project (CDP),
the following programs are presented: the Global Reporting Initiative, the United Nation Global
Compact, the International Organisation for Standardisation 14000, or the Greenhouse Gas Proto-
col. The second part of this section reviews some initiatives and regulations promoting a low-carbon
economy and aiming the reduction of industrial GHG emissions in the European Union, the United
Kingdom and the United States. The reason for selecting these three geographic regions is that
we use them in our empirical analysis.
Finally, the last section of this chapter presents the Carbon Disclosure Program, one of the bind-
ing reporting standards that are evaluated by our study presented in chapter 5. We first present
the main collaborations between CDP with investors, governments and other international organi-
sations. And then we briefly introduce the main programs that are proposed to the firms and cities.
3.1 Climate change, international organisations and different regula-
tions
Last Intergovernmental Panel on Climate Change assessment reports, the Fifth Assessment Re-
port released between 2014 and 2015, confirms clear and growing human influence on the climate
system, with impacts observed across all continents and oceans. This climate change is due to
the increasing GHG concentration in the atmosphere, chemical pollution, abuse of the land use,
deforestation, bad water or waste management and many other factors. In this work, we are not
part of the sceptical environmentalists, and we do strongly believe that the climate change is due
to the human activity with its fatal impact on the entire ecosystem.
The Climate Change 2014 Synthesis Report (Core Writing Team et al. (2015, p. 4)) confirms
that: “Anthropogenic greenhouse gas emissions have increased since the pre-industrial era, driven
largely by economic and population growth, and are now higher than ever. This has led to atmo-
spheric concentrations of carbon dioxide, methane and nitrous oxide that are unprecedented in at
least the last 800000 years.”
The Stern Review (Stern (2006, p. 3)) asserts that: “If annual greenhouse gas emissions re-
mained at the current level, concentrations would be more that treble pre-industrial levels by 2100,
committing the world to 3-10°C.” This increasing GHG concentration has as consequences, inter
alia, dramatical raise of temperature, and at its turn the warming of oceans, melting ices, increase
of the see level and delocalisation of water system.
These alarming facts urged the governments, institutions, authorities and investors to take the
responsibilities in order to promote more sustainable and less polluting systems or economies. As
an answer, in the early 70’s, the pro-environmental international organisations and agreements saw
their light. There was a universal initiative to build a framework related to climate change, promoting
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the reduction of CO25 emissions, as for example the emissions trading, technology cooperation, or
actions to reduce deforestation and waste.
In this section, we give a small snapshot of few international organisations, regulations and
existing agreements. Note that this is not an exhaustive list but only an overview of the core
structure.
3.1.1 International organisations and regulations
As already mentioned, it is since early 70’s that there is a development of environmental organisa-
tions and tendencies to regulate the climate change. Nowadays, we can account for an endless list
of environmental organisations and agreements, divided by the status of intergovernmental, gov-
ernmental or non-governmental institutions, and subdivided in continental, international, regional
or local organisations. In this section, we present few of the international intergovernmental or-
ganisations, namely, the United Nations Environment Programme, the United Nations Framework
Convention on Climate Change, its related Kyoto Protocol and Paris Agreement, and finally, we
shortly describe the Intergovernmental Panel on Climate Change.
United Nations Environment Programme
United Nations Environment Programme (UNEP) was founded in Nairobi (Kenya) in 1972. UNEP
is one of the first and the leading global environmental authority. It sets the global environmental
agenda, promotes the coherent implementation of the environmental dimension of sustainable de-
velopment within the United Nations system and serves as an authoritative advocate for the global
environment.
The UNEP mission is: “To provide leadership and encourage partnership in caring for the en-
vironment by inspiring, informing, and enabling nations and peoples to improve their quality of
life without compromising that of future generations.6” Their focus is, for example, on the cli-
mate change, disasters, ecosystem management, environmental governance, waste and resource
efficiency. They get their work enclosed by: Assessing global, regional and national environmen-
tal conditions and trends; developing international and national environmental instruments; and
strengthening institutions for the wise management of the environment.
As already mentioned, UNEP stays in a position of one of the most important environmental
organisation. It has played a significant role in developing environmental conventions, promoting
environmental science and information. The organisation helps with development and implemen-
tation of policy with national governments, regional institutions in conjunction with environmental
non-governmental organisations.
5Carbon dioxide, even though naturally present in the atmosphere is the primary greenhouse gas emitted through
human activities. Based on global emissions from 2010, the CO2 accounts for 65% of the global greenhouse gas
emissions (Source: IPCC 2014: Climate Change 2014: Synthesis Report (Core Writing Team et al. (2015))). That is
why, we often take the carbon dioxide as a proxy of the greenhouse gas.
6Source: United Nations Environment Programme. Retrieved July 20, 2016, from http://www.unep.org/about/.
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United Nations Framework Convention on Climate Change
The United Nations Framework Convention on Climate Change (UNFCCC) is an international en-
vironmental treaty negotiated at the Earth Summit in Rio de Janeiro in 1992 and entered into force
in 1994. In 2015, the Convention included 197 ratifying countries that are so-called Parties to the
Convention. Its ultimate objective is to achieve “... stabilisation of greenhouse gas concentrations
in the atmosphere at a level that would prevent dangerous anthropogenic interference with the
climate system.7”
Since 1995, the Parties to the convention have annual meetings so-called Conferences of the
Parties. Two important universal agreements were established on these conferences, respectively
the Kyoto Protocole in 1997 and the Paris Agreement in 2015. These two agreements are briefly
described in the following paragraphs.
Kyoto Protocol
The Kyoto Protocol is an international agreement linked to the UNFCCC, that aims to reduce
carbon dioxide emissions and the presence of greenhouse gases. The Kyoto Protocol was adopted
in Kyoto (Japan) in 1997, and due to a complex ratification process, it entered into force in 2005
only.
Mainly, the Kyoto Protocol commits its Parties by setting internationally binding emission re-
duction targets. The Kyoto mechanisms that help to stimulate green investment and help Parties
to meet their emission targets in a cost-effective way are: International Emissions Trading, Clean
Development Mechanism and Joint Implementation.
With respect to the UNFCCC the Convention says: “In short, the Kyoto Protocol is what “oper-
ationalises” the Convention. It commits industrialised countries to stabilise greenhouse gas emis-
sions based on the principles of the Convention. The Convention itself only encourages countries
to do so.8”
The Paris Agreement
At the 21st Paris climate conference in December 2015, 195 countries adopted the first-ever
universal, legally binding global climate deal, that was called “Paris Agreement”. The agreement
sets out a global action plan to put the world on track to avoid dangerous climate change by limiting
global warming to well below 2°C. The agreement is due to enter into force in 2020.
7Source: Introduction to the Convention. Retrieved July 19, 2016, from http://unfccc.int/essential_background/conve-
ntion/items/6036.php.
8Source: Kyoto Protocol Intro. Retrieved July 26, 2016, from http://unfccc.int/essential_background/kyoto_protocol/ite-
ms/6034.php.
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Intergovernmental Panel on Climate Change
Intergovernmental Panel on Climate Change (IPCC) is the international intergovernmental organi-
sation evaluating the science related to climate change. The IPCC was set up in 1988 by the World
Meteorological Organisation and UNEP. Currently IPCC counts for 195 countries as members of
the organisation.
This body provides policymakers with regular assessments of the scientific basis of climate
change, its impacts and future risks, and options for adaptation and mitigation. IPCC assessments
issues a scientific basis for governments at all levels to develop climate-related policies, and they
underlined negotiations at the United Nations (UN) Climate Conference – the UNFCCC.
IPCC counts for several working groups and the task forces to provide different reports on the
regular basis. Among, we should mention the assessment reports, social reports, methodology
reports or new scenarios. These accounts are the daily basis for further scientific work or serve as
a support in governments decisions.
3.2 Climate change regulation at the firm’s level
As already explained in the previous part of this chapter, the world is more aware of climate change
and so increasingly sensitive to the “green” economics in order to assure the future. Consequently,
companies, the major GHG emitters, are pushed too rapidly and significantly cut down their CO2
emissions and review their policies in this direction. On one side, this problem is regulated by the
governments and authorities and, on the other side, there is also rising pressure from the investors
and stakeholders. Therefore, the companies have to react accordingly.
The sustainable behaviour of firms received closer attention only in the last three decades, and
since then the companies started slowly report their CO2 emissions. Mostly, the companies first
published their environmental activities in the annual reports. Later, they started to disclose their
social and environmental responsibility and sustainability reporting into so-called Corporate Social
& Sustainability Report (CSR).
In the beginning, the reported values were highly inaccurate, and the firms needed a better
guidance in how to collect and disclose the data. The companies did not have to wait long for
this help, and many governments, private companies or non-governmental organisations are now
proposing a multitude of programs to this effect. As an example, we can mention the United Nation
Global Compact, Global Reporting Initiative, the Greenhouse Gas Protocol, or the Carbon Dis-
closure Project. The main objectives of these organisations are to help the companies with the
environmental management, as well as to build the CSR of good quality. The first three programs
are briefly described in next sub-sections. The Carbon Disclosure Project gets some more attention
in the section 3.3, as it is the program that is studied in our empirical part.
Moreover, apart from the few disclosing programs, we shortly review the most common regu-
lations in the European Union, the United Kingdom and the United States. As already mentioned,
the choice of these regions is related to the study in chapter 4. The main regulations on the firm
level in these regions are the UK Carbon Reduction Commitment Energy Efficiency Scheme and
the US Environmental Protection Agency’s Mandatory GHG Reporting Rule. Note that the UK is
not purposely included in the EU, because of its specificity in sustainable development strategy.
54
Chapter 3. Environmental problematics at the international and firm’s level, and Carbon
Disclosure Project
3.2.1 Overview of the main disclosing programs
This section briefly reviews the main disclosing programs existing to serve the corporations, gov-
ernments, investors and stakeholders.
Global Reporting Initiative
The Global Reporting Initiative (GRI), founded in 1997 in Boston (US), is an international indepen-
dent standards organisation. It has as an objective to help businesses, governments and other
institutions to understand and communicate their impacts on issues such as climate change, hu-
man rights, corruption and many others.
The GRI is a nonprofit organisation and has strategic partnerships with a range of international
institutions, such as the International Organisation for Standardisation, the United Nations Envi-
ronment Programme, the United Nations Global Compact, the International Integrated Reporting
Council, and the Carbon Disclosure Project, among others.
The GRI is a pioneer in sustainability reporting. Thousands of reports are coming yearly from
over 90 countries. The GRI provides the world’s most widely used standards on sustainability
reporting and disclosure. This information enables businesses, governments and citizens to make
better decisions based on information that matters. The GRI’s sustainability reporting standards
are used in 35 countries in their sustainability policies and look to them for guidance.
GRI possesses so-called Sustainability Disclosure Database, which is one of the biggest database
containing the disclosing reports, including over 9300 organisations, 34000 reports and 23790
GRI reports. Note that the database contains three different kinds of reports: GRI reports9, GRI-
Referenced Reports10, Non-GRI reports11.
In 2013, the GRI introduced the GRI Content Index that is a sustainability reporting template
that offers a quick overview of an organisation’s publicly accessible information on economic, envi-
ronmental, social and governance performance.
9GRI reports use the GRI Sustainability Reporting Framework and have a GRI Content Index.
10GRI-Referenced Reports make reference to or use elements of GRI’s Sustainability Reporting Framework but do not
include a GRI Content Index.
11Non-GRI reports are any other type of sustainability, corporate responsibility, or integrated report which does not
reference or use the Guidelines.
3.2. Climate change regulation at the firm’s level 55
United Nation Global Compact
The United Nation Global Compact (UNGC) is a United Nations initiative, founded in 2000, to
encourage businesses worldwide to adopt sustainable and socially responsible policies and to
report on their implementation.
United Nation Global Compact is calling itself as the “The world’s largest corporate sustainability
initiative”. Its mission is: “A call to companies to align strategies and operations with universal
principles on human rights, labour, environment and anti-corruption, and take actions that advance
societal goals.12” In a way this is very similar to what the Global Reporting Initiative promotes.
Today, UNGC involves 12000 signatories in 170 countries, both developed and developing,
representing nearly every sector and size. Moreover, it promotes the sustainability reporting as a
mainstream for both companies and non-business organisations. This annual report, called Com-
munication on Progress (COP), is a requirement to be a part of the UN Global Compact, and
provides valuable information to the stakeholders. In 2014, 5404 COP were submitted, and based
on a company’s self-assessment, each COP falls into one of the following differentiation levels:
Global Compact (GC) Advanced13, GC Active14, GC Learner15.
International Organisation for Standardisation 14000
International Organization for Standardisation (ISO) 14000 is a series of standards developed by
the International Organisation for Standardisation related to the organisational environmental man-
agement. The ISO 14000 standards is an existing framework that helps organisations to system-
atise and improve their environmental management efforts. Note that the ISO 14000 standards
are not designed to assist the enforcement of environmental laws, or to regulate the environmental
behaviour of organisations and its adherence is non-compulsory.
The ISO 14001 standard is the most important standard within the ISO 14000 series. ISO
14001 is based on the Plan-Check-Do-Review-Improve cycle and specifies the requirements of
an environmental management system, that is, a systemic approach to deal with environmental
management for organisations.
Even though there is not an official requirement for companies and institutions to wear the label
ISO 14001, to do so gives them the marker “green”. This impulse satisfies the investors, stakehold-
ers, consumers and after all the whole organisation can take advantage of basic environmental
management tools.
12Source: What is the UN Global Compact | UN Global Compact. Retrieved July 28, 2016, from http://www.unglobal-
compact.org/what-is-gc.
13GC Advanced is a COP that qualifies as GC Active and, in addition, covers the company’s implementation of ad-
vanced criteria and best practices.
14GC Active is a COP that meets the minimum requirements.
15GC Learner is a COP that does not meet one or more of the minimum requirements.
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Greenhouse Gas Protocol
The Greenhouse Gas Protocol (GGP) Initiative is a multi-stakeholder partnership of businesses,
non-governmental organisations, governments, and others. The Initiative was launched in 1998 by
the World Resources Institute and World Business Council on Sustainable Development. GGP is
convened by the two organisations, plus a US-based environmental non-governmental organisation
and a Geneva-based coalition of 170 international companies. Its mission is to set the global
standard for how to measure, manage, and report greenhouse gas emissions.
The GGP Initiative comprises two separate but linked standards: GHG Protocol Corporate
Accounting and Reporting Standard (this document provides a guide how to quantify and report
the GHG emissions); and GHG Protocol Project Quantification Standard (a guide for quantifying
reductions from GHG mitigation projects).
The first edition of the Greenhouse Gas Protocol, A Corporate Accounting and Reporting Stan-
dard, was published in 2001 and since hundreds of companies and organisations around the world
are using GGP standards and tools to manage their emissions and become more efficient, resilient,
and prosperous organisations.
GGP offers not only the corporate protocols and standards, but also guidances, calculation
tools to assess the emissions or life cycles, and online training. Moreover, in 2006, the International
Organisation for Standardisation adopted the Corporate Standard as the basis for its ISO 14064-I.
To amplify the importance of this standard, the Greenhouse Gas Protocol states: “The 2010
GHG Workforce Survey from GHG Management Institute and Sequence Staffing found that the
overwhelming majority of respondents said GHG Protocol is the second most important climate pro-
gram after Kyoto Protocol in the successful measurement and management of climate change.16”
3.2.2 Overview of the European, British and American low-carbon politics
In this section, we briefly introduce the European Union, the United Kingdom and the United States
climate regulations. For example, we overview the regulations and organisations as the Emission
Trading System, United Kingdom Climate Change Programme, the Carbon Reduction Commitment
Energy Efficiency Scheme, or the US Environmental Protection Agency.
16Source: About the GHG Protocol. Retrieved July 25, 2016, from http://www.ghgprotocol.org/about-ghgp.
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Overview of the European Union climate regulations
As already mentioned, the European Union is one of the leaders in climate change prevention. The
European Commission proposes diverse climate strategies and has set itself targets for reducing
its greenhouse gas emissions progressively up to 2050. These targets are defined to achieve the
transformation towards the low-carbon economy. The EU tracks its progress on cutting the GHG
emissions through monitoring and reporting. Each new policy is first carefully assessed by the
European Commission of its potential impacts. The main EU climate change prevention strategies
are the Emission Trading System or the Effort Sharing Decision, described in following paragraphs.
Emission Trading System
The EU Emission Trading System (ETS) is a main EU policy to confront climate change and
its key tool for reducing industrial GHG emissions. It is the world’s first major carbon market and
still today remains the biggest one. The EU ETS operates in 31 countries (all 28 EU countries
plus Iceland, Liechtenstein and Norway), limits emissions from more than 11000 heavy polluting
installations and airlines, and covers around 45% of EU’s greenhouse gas emissions.
The EU ETS is based on the “cap and trade system”. That is, there is a certain amount of
greenhouse gases that can be emitted by the installations covered by the system, and the compa-
nies receive or buy emissions allowances which they trade with one another as needed. Note, that
the amount of trading permits is reduced over time, in order to assure the long-term decrease in
the emissions.
Other EU climate strategies
Another climate action is the so-called Effort Sharing Decision that establishes binding annual
greenhouse gas emission targets for the Member States for the period 2013–2020. These targets
concern emissions from most sectors not included in the EU ETS, such as transport, buildings, and
agriculture. The target, although very similar to the one for the EU ETS, is to form a set of policies
that will help move towards a low-carbon economy.
Aside from the previous strategies, EU also focus on low carbon technologies, improvement of
transport, protection of the ozone layer, forest and agriculture. Furthermore, it takes international
actions on climate change such as being part of the UNFCCC, bilateral relations with non-EU
countries, policies and initiatives at EU and international level, and financing to support developing
countries in their efforts to tackle climate change.
What is more, the EU also proposes the European Climate Change Programme containing a
comprehensive package of policy measures to reduce greenhouse gas emissions. This program is
applied on the European level, but also encourages each of the EU Member States to put in place
the domestic actions that are built on the specific European Climate Change Programme measures
or complement them.
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Overview of the United Kingdom climate regulations
The United Kingdom climate change protection is one of the strongest in the world. The government
puts a lot of pressure on the private as well as public sector to cut down their CO2 emissions,
review and implement new environmental strategies, obliges them to report their sustainable data
and pushes them to participate in many of the environmental programs. In this section, we present
few main organs and strategies implemented in the United Kingdom to regulate the low-carbon
economies.
Department of Energy & Climate Change
Apart from being a member of the European Union Emissions Trading System, the UK govern-
ment has its own Department of Energy & Climate Change. It makes sure that the UK has secure,
clean, affordable energy supplies and promote international action to mitigate climate change. One
important role of the department is, setting the carbon budget that places a restriction on the total
amount of greenhouse gases the UK can emit over a 5-years period.
United Kingdom Climate Change Programme
The United Kingdom signed the Framework Convention on Climate Change in 1992 and has
been signed up to the Kyoto Protocol since 1995. In January 1994 it published its first UK Pro-
gramme on Climate Change, identifying its obligations and commitments to help tackle the problem
of global warming.
In 2000, the UK Government undertook a major reappraisal of the Climate Change Programme,
and in order to implement the strategy, in 2008 the government introduced the Climate Change
Act. This Act established a framework to develop an economically credible emissions reduction
path. The UK government states: “The Climate Change Act also strengthened the UK’s leadership
internationally by highlighting the role it would take in contributing to urgent collective action to
tackle climate change under the Kyoto Protocol.17”
Carbon Reduction Commitment Energy Efficiency Scheme
In 2007, UK introduced a program called Carbon Reduction Commitment Energy Efficiency
Scheme that intends to promote and reduce the GHG emissions. It is a mandatory carbon emis-
sions reduction scheme in the United Kingdom that applies to large non-energy-intensive organi-
sations in the public and private sectors. It has been estimated that the scheme will reduce carbon
emissions by 1.2 million tonnes of carbon per year by 2020. Concerning the operating mecha-
nism, the Carbon Reduction Commitment Energy Efficiency Scheme involves self-certification of
emissions and is managed by Environment Agency18.
17Source: The Climate Change Act and UK regulations. Retrieved July 28, 2016, from https://www.theccc.org.uk/-
tackling-climate-change/the-legal-landscape/global-action-on-climate-change/.
18Environment Agencies an executive non-departmental public body, sponsored by the Department for Environment,
Food & Rural Affairs.
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As a complement, there was the introduction of the Committee on Climate Change, an indepen-
dent statutory body established under the Climate Change Act 2008. Its purpose is to advise the
UK Government and Administrations on emissions targets and report to Parliament on progress
made in reducing greenhouse gas emissions and preparing for climate change.
The committee provides independent advice to Government on setting and meeting carbon
budgets and preparing for climate change. Above that, it monitors progress in reducing emissions
and achieving carbon budgets. The committee also conducts an independent analysis into cli-
mate change science, economics and policy engagements with a wide range of organisations and
individuals to share evidence and analysis.
Overview of the United States climate regulations
In 2011, the United States were placed as the second biggest world CO2 emitter, counting for
about 16% of total emissions19. Even if they are a signatory part of the Kyoto Protocol since 1997,
they have neither ratified nor withdrawn from the Protocol. Out of the three presented regions in
this section, it is the one that puts the less effort to the climate change mitigation.
Nevertheless, there are established organisations and regulations to prevent the environment,
as for example, the US Environmental Protection Agency or the Unites States Global Change
Research Program, presented in the following paragraphs. Note, it was especially under the presi-
dential of the Presidents G. W. Bush and B. Obama, that there was a strong requirement of national
reduction of the greenhouse gas emissions.
United States Environmental Protection Agency
US Environmental Protection Agency is an agency of the US federal government founded in
1970 by the US President Richard Nixon. The Agency was created for the purpose of protecting
human health and the environment by writing and enforcing regulations based on laws passed by
Congress. The agency conducts the environmental assessment, research, and education.
In order to accomplish its mission, the Agency develops and enforces regulations based on
Congress environmental laws. The Agency also enforces their regulations, and helps companies
understand the requirements. They are in charge to help apply the environmental policy of the
United States, which is a federal governmental action to regulate activities that have an environ-
mental impact in the US.
Unites States Global Change Research Program
The United States Global Change Research Program was established by Presidential Initiative
in 1989 and mandated by Congress in the Global Change Research Act of 1990 to: “assist the
Nation and the world to understand, assess, predict, and respond to human-induced and natural
processes of global change.20” The program coordinates and integrates global change research
across 13 Federal agencies.
Their mission is to build a knowledge base through coordinated and integrated Federal pro-
grams of research, education, communication, and decision support. The focus is not only on the
Nation but also on the cooperation with the rest of the world.
19Source: Carbon Dioxide Information Analysis Center. Retrieved July 24, 2016, from http://cdiac.ornl.gov/.
20Source: Legal Mandate of the US Global Change Research Program. About USGCRP. Retrieved August 04, 2016,
from http://www.globalchange.gov/about.
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3.3 Carbon Disclosure Project
Carbon Disclosure Project (CDP) is an independent international nonprofit organisation founded in
2003 and based in the United Kingdom. Its primary goal is to help the corporations and cities to
disclose the greenhouse gas emissions and help them to manage the environmental risk. What
distinguishes this organisation from any other disclosing projects is that the quality of the data
reported to CDP is crucial and all data go under a loop of severe evaluations. The CDP collaborates
with investors, companies, cities, governments and policymakers from all over the world.
Today, thousands of organisations from across all countries measure and disclose their envi-
ronmental information through CDP. Thus it makes from CDP an organisation holding the largest
collection of self-reported climate change, water and forest-risk data. The reported information is
then put at the heart of financial and policy decision-making that motivates investors, corporations
and governments to take action to prevent climate change and protect natural resources.
In this section, we first introduce the background of the Carbon Disclosure Project. That is
we present the main purpose, numbers representing the CDP activities, and collaborations with
investors, cities, governments, customers and other international organisations. In the second part
of this section, we present the main programs proposed by CDP to the corporations. And we end up
the section by giving some information about Carbon Disclosure Leadership Index and the Climate
Disclosure Standards Board.
3.3.1 Introduction to the Carbon Disclosure Project
Carbon Disclosure Project is promoting collaboration and collective action that will achieve low-
carbon economy. As they declare: “We motivate companies and cities to disclose their environ-
mental impacts, giving decision makers the data they need to change market behaviour.21” More-
over, CDP tries to prevent dangerous climate change, protect natural resources, and improve the
environmental management by using measurement and information disclosure.
As already mentioned, CDP is an international, nonprofit organisation that provides the only
worldwide system for corporations and cities to measure, disclose and control their environmental
information. The organisation has a multiple funding including philanthropic and government grants
and donations, corporate and investor memberships, sponsorship and partnerships.
CDP has a global presence. It collects data from organisations and cities in some 60 countries,
and its programs are used in 81 countries around the world. About 20% of global emissions are
managed by the Program. More precisely, in 2003, CDP included only 253 reporting institutions,
and this number increased to 5600 in 2015, including companies and cities. Moreover, CDP uses
the Global partnerships to promote their mission. It possesses multitude local offices with local
representatives that are responsible for implementing the disclosure process within their region.
21Source: CDP - Driving sustainable economies. Retrieved August 04, 2016, from https://www.cdp.net/en-US/Pages/-
HomePage.aspx.
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Apart of corporations, to whom CDP proposes multitude programs described in section 3.3.2,
it also collaborates with the investors, cities, governments, policymakers, and forms different al-
liances with other pro-environmental organisations. Today, CDP works with 827 institutional in-
vestors, governments and policymakers holding US$100 trillion in assets. By providing a quality
environmental data, the CDP helps the investors to drive investment flows towards a low carbon
and more sustainable economy. Moreover, CDP manages about 2 billion metric tonnes of carbon
emissions in 600 cities over the world. In the following text, we explain the relations that CDP had
with investors, cities, customers, governments and other international institutions.
CDP investor initiatives
CDP works with investors in order to protect the long terms investments and provides them with
data that support long-term objectives and analyses. That is, by providing the evidence about
private sector greenhouse gas emissions, water usage, pro-environmental strategies, water and
deforestation risks, CDP helps investors to build balanced portfolio reducing the long-term risks
arising from environmental externalities.
Each investor has a possibility to become a signatory or member of the CDP, where the mem-
bership is an extension of the signatory. Being a signatory provides access to all company re-
sponses to the questionnaires which the investor endorses. The annual fee, although voluntary,
was in 2016 US$975, but will become mandatory from 2017. The membership fee in 2016 was be-
tween US$7000 to US$9000, giving the access to all CDP responses, and gives access to software
allowing easy analysis of company responses. Besides, the signatory investors have the possibility
to be a part of Carbon Action Initiative explained in the subsequent text.
Carbon Action Initiative
Carbon Action is an investors’ initiative focusing on motivating companies to take measures to
reduce emissions and expand pro-environmental behaviour in general that are promising a return
on investment. CDP Carbon Action is financed by 304 investor signatories, detaining US$ 22 trillion
in investment and coordinated by the Principles for Responsible Investment.
The investors ask the companies in heavy-emitting industries to take three specific actions in
response to climate change: set targets, reduce emissions, and generate the return on investment.
The Carbon Action request is sent as a letter to the Chair of the Board each year. In 2015, the
Carbon Action request went to over 1300 companies across 17 high emitting industries.
This program is two-sided. The companies can take the advantage of it in a way that it helps
them to generate positive returns through carbon reducing and energy efficiency projects and so
build long-term sustainable businesses. On the other side, signatory investors can better under-
stand company carbon management and energy efficiency initiatives and improve risk manage-
ment in areas including regulation, operations, fiduciary duty and reputation.
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Supply Chain member
Apart from investors, also corporations have an opportunity to be a member of the Carbon Dis-
closure Project. CDP proposes companies to become either a Supply Chain member or Reporter
Service member. The first membership we explain in the following paragraphs, and the second
type of membership gets closer attention in section 3.3.2.
As a Supply Chain member, company has access to the Supply Chain Program. In 2015, CDP
counted for 89 Supply Chain members representing combined purchasing power of over US$2
trillion. The membership gives access to the supply chain disclosure platform, providing information
about their suppliers’ approach to climate change or water management.
Moreover, members can request their suppliers to answer CDP’s questionnaire. The requested
suppliers get CDP’s support in answering, but also the help in improving their performance. CDP
proposes the analysis of member’s environmental data and advice the implementation of the strate-
gies. In 2015 CDP collected climate change and water information from over 4000 companies.
Cities
As already mentioned, cities have a possibility to measure, monitor and manage their impact on
the environment through the CDP’s cities program. The program exists since 2006, and during the
five years of its existence, CDP collaborated with over 500 cities to manage over 2 billion metric
tonnes of greenhouse gas emissions, which estimate protections of about 621 milliards of people
by cities that are taking the lead on climate adaptation.
By participating in the program, cities has an opportunity to detect and manage their risk and
increase resiliency through more than 4800 activities to reduce and adjust to climate change.
CDP with governments & policymakers
As already mentioned, the CDP collaborates with governments, policymakers and international in-
stitutions in order to help them in areas such as mitigation and adaptation to the climate change.
The aim is to support the green economic growth, by giving assistance to governments and pro-
viding tools that lead to the creation of more sustainable policies and regulations, by encouraging
governments to adopt regulatory standards for disclosure of environmental data and support gov-
ernments in designing and implementing corporate reporting systems.
CDP provides governments with researches and analyses based on the unique data on envi-
ronmental issues. Moreover, it informs policymakers about the efforts, actions and impact of the
corporation and cities with respect to the environmental issues. CDP also advises regulators on
formulating policy, supports governments in designing and develop tailored programs hand in hand
with them.
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Alliances
The data and programs that CDP proposes are of high quality. In order to be on the top of the
research, and to propose to the firms, investors and institutions the best solutions, the CDP is
collaborating with a multitude of other organisations and institutions, creating a number of mutually
profitable partnerships.
CDP claims that: “Collaboration is crucial to achieve more sustainable economies.22” CDP
supports many different initiatives and has strong alliances around the world with policy-makers,
researchers, academic institutions, standard setters, other Non Governmental Organisations. As
an example, we can name the Global Reporting Initiative, UN Environment Programme, UN Global
Compact, Greenhouse Gas Protocol. All these organisations are described in sections 3.1 and 3.2.
Moreover, CDP is being part of the Caring for Climate Initiative23.
3.3.2 Corporate reporting to Carbon Disclosure Project
From the firm’s perspective, CDP’s main objective is to help companies to take action toward a more
sustainable world. Reporting companies get help in building environmental strategies that improve
the management of environmental risk. That is, the focus is on reduction of CO2 emissions, use of
energy, investment in new lower pollution production, improvement of supply chain and many other
pro-environmental tactics.
CDP believes that companies that are aware of the scope of their environmental risk can better
manage the environmental strategies and improve their “green” footprint. CDP is convinced of the
crucial importance of firm’s carbon disclosure transparency and the necessity to provide the envi-
ronmental information to the decision makers in order to drive the appropriate action in sustainable
development.
On one side, the corporations are required either by investors (CDP investor initiative) or cus-
tomers (Supply Chain members) to report their data. By this channel, the companies do not have
to pay participation fees. On the other side, each company also has the opportunity to take the ini-
tiative to report their data voluntary and become a Reporter Services member. Reporter Services
membership gives organisations data, support and insights to reduce emissions, enhance water
stewardship and improve business performance. Companies can benchmark their performance
against peers and identify material risks.
CDP proposes four main programs focusing on firms: climate change, water, forest or supply
chain. These programs are described in this section. Moreover, we also present the Climate Per-
formance Leadership Index, which is a CDP tool to reveal which companies around the world are
doing the most to combat climate change. And we conclude by presenting a special CDP project,
so-called Climate Disclosure Standards Board, that attempt to integrate the climate change-related
information into the main financial reports.
22Source: Alliances. Retrieved August 01, 2016, from https://www.cdp.net/en-us/ournetwork/pages/alliances.aspx.
23Caring for Climate is a CEO-level business initiative that promotes climate leadership and transparency, founded in
2007 by UN Environment Programme, UN Global Compact, UN Framework Convention on Climate Change.
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CDP programs focusing on firms
Climate Change
CDP’s climate change program’s target is the reduction of companies’ greenhouse gases emis-
sions and the mitigation of the climate change risk. As a part of the program, the corporations
measure, manage and disclose their greenhouse gas emissions and climate change data. The
main benefits of being part of the program are the increased transparency, assessment of the
climate change management, evaluation of available business opportunities, increasing efficiency
and reduce unnecessary costs.
Water
The CDP’s water program main objective is to mobilise action on corporate water management
in order to secure water resources and alleviate the global water crises. The process of respond-
ing to the water questionnaire helps corporations to better understand the risks and opportunities
associated with water scarcity and other water-related issues. Business reporting to water pro-
gram gets similar benefits as one of the Climate Change programs and can be transparent, better
manage the risks, discover the opportunities.
Forest
CDP’s forest program intends to manage companies’ impact on the deforestation risk and as a
consequence regulate the land use change for agriculture as being the main driver of deforestation.
The program assists companies to disclose the four forest risk commodities most responsible for
deforestation globally. Reporting the forest-related information helps firms with communication
with investors or stakeholders, managing internal risk, discovering new opportunities, encourage
collaborations.
Supply Chain
CDP’s supply chain program objective is to achieve sustainable supply chain management for
firms and their suppliers by optimising the risks and opportunities that climate change puts to the
globalised supply chain. More details about the program is in section 3.3.1.
Climate Performance Leadership Index
Since October 2010, CDP ranks companies with high-quality disclosure as top scoring companies
in the Climate Performance Leadership Index (CPLI). The leading firms with high-performance
score figure on the “Climate or Water A list”. These companies are gaining competitive advantage
and commercial benefits over their competitors and can potentially count on more investors or
government help. For many investors, the CPLI has become a standard, and they may expect the
companies not only be reporting to the CDP but also to have a certain index position.
CDP works with a number of partners to deliver the scores for all responding companies. More-
over, only the top-scoring companies that have made their response public will be eligible for recog-
nition as leaders. If a company requires the response to be non-public, the response may still be
scored, and that score may be published. This makes from the CDP an organisation, which moti-
vates the reporting companies to provide data of good quality. But also discourages the companies
to report their climate change-related data, under a fear of getting an unsatisfactory rating.
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Climate Disclosure Standards Board
Climate Disclosure Standards Board is CDP’s special project focusing on integrating climate change
information into private sector’s financial reporting. CDP claims “In short, it is about linking finan-
cial and climate change-related reporting to provide policy-makers and investors with clear, reliable
information for robust decision making.24.”
It does not try to create new reporting standards but adopts existing standards and practices
including the Greenhouse Gas Protocol and International Financial Reporting Standards and oth-
ers. Moreover, it works as a collaborative forum to improve these standards and practices, ensures
transparent markets and encourages standardised approach of reporting the climate change data.
24Source: Special projects. Retrieved August 05, 2016, from https://www.cdp.net/en-US/OurNetwork/Pages/special-
projects.
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Research question, data and model
implementation
As we are going to start the empirical part of the investigation, it is the time and place to present
the research program.
In this chapter, we first do a short literature review of firms’ environmental evaluations. The
first section also sets up the hypotheses and expectations that we have with respect to the Carbon
Disclosure Project (CDP) evaluation. The second section talks about our unique database used
in the empirical part. We present not only the building process but also the variables and descrip-
tive statistics. The third section of this chapter introduces the methodological part of our study.
We present the model and the application of the synthetic control method to our study. We also
establish the inference tests used to evaluate the significance of the results. The last section is
dedicated to the implementation of the model with the statistical program R, that we used to run the
study. We briefly introduce the package “Synth”, but we focus on the presentation of the code and
showing the results of the most important functions, to help to present the results of our analysis in
the following chapter.
4.1 Literature review and main goals of the study
As already mentioned, we intend in our study to evaluate the introduction of one of the environmen-
tal reporting standards at the business level. In this section, first of all, we present a brief literature
review of firms’ environmental evaluations studies done by other authors. Note that it is just an
introduction and not an exhaustive list of all studies. Next, we develop the research question. More
precisely, we explain why we evaluate the Carbon Disclosure Project with the synthetic control
method, one of the program evaluations approaches. We also shortly introduce the study, and we
set up the expectations and hypotheses. Note that the details of the model and the application of
the method are explained in the section 4.3.
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4.1.1 Brief literature review of firms’ environmental evaluations
We are not the first to evaluate the firm’s environmental disclosures, but other studies have a
slightly different emphasis on the problematic. Already in early 90’s Wiseman (1982) assesses
the environmental disclosures made in corporate annual reports, and reveals the poor quality of
reported data. Other studies focusing on the quality of disclosed data, as for example Dragomir
(2012), or Andrew and Cortese (2011), found similar deceiving features of disclosed environmental
information.
Different categories of findings in environmental accounting are for example due to Al-Tuwaijri
et al. (2004), or Clarkson et al. (2008). These studies found a positive association between
environmental performance and the level of environmental disclosure. Nevertheless these articles
centre more on building and evaluating the so-called disclosure index and less on the actual policy
evaluation.
Luo and Tang (2014) is the closest study to ours since they evaluate the Carbon Disclosure
Project. But again, their focus is on the relationship between the degree of disclosure and carbon
performance, rather than on the program evaluation itself. They conclude that the firms’ voluntary
carbon disclosure in the CDP is indicative of their underlying actual carbon performance and that
the firms with good performance are likely to disclose more to distinguish themselves for investors
and other stakeholders. The limit of their research is that the analysis is merely a snapshot of
reporting practice over a single year.
Finally, Abrell et al. (2011) assess the impact of the European Union Emission Trading System
(ETS) using firm-level data. This study is very close to our analysis, with the difference being their
focus on a different program and the use of another method to evaluate the effect. Even though
they found positive results of the program on firm’s emissions, they conclude that the result has to
be interpreted with caution, as the counterfactual built (similar companies that are not part of EU
ETS) is not of very good quality.
Comparing to all these studies, we bring a new light to the evaluation of the CDP over a longer
period of time with a more reliable method to assess the effect of the program.
4.1.2 Research questions
This section develops our frame of hypotheses and research questions. First, we present the
objectives and a brief description of our study. Then we set up the expectations and hypotheses
that we have for the Carbon Disclosure Project assessment. The table 4.1 briefly introduces the
concept of the research questions and the expectations that are presented in more details on the
following pages.
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Research questions Theory Identification of the vari-
ables
Expectations
Main:
Is there a positive im-
pact of the Carbon Dis-
closure Project on the
participating firms?
The impact of the en-
vironmental policy is
a typical causal effect
evaluation. We use
the synthetic control
method to solve the
assessment of the
treatment effect.
The outcome variable
is the carbon dioxide
emissions per firm. The
confounding variables
are different firms’
characteristics.
We expect a positive ef-
fect of CDP on the firm’s
emissions.
Subsequent:
Is there a difference
of the impact on the
international level, be-
tween European Union,
United Kingdom, United
States?
We do not expect a big
difference between the
geographical regions.
Is there a difference of
the impact between the
sectors of activities?
We can not predict the
outcome of the compar-
ison between the sec-
tors.
Source: Author’s elaboration.
Table 4.1: Research questions, variables and expectations
Objectives and theory
The objective of the study is to evaluate the impact of the Carbon Disclosure Project on the firm’s
greenhouse gas emissions. Moreover, we want to compare the results of the assessment on an
international and sectoral level.
The impact of the CDP is a causal effect that can be measured by a program evaluation method.
In our case, the potential outcome (see section 1.2.1) is the carbon dioxide emissions of the firm,
and the treatment effect is the comparison of the carbon path of the firm that participates to the
Project and the carbon path of the same firm that do not participate to the CDP. Comparing the
carbon path before and after the company started to report to the CDP would be a naive solution,
as it does not take into consideration the business as the usual evolution of the firm. Conse-
quently, we have to reproduce the potential outcome of the treated firm in case of no-participation
to the program and this control unit is created, as already mentioned, by using the synthetic control
method.
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Identification of the variables
To measure the impact of the green policy, the outcome variable that we selected is the yearly
CO2 emissions of each firm. Evidently, the CO2 emissions are also influenced by other company
characteristics and not only by the participation to the CDP. Also, we have to collect also other
information on the firms. The variables are described in the section 4.2.
Expectations and hypotheses
We do have several expectations as predicted results of our study. First of all, we expect to have a
positive impact of the CDP on the carbon path. That is, decreasing CO2 after the company started
to report the environmental data to the project. This expectation comes from the hypothesis, that
the CDP has a positive incentive power on the company to diminish their emissions.
Moreover, our data contains companies from the three regions: the European Union, the United
Kingdom and the United States. The driving factor for this choice is that we consider these different
regions as being in the same economic development. Therefore, if there is a shock to one of
these economies, as an economic crisis, all of these interdependent regions will be hit, so there
should not be an external shock influencing the main study variable. As a result, we do not expect
big differences with respect to the number of positive treatment effects between the regions. This
expectation comes from the hypothesis that the three regions have a similar degree of economic
development, but also have similarities in corporate social responsibility policy, which influence the
degree of emissions.
Additionally, our data are divided into nine different sectors. The first reason behind this is
that the firms from different sectors have a different behaviour which influences a number of their
emissions. As for example, the firm from the industrial sector will have much higher emissions than
the firm from the financial sector. The second reason is that firms are influenced by sectoral shocks,
which reverberate on the companies from the same sector. We suppose that this sub-classification
will help to build an appropriate synthetic control that would reproduce the behaviour of the treated
unit in case of non-treatment.
Finally, with respect to the synthetic control method, we suppose that the assumptions 4 (First
SCM assumption) and 5 (Second SCM assumption), presented in the section 2.2.1, are satisfied.
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4.2 Database and descriptive statistics
For our study we are using a unique database that we built by adding several firm’s characteristics
to an initially requested database provided by South Pole Group1. Based on particular companies’
specifics, we were then able to select the suitable treated and control groups. In this chapter, we
describe the creation of the database, the variables and we provide some descriptive statistics.
4.2.1 Database creation
Once the objectives of our research had been set, we collect the data on the company’s CO2
emissions as well as on additional firm’s characteristics. This was a very challenging step as
the information on the amount of greenhouse gases produced by the companies are not easily
available. We got in contact with South Pole Group concerning the existing data on the company’s
emissions. The South Pole Group provided the data for 119 potential companies containing their
names, stock ticker symbols and CO2 emissions for the period from the year 2005 to 2013.
We created several variables, NAME, CDP_IN, CDP_YEAR, which are briefly described in annexe
in the table A.1. We found the information for all companies in the official CDP database2. We
discovered that all the companies were participating to the CDP program and that most of the
participations started in the first years of the CDP foundation in 2003. The problem was that we
needed to create two pools of companies: treated and control. For the treated companies we
needed observations from a few years prior to, and post treatment. For the control companies,
we needed companies that did not participate to the CDP program. None of these requests was
satisfied, so these companies were deemed not appropriate for our research.
As a result, we needed to constitute a new database. Hence new data was requested from
South Pole Group. We subsequently received the names of 1500 potential companies, and as
for the previous database, we collected the information on the same variables: NAME, CDP_IN,
CDP_YEAR. At first glance, we verified that there were participating and non-participating companies
to the CDP with respect to our requirement. Note that most of the companies, even the one non-
participating to the Carbon Disclosure Project, were present in the CDP database, so we had a
unified source of information.
As already mentioned, our goal was to create a database containing companies that did and did
not participate in the Carbon Disclosure Project, respectively the treated and control units’ pools.
Moreover, in order to measure the treatment effect, we had to get information on the emissions
few years before and few years after the firm signed to the CDP. As a consequence, we decided
that the treatment year will be 2009 or 2010, which will allow covering four to five year before the
treatment and three to four years after the treatment.
1South Pole Group is a specialist provider of climate action solutions that is, among other solutions, offering consulting
services, data and products for investors in the area of assessing investment climate impact.
2Source: Results - responses. Retrieved August 18, 2016, from https://www.cdp.net/en-US/Results/Pages-
/responses.aspx.
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Another important aspect was to create a donor pool with units that are good potential adepts
for a synthetic control. Remind, that a good synthetic control is as similar as possible with its
treated unit. Thus we not only concentrated on firms from the three geographic regions that
do have similar pro-environmental behaviour and economic development, that is the European
Union, the United Kingdom and the United States; but also we intended to equally cover all
economic sectors. Moreover, in order to select the firms for the analysis, we added the follow-
ing variables: COUNTRY, SECTOR, INDUSTRY_SECTOR, SUB_INDUSTRY, CLIMAT_CDP, WATER_CDP,
SUPPLY_CHAIN_CDP, FOREST_CDP. The variables are described in the annexe in the table A.1.
We found the information for all companies and then started the selection process. First, we
selected all the companies that participated to the CDP and we formed the first “treated” pool.
From this pool we picked only the firms from the three selected geographic regions, the EU, UK
and US, which signed to the CDP in 2009 or 2010. For the donor pool, we got exclusively non-
participating companies coming from the three mentioned geographic regions. Moreover, we also
checked that each sector from the treated pool was represented in the donor pool. So, by this
process, depending on the firm’s characteristics, we have chosen 300 companies. In the end, after
a closer analysis, only half of them were kept.
To complete the database, we required from South Pole Group different companies character-
istics as the source of the reported CO2 emissions, revenues, gross profit, the cost of goods sold,
fixed assets and a number of employees. We also added two additional variables to the database,
the share price and the return on investment that are also the variables supposed to be highly
related to the companies environmental activities. These two variables were collected from the
database Thomson Reuters. All the variables are described in the table A.1.
As the primary database had missing data, we needed to complete the missing values via
the companies annual reports, or other verified sources as CDP database3, Thomson Reuters,
Statista, YCharts, companies’ annual reports or CSR report. In some cases, values needed to
be aligned to the new officially published information. In cases where it was not possible to ver-
ify suspicious values or to complete missing data, the company was deleted from the database.
Eventually, we collected fully complete, verified information on 135 companies.
Note that for the later analysis we needed to transform the original transversal structure to a
panel database. To do so, we used the R packages “reshape” (Wickham (2007)) for the purpose
of changing the structure of the data and the package “gdata” Warnes et al. (2014) to rename and
remove the variables. We also reduced the number of the variables from 77 to 22, as we had the
observations per year in panel data. Certain variables remained the same, other changed. The
variables and their description of the reshaped panel database figure in the table 4.2.
4.2.2 Variables description
For our analysis, we are using a database which has 135 observations (firms) and contains 22 vari-
ables observed over a period of 9 years, from 2005 to 2013. All variables from panel database are
3Source: Home - CDP. Retrieved November 02, 2016, from https://www.cdp.net/.
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described in table 4.2, and few variables that exist only in the transversal database are presented
again in the table A.1. Note, we had several variables that served as identification variables, al-
though important for us, they do not get any attention in the description. In this section, we describe
the selected principal variables into more details.
Variables Description
ID Company’s identification number (numeric);
NAME Company’s name (nominal);
YEAR Year (numeric);
CDP Indicator variable defining if the company is reporting to the CDP (0: not
reporting, 1: in 2009; 2: in 2010) (numeric);
COUNTRY Company’s headquarter (nominal);
SECTOR Company’s sector (nominal);
INDUSTRY_SECTOR Company’s industry (nominal);
SUB_INDUSTRY Company’s sub-industry (nominal);
CLIMAT_CDP Indicator variable defining if the company is reporting to the Climate
Change program (0: No; 1: Yes)(numeric);
WATER_CDP Indicator variable defining if the company is reporting to the Water program
(0: No; 1: Yes) (numeric);
SUPPLY_CHAIN_CDP Indicator variable defining if the company is reporting to the Supply chain
program (0: No; 1: Yes) (numeric);
FOREST_CDP Indicator variable defining if the company is reporting to the Forest program
(0: No; 1: Yes) (numeric);
GHG Company’s greenhouse gas emissions in metric tons (numeric);
S Source of the reported company’s greenhouse gas;
R Company’s revenue in mio Swiss fancs (CHF) (numeric);
GP Company’s gross profit in mio CHF (numeric);
COGS Company’s cost of goods sold in mio CHF (numeric);
FA Company’s fixed assets in mio CHF (numeric);
EMP Company’s number of employees (numeric);
P Company’s share price in CHF (numeric);
RI Company’s return on investment in CHF (numeric);
KL Company’s capital-labor ratio (numeric);
GHG_EMP Company’s greenhouse gas emissions in metric tons per employee
(numeric).
Source: Author’s elaboration.
Table 4.2: Variables in the panel database
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CDP, CDP_IN
The variable CDP, which figures in the panel database, is a categorical variable, defining whether
the company is reporting to the CDP. It takes three values: 0 for non-participating companies, 1 and
2 for participating companies that signed to the CDP in 2009 or 2010 respectively. In the transversal
database, this variable is called CDP_IN and takes values 1 for participating companies and 0 for
non-participating companies, without any reference to the year. This information was handled by
the variable CDP_YEAR, described in the next section.
The variable CDP_IN, in the transversal database, was built in two steps. First, we checked if
the company is contained in the CDP database. Note that with the exception of one observation, all
the selected companies figured in the CDP database. The second step was to verify the reporting
status in the CDP database. The six possible reporting statuses were:
• Answered questionnaire: answered some or all of the questions in the questionnaire;
• Declined to participate: declined to participate in the project;
• Information provided: provided information relevant to the questionnaire; did not answer the
questionnaire;
• No response: did not reply to CDP regarding the request;
• Not in CDP: not in a CDP sample for the year specified;
• See another: the response is covered by another company, usually the parent company.
The companies that answered the questionnaire in some year t and all the following years took the
status 1. If the company did not answer the questionnaire for just one of the years after the year
t, we still considered the company to be part of the program. Companies with a discontinuity in
their answers, or with reporting status “See another”, were rejected from our database, and were
not even considered as non-treated companies. We considered the company as non-participating,
with the status 0 if one of the following conditions were satisfied: company was not in the CDP
database and so we considered that it does not participate to the CDP program; company de-
clined to participate; company only provided the information without answering the questionnaire;
company did not provide the response.
Note that all companies with value 0 for the variable CDP_IN in the transversal database took
the same value 0 for the variable CDP in the panel database. In order to be considered as a treated
unit, and so have values 1 or 2 in panel database, the company needed to have completed the
questionnaire for the treatment year T +1 (years 2009 or 2010 - see variable CDP_YEAR), and also
all the following years. The information on the year came from the transversal database. Firms with
other CDP_YEAR than 2009 and 2010 were not considered in our analysis and so do not figure in the
final database.
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CDP_YEAR
The variable CDP_YEAR appeared only in the transversal database but helped to build the variable
CDP in the panel database. The variable provides the information on the year when the company
started to report to the CDP. It does concern only the years 2003 to 2013, as the CDP exists only
since 2003, and for the year 2014, the data were not yet published. If the company does not report
to the CDP program, the variable takes value NA.
In order to create this variable, we search in the official CDP database whether the company
does exist. If it was the case, we verified the year of the first report to one of the four CDP’s
programs (Climate change, Water, Supply chain, Forest; cf., section 3.3.2).
As already mentioned, this variable was one of the selection’s variables, and the final database
contains only observations with values equal to 2009, 2010 or NA. By default, the variable CDP_IN in
the transversal database is the filter variable and already defined the reporting status and conditions
for variable CDP_YEAR. That is why in the panel database the variable CDP contains both pieces
of information as there are only three possible values. But remember that when selecting the
observations from the transversal database we had more than 1600 firms to choose from.
COUNTRY
The variable COUNTRY defines the country where the company’s headquarters are based. The
values for this variable were taken from the CDP database. This variable is very important because
the origin of the company mostly defines company’s politics including the sustainability. As already
mentioned, the final panel database contains only the three values: European Union (EU), United
Kingdom (UK), and United States (US).
We have selected these regions not only because of their similarities in economic development
but also and especially because of the similarities in corporate social responsibility policy. We can
name the most common regulations in these regions, which are the EU Emission Trading Sys-
tem, the UK Carbon Reduction Commitment Energy Efficiency Scheme and the US Environmental
Protection Agency’s Mandatory GHG Reporting Rule. UK is not purposely included in the EU,
because of its specificity in sustainable development strategy. More detailed information about the
European, British and American low-carbon politics are presented in the section 3.2.2.
SECTOR, INDUSTRY_SECTOR and SUB_INDUSTRY
The variable SECTOR, INDUSTRY_SECTOR and SUB_INDUSTRY specify the company’s sector, in-
dustry and sub-industry. The coding was defined by Global Industry Classification Standard (GICS).
The GICS structure consists of 10 sectors, 24 industry groups, 68 industries and 154 sub-industries.
We found the values for the three variables in the CDP database.
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The variable SECTOR contains the following values: Consumer Discretionary (CD), Consumer
Staples (CS), Energy (ENGY), Financials (FINA), Health Care (HC), Industrial (INDU), Informa-
tion Technology (IT), Materials (MATR), Telecommunications (TC), Utilities (UTIL). We describe the
sector classification in the annexe A.2. Note that we had only one observation in the telecom-
munication sector. Thus we combined it with Information Technology and created sector called
Information Technology and Telecommunication ITTE. For more information on GICS classification
please see the CDP Technical Note on Global Industry Classification Standards 4 Carbon Diclosure
Project (CDP) (2014a).
CLIMAT_CDP, WATER_CDP, SUPPLY_CHAIN_CDP and FOREST_CDP
The variables CLIMAT_CDP, WATER_CDP, SUPPLY_CHAIN_CDP, FOREST_CDP define the year the com-
pany began reporting to the CDP’s Climate change, Water, Supply chain or Forest programs, re-
spectively. This concerns only the period between 2003 – 2013, and the variable takes value NA if
the company does not report to one of the CDP’s programs. Company’s reporting continuity to the
program is a necessary condition to consider the firm being part of the program.
We can sum up the properties in the following manner:
• CDP’s climate change program target is the reduction of companies greenhouse gases emis-
sions and the mitigation of the climate change risk;
• CDP’s water program main objective is to mobilise action on corporate water management in
order to secure water resources and alleviate the global water crisis;
• CDP’s supply chain program objective is to achieve sustainable supply chain management
for the firms and their suppliers by optimising the risks and opportunities that climate change
and water pose to the globalised supply chain model;
• CDP’s forest program intends to manage companies impact on the deforestation risks and
as a consequence regulate the land use change for agriculture as being the main driver of
deforestation.
GHG
The variable GHG gives the values of company’s greenhouse gas or CO2 emissions (used as a
proxy) for the years 2005 – 2013. The emissions were mostly provided by South Pole Group. South
Pole Group got the information on the CO2 emissions either from different reports, or they did
estimate them via different appropriate models. The origin of the reported values is given by the
variables S - source presented below.
4Source: CDP technical note on Global Industry Classification. Retrieved November 2, 2016, from
https://www.cdp.net/Documents/Guidance/2014/cdp-technical-note-gics-2014.pdf.
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In order to calculate the amount of emissions released into the environment by the company, the
Greenhouse Gas Protocol, also used by CDP, suggests reporting the values from different sources:
direct and indirect emissions. Furthermore, the Greenhouse Gas Protocol specifies: “Direct GHG
emissions are emissions from sources that are owned or controlled by the reporting entity. Indirect
GHG emissions are emissions that are a consequence of the activities of the reporting entity but
occur at sources owned or controlled by another entity. The GHG Protocol further categorises
these direct and indirect emissions into three broad scopes:
• Scope 1: All direct GHG emissions;
• Scope 2: Indirect GHG emissions from consumption of purchased electricity, heat or steam;
• Scope 3: Other indirect emissions, such as the extraction and production of purchased mate-
rials and fuels, transport-related activities in vehicles not owned or controlled by the reporting
entity, electricity-related activities (e.g., T&D losses) not covered in Scope 2, outsourced ac-
tivities, waste disposal, etc.5”
The reported values in our database contain only Scope 1 and Scope 2 emissions.
Note that we verified all suspicious values having big differences between GHG’s emissions
within the years. If any pieces of information that helped us to correct the difference was found,
we adjusted the GHG’s emissions. If we still had doubts with respect to the reported values, we
deleted the firm from our database.
S
The variable S defines the source of the reported GHG’s emissions for the years 2005 to 2013.
Each of the values is associated to the corresponding value of the variable GHG. The variable was
provided by South Pole Group, with certain adjustments depending on corrections of the variable
GHG.
The variable source takes the four following values:
• APROX: approximation by the model;
• CDP: carbon disclosure project database;
• CSR: corporate social & sustainability responsibility report;
• REP: various reports (may include CDP or CSR reports).
5Source: Greenhouse Gas Protocol - FAQ. Retrieved October 13, 2016, from http://www.ghgprotocol.org/calculation-
tools/faq.
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R, GP, COGS, FA, EMP, P, RI, KL, GHG_EMP
The following variables: R, GP, COGS, FA, EMP, P, RI, KL, GHG_EMP, report different company’s
characteristics. Apart of the variables P, RI, they were provided by South Pole Group and we have
completed the database in case of missing data. The financial data are in Swiss Francs (CHF).
Note that the data collected in different currencies were converted in Swiss Francs with respect to
a specific year6. The two variables: P, RI, were collected via Thomson Reuters. We describe the
variables in the upcoming paragraphs.
The variable R defines company’s annual revenue in million CHF. The Sales/Revenue/Turnover
represent the total of operating revenues less various adjustments to Gross Sales. The adjustments
are: returns, discounts, allowances, excise taxes, insurance charges, sales taxes, and value added
taxes (VAT). Moreover, this variable includes revenues from financial subsidiaries in industrial com-
panies if the consolidation includes those subsidiaries throughout the report, and subsidies from
the federal or local government in certain industries (i.e., transportation or utilities). Additionally,
the variable excludes inter-company revenues and revenues from discontinued operations.
The variable GP gives companies gross profit in million CHF respectively. Gross profit, as
defined by South Pole Group, is a company’s residual revenue after selling a product or providing a
service minus the costs associated with the production or service. In other words, it is a company’s
revenue minus its cost of goods sold. Concerning financial companies, they do not have figures on
the cost of goods sold, so by default, it was not possible to have the gross profit numbers. In this
case, we opted for the operating income to replace the missing values of the gross profit, which is
the revenue minus the operating costs.
The variable COGS delineates company’s annual cost of goods sold in million CHF respectively.
The definition for the cost of goods sold is specific to the sector or industry. The specifics also
change as well within production or service companies. One of the definitions, from Investopedia,
we used while collecting the missing data is: “Cost of goods sold (COGS) is the direct costs at-
tributable to the production of the goods sold by a company. This amount includes the cost of the
materials used in creating the good along with the direct labour costs used to produce the good.
It excludes indirect expenses such as distribution costs and sales force costs.7” In order to define
the COGS for the missing data, we either used the COGS directly reported by the company, or in
case the company did not specify it, we used the standard definition of COGS in order to evaluate
the right amount with respect to the specifics of the company. The financial sector does not report
the cost of goods sold, so for these firms, we use operating cost instead of the cost of good sold.
The variable FA determined company’s annual fixed assets in million CHF. It represents assets
which are purchased for long-term use and are not likely to be converted quickly into cash, such as
land, buildings, and equipment.
The variable EMP describes company’s number of full-time employees.
6For exchange rate we used http://freecurrencyrates.com/.
7Source: Www.investopedia.com. Retrieved Octobre 21, 2016, from http://www.investopedia.com/terms/c/cogs.asp.
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The variable KL is company’s capital-labor ratio. It measures the ratio of capital employed to
labour employed. We build this variable by making the ratio between the fixed assets and the
number of employees, that is KL= FAEMP .
The variable GHG_EMP represents the amount of the CO2 emissions produced by one employee
in the firm. The variable was constructed by dividing the number of the emissions produced by the
firm by the number of employees, that is GHG_EMP= GHGEMP .
The variable P defines the latest company’s share price in CHF available from the appropriate
market. It is the previous day’s closing price from the default exchange except where more recent
or real-time prices are available8.
The variable RI describes company’s return on investment in CHF. It is available for individual
equities and unit trusts. This shows a theoretical growth in value of a shareholding over a specified
period, assuming that dividends are re-invested to purchase additional units of equity or unit trusts
at the closing price applicable on the ex-dividend date. For unit trusts, the closing bid price is used9.
4.2.3 Descriptive statistics
As already mentioned, our database is unique and contains personally collected data with contri-
bution from South Pole Group. For our analysis, we are using 135 observations on 22 variables
observed over a period of 9 years, from 2005 to 2013. The variables are described in the previous
section 4.2.2, and a brief explanation is given in the table 4.2. This section gives the descriptive
statistics of our database. The table 4.3 presents the main quantitative information concerning the
databases.
The names of all the observations are presented in annexee in table A.2, in addition, an example
of one company is presented in table A.3. Out of the 135 companies, 73 do participate to the
Carbon Disclosure Project, and 62 companies constitute the potential control units. As already
mentioned, the observation period is nine years, from 2005 to 2009. Note that the time period is a
very important parameter in our analysis, and so merits closer attention.
Ideally, we would like to use observations over a longer longitudinal scale, but the provided
data by South Pole Group contains information from 2005 to 2013 only. Moreover, our main study
variable, which is a company’s greenhouse gas emission, could not be tracked for additional years.
Even though we can easily find this information for the majority of the countries, for example, the
World Bank provides the data going to 1960, the firms’ level emissions are not so easily attainable.
The sustainable behaviour of firms received closer attention only in the last two decades, and
since then the companies started slowly reporting their CO2 emissions. In the beginning, the
reported values were highly inaccurate, and the firms needed a better guidance in how to collect
and disclose the data. The companies did not have to wait long for this help, and many governments
and private companies are now proposing a multitude of programs to this effect, as we explained in
8Source of definition: Thomson Reuters.
9Source of definition: Thomson Reuters.
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Number of companies: 135
Number of participating companies: 73
Number of non-participating companies: 62
Period: 2005 - 2013
Regions: EU (48, 29, 19), UK (34, 16, 18). US (53, 28, 25)
Sectors: Consumer Discretionary (22, 10, 12), Consumer Staples (16, 12, 4),
Industrials (36, 18, 18), IT & Telecommunications (14, 12, 2),
Energy (8, 3, 5), Materials (11, 5, 6), Financials (12, 3, 9),
Health Care (10, 7, 3), Utilities (6, 3, 3)
Note: In parenthesis you find number of observations for total, participating
companies and non-participating companies respectively.
Source: Author’s elaboration.
Table 4.3: Global database in numbers
chapter 3. To our knowledge, there is no existing obtainable databases containing company CO2
emissions for a longer period. Neither the companies themselves do not generally hold historical
data on their emissions as it is a fairly new measurement, often neglected in the past. As Max
Horster, Managing Partner of South Pole Climate Neutral Investments confirmed: “It is not that
companies are purposely hiding the correct numbers, they just did not put much effort into it.”
Another important information from table 4.3 is in the geographic regions. In total 14 different
countries are represented: 48 from the European Union (excluded UK), 34 observations are from
the United Kingdom, and 53 from the United States. The distribution between the treated and
control units is quite equal, and we have always almost half of the observations of non-participating
companies in each of the regions.
If we have a look at the variable sector, we see that the industrial sector is mainly represented
with 27% of observations, followed by the consumer discretionary and consumer staples sectors
with 16% and 12% observations. The rest of the sectors contains between 6 to 10% of companies.
Moreover, the data contains information on 57 industries and 85 sub-industries.
Besides the table 4.3, the table A.4 in annexe contains other additional information on the
variables. We can observe that 72 out of the 73 participating companies are in the CDP climate
change program. Only 14 companies are in the CDP water program, 26 in CDP supply chain
program and we see a smallest participation with only 5 companies in the CDP forest program.
The last three programs were created after the pioneer climate change, respectively in 2008 the
supply chain program, followed two years later by water program and in 2012 by forest program.
The later founding of these complementary programs can explain the poor participation.
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Another important part of the data descriptives is the distribution of companies between the
sectors and countries. We find in annexe the cross-tables representing these statistics. Table A.5
in annexe presents the cross-table for all companies. More interesting is the distribution between
participating and non-participating companies represented in tables A.6 and A.7 in annexe. We
can see that the distribution of the companies within countries and sectors is quite similar and so
none of the treated companies is without potential synthetic control, as the treated and control units
are represented in all sectors and countries.
And another variable that needs a bit more attention is the variable source, S, and is reported in
the table 4.4. We can see that most of the emissions for the year 2005 to 2007 were approximated
by South Pole Group, starting with 97% of approximated data in 2005, still with 76% in 2007 and
then radical dropping down since 2008. We end up with only 30% of approximated data in 2013.
One aspect that can explain this number is that companies started to report to CDP in 2009 or 2010,
42 and 34 companies respectively, and the rest, meaning half of the total, do not report to CDP at
all. Theses numbers can possible approve our theory on the fact that the companies started to be
interested in their emissions only in last few years. The evolution of reporting can also give some
credits to the hypothesis that the CDP participants have a bigger will concerning the transparency
of reported CO2 emissions, compared to non-participants.
YEAR APPROX CDP CSR REP
2005 131 0 2 2
2006 116 2 13 4
2007 103 2 30 0
2008 85 4 44 2
2009 58 19 55 3
2010 44 18 70 3
2011 42 21 68 4
2012 36 29 68 2
2013 40 24 67 4
Source: Author’s elaboration.
Table 4.4: Source of the reported company’s emissions within the years
Figure 4.1 represents yearly averages and its evolution for different variables between years
2005 and 2013. We find the summary statistics for treated and control companies for each of the
variables in table 4.5. First, let’s analyse the figure. For each graph the blue line represents the av-
erage value for all companies, the red line is the average for participating companies, and in green,
we have the mean for non-participating companies. The statistics in annexe show the number of
observations, average, median, standard deviation, minimum and maximum. By observing these
tables, we note that there is a big range for each of the variables and types of companies. The
big difference is also remarkable between the mean and median. This shows the heterogeneity
between the observations and the two pools (treated and control). After closer analysis, we found
that different observations with very extreme values have a large influence on the mean. That is
why we accompanied the average graphs with figure 4.2 which represents yearly median and its
evolution for different variables between years 2005 and 2013.
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Figure 4.1: Graph of average statistics
We are mainly interested by companies’ emissions. The other variables as revenue, gross
profit, cost of goods sold, fixed assets, share price, return on investment and employees represent
different characteristics of the companies. They will help us for normalising purpose and to build
the synthetic control.
The graphics on figures 4.1 and 4.2 show gradual rise of all the variables from 2005 to 2013, and
we notice the drop during the 2008 economic crisis. The variables that were not really influenced by
the crisis are the fixed assets and number of employees. Concerning the fixed assets, companies
could not react on that as quickly because there are very small degrees of liquidity for fixed assets.
Concerning the number of employees, the main reason is that companies did cut the number of
employees by serving a notice to the part-time, causal, daily or weekly hire employees in order to
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Figure 4.2: Graph of median statistics
compensate the loss in production. As during the 2008 crisis the companies’ production collapsed,
the financial results of the companies were influenced as well. The revenues and cost of goods
sold dropped, but gross profit conceived less influence. The average share price and return on
investment seem to be also partially influenced by the crisis 2008.
Concerning the greenhouse gas emissions, they generally went up for all the companies. We
observe a little drop of median CO2 emissions for the participating companies after 2009 and 2010.
On the opposite, the average CO2 emissions went up after 2009 for participating as well as non-
participating companies. But before we can get to any conclusion, we need to do more profound
analyses to see whether this effect is due to the CDP project.
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Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 2055589 192362 6888017 1910 56739464 657
R 8290 3714 15061 86 108000 657
COGS 5337 2058 12261 0.16 103000 657
EMP 26785 9590 35561 67 171400 657
P 56 23 234 0.04 3117 657
RI 37559 1148 164030 7 1389152 657
KL 756718 145336 1910218 1376 11384492 657
GHG_EMP 168 13 587 1 7432 657
Non-CDP companies
GHG 887478 96676 1727858 228 9842151 558
R 16013 2395 84223 15 6950000 558
COGS 4599 1248 11226 4 88012 558
EMP 14884 6206 29635 6 2470000 558
P 39 16 78 0.08 932 558
RI 3889 505 15652 6 193627 558
KL 1877658 129950 6505555 2370 58158299 558
GHG_EMP 217 15 673 1 6030 558
Source: Author’s elaboration.
Table 4.5: Summary statistics (panel data on 9 years)
Table 4.5 reports the key descriptive statistics for our sample. We observe different values of
the variable GHG for both participating and non-participating companies, with high average CO2
emissions and extremely big range. On the other side, the CO2 emissions per employee have
much lower values and relatively to absolute emissions, this intensity measure considers the size
of the firm and thus is more comparable across firms and also between different reporting periods.
Thus we suggest considering the variable GHG_EMP as the measurement of carbon performance.
While exploring the data, we also did the same analysis by sector and by country (EU, UK,
US). We remark that in general the conclusions were the same, except that the impact of the crisis
was more or less pronounced. Also, the number of observations in each class is different, and due
to this heterogeneity, the evolution might slightly differ from the general analyse that we have just
presented.
Additional conclusions can be done from the detailed analysis per sector and per CDP partic-
ipation for several variables (GHG, R, COGS, EMP, KL, GHG_EMP). The tables A.8 – A.16 in annexe
contains the descriptive summary statistics for each sector. The first conclusion by analysing the
tables is that the statistics are similar inside each sector and relatively different between the sec-
tors, with smaller or bigger differences. The second conclusion is that we can divide the sectors
into three categories with respect to the CO2 emissions: heavy, medium or lighter emitters. In
the first group, we qualify the energy, the materials and the utility sectors. They are characterised
by very high Scope 1 and 2 emissions and the CO2 emissions per employee, but also important
capital-labor ratios. In the second group belong the consumer discretionary, the consumer sta-
ples and the industrial sector. These three sectors have relatively important CO2 emissions, but
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with the high number of employees, their emissions per employee are relatively low. Note that it
is better to check the median value for different variables, as the sectors contain some extreme
values with respect to the emissions. The last group contains the financial, the health care, and the
information technology and communication sectors. These three sectors have relatively low CO2
emissions and emissions per employee. They also have quite important number of employees and
the capital-labor ratios. Concerning all other statistics, they are comparable between the sectors.
Note, that the division of the sectors into these three groups also confirm the information provided
in the Global 500 Climate Change Report 2013 by CDP (Carbon Diclosure Project (CDP) (2013)).
Source: Author’s elaboration.
Figure 4.3: Average emissions per employee (company and regions)
The figure 4.3 presents the average emissions per employee without extreme values. The four
quadrants show the nine years path not only for all companies but also per region. The green
line denotes the non-participating companies, the blue one all companies and the red one the
participating companies. These graphs represent only tendencies in an evolution of emissions per
employee and cannot be used for the final conclusion to approve that there is a positive effect from
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the CDP program, even if the graphs would suggest otherwise. We also can observe the different
evolution of the emissions per employee in each of the regions.
We also wanted to do the analysis by the size of the company, which means small, medium
and large. This type of analyses is not possible, because with respect to the definition by European
Commission10 only 8 companies in 2005 and 4 in 2013 satisfied the definition of the small or medium
company.
As a conclusion we must add that for our analysis, we are a bit of concern by the short time
period of observations and as well by the 2008 crisis, that might influence our study.
4.3 Methodology
The objective of our study is to assess the effect of the Carbon Disclosure Project on the companies’
carbon dioxide emissions. To do so, we use the synthetic control method presented in the chapter
2, one of the program evaluation methods that intend to assess the causal effect of exposure to a
set of units to a program treatment on some outcomes.
In this section, we first explain the principal components of the model with respect to our case,
such as the variables that constitute it. We further describe the way we estimate the optimal
synthetic controls and the treatment effect, and we also present the alternative model that we
considered for our analysis. In the second part, we talk about how we examined the results of the
analysis. The third section presents the applied tests. And finally, in the last section we justify the
selection of the model variables.
4.3.1 Model
The ultimate objective of the synthetic control method is to estimate the treatment effect, aˆ , de-
scribed by equation (2.5). In our case, the treatment is supposed to be the participation to the
Carbon Disclosure Project. And we want to measure what is the effect of the CDP on the firms’
greenhouse gas emissions. The program is assessed by the treatment effect, which is the differ-
ence between the observed emissions per employee of the company participating to the CDP and
the estimated emissions per employee of its synthetic control company. To estimate the synthetic
control, more precisely the weight representing the optimal synthetic control, we make use of the
observed characteristics and the pre-treatment outcome of the units from the donor pool. The
important elements of the model are described in the tables 4.6 and developed more in details
bellow11.
10Source: What is an SME? - Growth - European Commission. Retrieved November 01, 2016, from
http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_en.
11For more detail about the synthetic control, please check the section 2.2.1.
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Research question: The effect of the Carbon Disclosure Project on the firms’ emissions;
Treatment: Participation to the Carbon Disclosure Project;
Treatment effect: The difference between the observed emissions per employee of the participating company and the
estimated emissions per employee of its synthetic control;
Used method to estimate
the treatment effect:
Synthetic control method;
Potential outcome: Company’s greenhouse gas emissions per employee (GHG_EMP)
Predictors: Pre-treatment averages of the variables R, GP, COGS, EMP, KL, GHG, P and RI;
Special predictors: Company’s greenhouse gas emissions per employee for each pre-treatment year;
Donor pool selection: For each of the treated unit we select the control units with respect to the sector characteristics of
the firm (For more details check table 4.7);
Optimal choice of the
weights for the control unit:
Data driven procedure, in particular the nested optimisation, to estimate the optimal weights V and
W for the predictors and control units respectively;
Observed time period: 2005 – 2013;
Pre-treatment period: 2005 – 2008 or 2005 – 2009;
Post-treatment period: 2009 – 2013 or 2010 – 2013.
Source: Author’s elaboration.
Table 4.6: Important elements of the model
Main elements of the model
For each treated firm we suppose a balanced sample of J+1 companies, indexed by j= 1, . . . ,J+
1, that are observed at time period t = 1, . . . ,T . We suppose a positive number of pre-treatment
periods T0 and of post-treatment periods T1, with T0 + T1 = T and 1 < T0 < T . In our case, we
observe the companies between years 2005 – 2013. Therefore the total number of periods is T = 9,
the first period t = 1 is year 2005, and the treatment years are either T 20080 +1= 5 or T
2009
0 +1= 6
for 2009 and 2010 respectively.
The potential outcome variable Y, that measures the impact of CDP, is the CO2 emissions per
employee (GHG_EMP). So, the outcome variable for the unit j at time t is:
Yjt = GHG_EMPjt .
Without loss of generality, we assume that only the first company is exposed to the CDP and is
uninterruptedly exposed to the program after some initial period. The rest of companies, which are
not exposed, constitutes the donor pool of J control companies. Note that the number J changes
from one treated company to another, depending on which sector the treated companies belongs
to (see table 4.7). As only the first company from the sample is participating in the program, we
denote by Y1t the CO2 emissions per employee of the treated company at time t, and similarly by
YNjt , which is simply Yjt 8 j > 1, for the company without the participation to the CDP.
Moreover, in order to construct the synthetic control, we need to define the variables contained
in the vector and matrix of the pre-treatment characteristics of the unaffected and controls units, X1
and X0 respectively (defined in equation (2.12)).
The variables, R, GP, COGS, EMP, KL, GHG, P and RI, are the confounding variables constituting
the (m⇥ T ) matrix, where m, the number of the confounders, is equal to 8 and T = 9. The Cl ,
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l = 1, . . . ,8, confounding variables constitute the (r⇥ 1) vector of observed covariates Z j. In our
case r = l, that is, for each confounder we have one specific linear combination of past values of
the corresponding covariate. In particular, the covariates are the pre-treatment averages of the
analogous confounder, that is:
ZLlj = T
 1
0
T0
Â
s=1
Cljs, 8l.
Thus the vector of predictors for the unit j is:
Z j = (R,GP,COGS,EMP,KL,GHG,P,RI)0. (4.1)
To complete the pre-treatment characteristics we define the special predictors. In our case they are
the values of the CO2 emissions per employee for each pre-treatment year. Specifically, we define
M = T0 vectors K of order (T0⇥ 1), and each special predictor is YKtj = Yjt for t = 1, . . . ,T0. As a
result, the values of the special predictors for the unit j are:
YK1j , . . . ,Y
KM
j = GHG_EMPj1, . . . ,GHG_EMPjT0 . (4.2)
Based on the figure 2.1 from chapter 2.2.1, the figure 4.4 represents the application of the
synthetic control method to our case (the example is for the treatment year 2009). In order to
estimate the treatment effect, the first step is to use the predictors to estimate the synthetic control
for each of the treated units during the pre-treatment period. The second step is to estimate the
treatment effect during the treatment period. Let’s first focus on the estimation of the optimal
weights of the control unit.
Estimation of the optimal weights
For each of the 73 treated units, we selected a limited number of control units into the donor pool.
The selection was based on the sector membership of the treated and control units. Table 4.7 gives
the number of the treated units from each sector and the number of the control units constituting the
donor pool. The last column of the table 4.7 shows the composition of the donor pool. Depending
on the sector we analyse, we were obliged to enlarge our donor pool by selecting companies
from another sector than the one of the treated unit only. The selection was always based on
the characteristics of the sectors and the respective companies, that we already explained in the
previous section 4.2.3.
Once we know the constitution of the donor pool and the values of the predictors, the next
step is to estimate the (J ⇥ 1) vector of weights W = (w2, . . . ,wJ+1)0 such that 0  wj  1, for
j = 2, . . . ,J+ 1, and ÂJ+1j=2wj = 1. Remind that these weights give different importance to each of
the control units that constitute the synthetic control (bigger is the weight, more important is the
control unit).
We chose a vector W⇤ = (w⇤2, . . . ,w⇤J+1)0 such that the resulting synthetic control best approx-
imates the company exposed to the CDP with respect to the outcome predictors Z, defined in
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Source: Author’s elaboration.
Figure 4.4: Application of synthetic control method (with TO+1= 5)
Sector Treated Total controls Controls per sector
Consumer Discretionary 10 12 (12 CD)
Consumer Staples 12 16 (4 CS, 12 CD)
Industrial 18 18 (18 INDU)
Information Technology and Telecommunication 12 18 (2 ITTE, 3 HC, 9 FINA, 4 CS)
Energy 3 14 (5 ENGY, 3 UTIL, 6 MATR)
Materials 5 11 (6 MATR, 5 ENGY)
Financials 3 9 (9 FINA)
Health Care 7 9 (3 HC, 4 CS, 2 ITTE)
Utilities 3 14 (3 UTIL, 5 ENGY, 6 MATR)
Note: In parenthesis you find the composition of the donor pool per sector.
Source: Author’s elaboration.
Table 4.7: Constitution of the donor pools
equation (4.1), and special predictors YK1j , . . . ,Y
KM
j , defined in equation (4.2). That is, we want the
equations (2.7) be satisfied. As we saw in chapter 2.2.1, the equations (2.7) do not hold exactly, so
we select the vectorW⇤ such that the distance given by equation (2.8) is minimised (the values of
the vector and matrix X1 and X0 have been defined below).
Note that the vector W⇤ is a function of the diagonal matrix V. The matrix V defines the
weights of the company’s characteristics in the synthetic control, and so we can consequently get
the similitudes between the treated firm and its synthetic control.
In order to estimate the weights in vector V and by consequence the ones in W⇤, we use the
data-driven procedure, more specifically the nested optimisation procedure described in section
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2.2.2. By this method, we choose V⇤ among all positive definite (k⇥ k)12 diagonal matrix V, in our
case k= 8+T013, such that the mean squared prediction error of the outcome variable is minimised
over the entire pre-treatment period, that is Tp14 is equal T0.
Estimation of the treatment effect
Once the optimal weights of the synthetic control have been estimated by the nested optimisation,
we can calculate the estimated treatment effect for each of the treated unit by the following equation:
aˆ1t = GHG_EMP1t  
J+1
Â
j=2
w⇤jGHG_EMPjt , 8t > T0. (4.3)
Alternative model
In the model selection process we also considered a model with the variable GHG (CO2 emissions)
as potential outcome variable. We selected Z j = (R,GP,COGS,EMP,KL,GHG_EMP,P,RI)0 as
the vector of predictors for the unit j and YK1j , . . . ,Y
KM
j = GHG_EMPj1, . . . ,GHG_EMPjT0 as the
vector of special predictors for the unit j. This model had extremely high values of the loss functions
that we tried to minimise by the nested optimisation. This effect is coming from the fact that the
CO2 emissions are very different between the companies and therefore this heterogeneity does not
allow to find a good fit. Though we opted for the model with the variable GHG_EMP as the potential
outcome variable, given that this variable normalises the emissions and becomes adjusted to the
size of the company.
4.3.2 Check of the results
Before applying any statistical tests the first step is to check the results of the analysis. There are
two ways to examine the results: visually on the graphs and quantitatively by the tables15.
First of all, we check the path and gaps plots of the treated unit. Figure 2.4 shows different
possible results. But we mainly use the figure 2.5 to analyse if there is a good matching in the
pre-treatment period between the treated unit and its synthetic control, and whether there is a
treatment effect during the post-treatment period. In order to have a good match, there should be
a very small (or even nonexistent) gap between the treated unit and its synthetic control. That is,
the gap’s line should be as close as possible to the zero gap line during the pre-treatment period.
And in order to consider positive treatment effect of the CDP on the CO2 emissions, the treated
12k is the number of predictors.
13Where 8 is the number of confounders and T0 is the number of the special predictors. T0 varies between 4 and 5,
depending on the treatment year of the treated company.
14Tp is some set of pre-treatment periods over which the RMSPE is minimised.
15The presentation of the results of the analysis is explained in details in section 2.2.3.
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unit’s carbon path should be lower than its synthetic control’s carbon path. That is, the gap’s line
should be decreasing after some initial treatment period T0+1. If the gap’s line lays close to zero
or is even increasing in our case, we consider the results are showing no effect of the CDP.
Once we checked graphically the carbon path, we analyse the quantitative results. More pre-
cisely, we built tables analog to tables 2.2 – 2.5 representing some outcomes of the analysis. First,
we check the results of the table 2.5 that gives us an idea how well the synthetic control reproduces
the values of different companies’ characteristics before the treatment and how well it outperforms
the averages.
Then we check the relative contribution of each predictor and control units, as explained in
tables 2.2 and 2.3, as well as the loss functions values for w and v, that are the mean squared
predictors errors defined in the equations (2.8) and (2.9) respectively, which we have minimised by
nested optimisation method.
The last step is to analyse the gaps (cf. table 2.4). We want to have the gap close to 0 during
the pre-treatment period and negative during the post-treatment period. Moreover we calculate
the average treatment effect for the full post-treatment period (equation (2.11) with aˆ1t defined in
equation (4.3), t1 = To+ 1 and t2 = T ), which gives us an indication of the size of the treatment
effect. But we do not take it as an ultimate indicator, as we also check the path plot and gaps during
all periods. Say that it might be that there is a very high negative treatment effect for only one single
period, and the rest of the time there is no effect.
Note that if there is no good match between the treated company and its synthetic control, the
plots and tables that we use for the results’ analysis helps to detect different potential problems.
We can identify if there is any kind of influence of just one year or one control unit and where the
problem is. In some cases just to take one variable or one observation out helps already to get
more satisfying results.
4.3.3 Applied tests
By using the synthetic control method, we can test the results of the analysis. In our case, we
tested the treatment effect by using one of the falsification test so-called “in-space placebo”. We
also examined the misspecification of the model by using the root mean squared prediction error
and its related indicators. Finally, we applied robustness tests in order to check the quality of our
model with respect to the number of variables and observations in the donor pool. The application
of these methods is explained in this section, but for more detailed information about statistical
inferences applied in the case of the synthetic control method see the chapter 2.3.
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In-space placebo
The main idea of placebo studies is to predict the counterfactual outcome path for the companies
in the donor pool, knowing that the units that do not receive the treatment should not be affected
by it16. As already mentioned, in our case we do use the “in-space placebo” test, where we apply
the synthetic control method to every potential control company in the respective sample.
For each of “placebo-treated” company we calculate the treatment effects, the gaps and con-
struct the placebo effect graphs (see the figure 2.7) which helps us to analyse the significant evi-
dence of a treatment effect for the treated unit. Ideally, we would like to get for each treated unit
the results similar to the one on the graph 2.7a. That is, negative values of the gaps for the treated
unit and as a consequence, its gaps’ line laying below the “placebo-treated” units’ gaps lines.
Additionally, we use the placebo effect graph to calculate a specific pseudo p-value (see defi-
nition 2.1) by using the equation (2.12), where the number of bad estimates is the number of lines
laying above the treated unit’s gaps line and the total number of units is the number of lines. Note
that the number of the tested units might be different to the number of the units in the specific
sample as we have excluded observations with respect to the certain threshold of the RMSPE from
the placebo test donor pool (see the next section).
Root mean squared prediction error
Moreover, we calculated for each unit in the sample the root mean squared prediction error, which
is another measure to evaluate the treatment effect17.
More precisely we calculated the pre-treatment and the post-treatment RMSPE using the for-
mula (2.13), where the number of periods varies between 4 and 5 depending on which is the year
the treated company started to participate to the CDP. The values of t1 and t2 are equal to 1 and
T0 for the pre-treatment RMSPE, then T0+1 and T for the post-treatment RMSPE. The value of k
(treated unit) varies with respect to the company that we calculate the RMSPE for.
With the pre-treatment and post-treatment RMSPE, we get for each unit in the sample the
RMSPE-ratio defined in the equation (2.14). And we obtain consequently the RMSPE-ratio p-value
defined in the equation (2.15), where the number of RMSPE-ratio bad estimations is the number
of companies that did not participate to the CDP and have larger RMSPE-ratio than the one that
participates to the program. In order to interpret the values of the RMSPE and its associated
indicators we use the table 2.7.
As already mentioned before, for the in-space placebo test we construct four different placebo
effect graphs. The first one excludes all the companies having the RMSPE hundred times larger
than the treated company. The second one uses twenty times rule, the third one five times rule and
the last one excludes the control companies having the RMSPE two times larger than the company
participating to the CDP. An example of the four graphs is represented by the figure A.12 in the
annexe. For each graph, we get a pseudo p-value and then we do the average pseudo p-value for
the four graphs. It is another control p-value, but as the main pseudo p-value, we use the five times
rules.
16For more information about the placebo tests see section 2.3.1.
17For more information about the RMSPE see section 2.3.2.
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Robustness tests
In order to set the robustness of our model we used the sensitivity analysis of the number of
controls and the number of variables, both described in section 2.3.3. We conclude that adding
different variables to the model does not improve the estimations and the v loss function remains
constant. Though, the selected variables have a good predictive power already. Also, in general,
having a large number of control units will apriori increase the quality of the estimation and the
likelihood to get a perfectly fitting synthetic control. But on the other side, once the synthetic control
is estimated, decreasing the number of the control units in the donor pool does not necessarily
decrease the quality of the estimation, that is, the w loss function reminds more or less the same.
We did not carry any other robustness tests.
4.3.4 Justification of the choice of the variables
Table 4.8 shows results that confirm the choice of the predictors. We found positive and significant
relations between CO2 emissions (GHG) and revenue, cost of goods sold, share price and capital-
labour ratio. The first two results suggest that a bigger firm usually has higher emissions. The
positive relation between CO2 emissions and share price seems unexpected, as we would antic-
ipate that the market would punish firms with increasing emissions. This result could be due to
the strong positive correlation that we found between share price and revenue. And as the market
reflects the financial result immediately to the share price, this relation could be potentially stronger
that the one with the emissions. Furthermore, the positive relationship of CO2 emissions with the
capital-labour ratio advocate that the firms that are heavily dependent on machinery and equipment
tend to be more polluting than those that are labour intensive.
Predictors GHG GHG_EMP
R 0.18⇤⇤⇤⇤ 0.62⇤⇤⇤⇤
COGS 0.17⇤⇤⇤⇤ 0.14⇤⇤⇤⇤
EMP 0.25⇤⇤⇤⇤  0.12⇤⇤⇤⇤
P 0.65⇤⇤⇤⇤ 0.24
RI  0.01  0.01
KL 0.19⇤⇤⇤⇤ 0.06⇤
Note: non significant p> 0.05, ⇤p 0.05,
⇤⇤⇤⇤ p 0.0001
Source: Author’s elaboration.
Table 4.8: Correlations and significance of the correlations
Still, based on table 4.8, a negative correlation was found between CO2 emissions and return
on investment. This result was expected, but not significant. The number of employees showed
a positive correlation with the CO2 emissions. Again, this approves the theory that emissions
are generally growing with the size of the firm. Although we found that large firms try to be less
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pollution-intensive than smaller firms, which can be associated with the economics of scale. That
is, we detect a negative and significant relationship between a number of employees and CO2
emissions per employee (GHG_EMP), and the relationship was even more evident in each sector.
Our results support most of the previous research that we presented in the brief literature review of
firms’ environmental evaluation in the section 4.1.1.
4.4 Application in R
For the construction of the panel database, the computation of the descriptive statistics, the deter-
mination of the pertinent variables and the adjustment of the model, we used the statistic program
R (R Core Team (2013)). More precisely we applied the libraries Hmisc (Harrell et al. (2016)),
gmodels (Warnes et al. (2015)), vcd (Meyer et al. (2016)), reshape (Wickham (2007)), and gdata
(Warnes et al. (2015)). In this section, we will not describe the cited packages or their associated
functions, but we concentrate on the library “Synth”, the R package developed by Hainmueller and
Diamond (2015) for synthetic control methods in comparative case studies. Moreover, we present
the library “Mylib”, a package we built, that contains different functions created in order to adapt
the package “Synth” on our case. We also present the “Jobs” that produce the synthetic control
analysis. Furthermore, in order to help the presentation of the results of our study in chapter 5 we
also show the outcomes of the most important functions in the annexe A.4 by using an example of
one company from the consumer discretionary sector.
4.4.1 Package “Synth”
The package “Synth”: “Synthetic Control Group Method for Comparative Case Studies” imple-
ments the synthetic control group method for comparative case studies as described in Abadie
and Gardeazabal (2003); Abadie et al. (2010, 2011, 2015). For a better understanding, there is a
manual by Abadie et al. (2011), that uses the example that takes example of the terrorist conflict
in the Basque Country as a study case (see Abadie and Gardeazabal (2003)). This article shows
how to run the library “Synth” and shows the concrete implementations of different functions and
the results of the analysis. Therefore for a better understanding of the implementation of the SCM,
we are referencing the reader to this article.
The five most important functions of the package and their descriptions are presented in the
table 4.9. The application of these functions in our study (construction of the “Job”) is shown in the
figure 4.5, where the functions from the “Synth” package are in red boxes.
An example of outcome of the function synth() is presented in the annexe on the figure A.3. The
values are the estimate of the loss function from the nested optimisation (functions (2.8) and (2.9)),
the weights of the vectors V⇤ and W⇤. Moreover, examples of the gaps.plot() and path.plots()
outcomes are shown on the figure 2.4. Further, examples of the outcome of the synth.tab() are
shown on the figures A.5 – A.7 in annexe, which represents a concrete numerical view of the tables
2.2, 2.3, 2.5 respectively.
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Synth
dataprep() Constructs a list of matrices from panel dataset to be loaded into the function synth(). The output of the
function dataprep() contains a list of matrices. In order to run the function we need the following arguments:
data frame with the panel data (wdf), predictors (pr), operators that act upon these predictors – eg. “mean”
(pr.op), dependent variable (pr.op), unit variable numbers (u.v), time periods (t.v), unit names variable
(u.n.v), time-period over which outcome data should be plotted (t.p), treated unit (tr.id), control units (cd.id),
special predictors (sp.pr), the time-period over which to select the predictors (t.pr.p), time-period over which
to optimise (t.op.ssr);
gaps.plot() Plots gap in outcome trajectories between the treated and its synthetic control unit. This function plots
the gaps in the trajectories of the outcome variable for the treated unit and the synthetic control group
constructed by synth() and dataprep(). The user can specify whether the whole time period or only the
pre-treatment period should be plotted;
path.plot() Plots outcome trajectories between the treated and its synthetic control unit. This function plots the trajec-
tories of the outcome variable for the treated unit and the synthetic control group constructed by synth()
and dataprep(). The user can specify whether the whole time period or only the pretreatment period should
be plotted;
synth() Constructs synthetic control units for comparative case studies. synth() estimates the effect of an inter-
vention by comparing the evolution of an aggregate outcome for a unit affected by the intervention to the
evolution of the same aggregate outcome for a synthetic control group. synth() constructs this synthetic
control group by searching for a weighted combination of control units chosen to approximate the unit af-
fected by the intervention in terms of characteristics that are predictive of the outcome. The evolution of the
outcome for the resulting synthetic control group is an estimate of the counterfactual of what would have
been observed for the affected unit in the absence of the intervention;
synth.tab() Creates tables that summarise results of synthetic control group method. This function is called after
dataprep() and synth() in order to create tables summarising the results of the run of the synthetic control
method.
Mylib
sp.pr.f Creates a list of the special predictors to be used in the function dataprep();
year.vec.f Creates a vector that defines the time vector that is specific to the treatment variable with respect to the
treatment year;
unit.par.f Gives the values of the parameters for the unit of interest;
dataprep.arg Creates a list of arguments to be used in the function dataprep();
gaps.f Calculates the gaps of the output variable between the treated unit and its synthetic control;
path.plot.f Gives summary “path” plots;
gaps.plot.f Gives summary “gaps” plots;
p.vec.par.f Gives the vector of values of the parameters for the unit of interest, which will be used in the placebo tests;
placebo.data.f Produce the placebo data, as the placebo gaps, synth.tables(), daparep() values and synth() outputs;
mse.f Creates a list of different mean squared prediction errors, root mean squared errors and associated ratios;
p.synth.plot.f Gives summary gaps plot, that represents the “true” treated unit and the “placebo” (control) treated units.
Table 4.9: Functions in the package “Synth” and library “Mylib”
4.4.2 “Mylib”
The library “Mylib” prepares the data to be used by certain functions in package “Synth”, but also
contains new functions that calculate important elements in the synthetic control analysis. The
package “Mylib” is presented in the annexe B.1. Each of the eleven functions is briefly described in
the table 4.9 (for more details see the annexe B.1). In the figure 4.5 we describe the combination
and interactions between the library “Mylib” and the package “Synth”. It shows, in particular, the
structure of the different “Jobs” we constructed. The function of the “Mylib” is in the green boxes.
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Indeed, there are five main functions: gaps.f(), gaps.plot.f(), path.plot.f(), g.gaps.data.f(), and
mse.f(). We provide for the interested reader in annexe A.4 a reflective example which gives the
output of our functions.
An example of the outcome of the function gaps.f() is presented in the annexe on the figure A.4.
The gaps represent the treatment effect for each of the year, respectively the difference between
the treated company’s CO2 emissions per employee and the values of the same outcome variable
of its synthetic control. Moreover, examples of the gaps.plot.f() and path.plot.f() functions’ outcomes
are shown in the annexe on the figure A.8. Further, the example of the placebo gaps, as one of
the values of the p.gaps.data.f() function, is shown in the annexe on the figure A.9, where we have
the gaps of each “placebo-treated” companies. Figure A.10 in annexe represents outcomes of the
function mse.f(). And finally, the figure A.11 in annexe shows an example of the placebo effect
plots, as already presented theoretically on the figure 2.7.
4.4.3 Workflow implementation
For each of the sectors, we programmed a specific “Job” in order to execute the synthetic control
analysis, test and prepare the results to be evaluated and compared. The “Job” uses the packages
“Synth” and “Mylib” that we have presented in the previous sections. Each of the jobs performs
analysis for the individual company from the specific sector. One of the jobs of the consumer
discretionary sector, more specifically for the company “DEBREHAM PLC”, is presented in the
annexe B.2.
Moreover, detail explanations of the five important steps in the “Job” are explained in following
paragraphs. These correspond to the bullets in the figure 4.5. Concerning the figure, note that
the red boxes contain functions from the package “Synth” and the green boxes the ones from the
package “Mylib”. If the function is used by another function or to create another argument, it is
also represented in the box (e.g., t.pr.p and *sp.pr.f() respectively). The black box contains the
arguments to be used in the function dataprep.arg().
The steps are the following:
1. Define general and specific values of the arguments to be used in the function dataprep.arg()
and consequently in dataprep(). The arguments are briefly described in the table 4.9 in the
dataprep() description. In this step and with respect to the methodology, we describe all the
main elements of the model (see section 4.3.1).
2. Run the dataprep.arg() and dataprep() functions in order to prepare the list of objects neces-
sary for running function synth() and the other functions of the package “Synth” to construct
synthetic control groups.
3. Run the synth() function, which is the synthetic control command to identify the optimal
weights of the synthetic control. In this step, we are estimating the optimal weights as de-
scribed in the section 4.3.1.
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4. Compute the gaps (estimation of the treatment effect as described in the section 4.3.1), the
treatment effects for each of the periods, and summarise the results in the tables, print out
the path and gaps plots. In this step, we use the functions gaps.f(), synth.tab(), path.plot.f()
and gaps.plot() respectively. This part is corresponding to the section 4.3.2.
5. Execute the placebo test, as explained in the section 4.3.2, in the three following steps:
• Define the vector of the id’s and names for the placebo-treated units via function p.vec.-
par.f();
• Produce the placebo data. That means that we run the synthetic control estimation via
function synth() for each of the “placebo-treated” companies. This step is managed by
the function placebo.data.f();
• Compute the gaps for each of the “placebo-treated” companies, which is just one of
the values of the function placebo.data.f(), more precisely the value p.gaps.data. The
example of the output is given in the figure A.9 in the annexe.
• Calculate the root mean squared prediction error and related statistics for each unit in
the sample by using the function mse.f(). An example of the output is in the figure A.10
in the annexe.
• Produce the placebo gaps plot by using function p.synth.plot.f(). An example of the
output is in the figure A.11 in the annexe. Note that we exclude all the observations
having the mean squared prediction error higher than five times the mean squared
prediction error of the treated unit and with these observations.
100 Chapter 4. Research question, data and model implementation
Fi
gu
re
4.
5:
Fu
nc
tio
ns
in
te
ra
ct
io
ns
in
R
an
d
st
ep
s
in
th
e
jo
b
Chapter 5
Estimations and results
In the previous chapter, we set up the objective of our study, which is to evaluate the impact of
the Carbon Disclosure Project CDP on the firm’s greenhouse gas emissions. Moreover, we want
to compare the results of the assessment on international and sectoral levels. The three research
questions, that we already mentioned in the table 4.1 are the following.
The first one is: “Is there a positive impact of the Carbon Disclosure Project on the participating
firms?” The second one is: “Is there a difference in the impact on the international level, between
European Union, United Kingdom, United States?” And the last one is: “Is there a difference in the
impact between the sectors of activities?”
To answer these questions we used the synthetic control analysis covered in chapter 2. All the
details about data, including the descriptive statistics, the model and its implementation, and the
used tests, are covered in chapter 4. In this chapter, we present the results of our analysis and
answer the three research questions.
As we already discussed before, our data contains 73 treated companies, divided into 3 geo-
graphic regions1 and 9 sectors2. In the first section of this chapter, we present the overall analysis
results regardless the sector or geographic region. In the second section, we detail the results
of the analysis by region. We also give an example of the interpretation of the results from the
three regions for the companies that are part of the information technology and telecommunica-
tion sector. More precisely we interpret the results for the companies having a decline in the CO2
emissions per employee after starting to report to the CDP. We will be able to note if there is no
treatment effect, a small not significant treatment effect, significant treatment effect, and a highly
significant treatment effect. In the third section, we depict the results by sector. First, we analyse
and compare the results in different emitter groups: the light emitters, the middle carbon emitters,
and the heavy emitters. Then we present more detailed analysis in each sector. And finally, in the
last section, we terminate the chapter by a short conclusion on the three research questions. Note
that the statistical inferences results are presented in table 5.4 and the annexe A.5, where we show
the figures of the path and placebo plots for all the treated companies with a positive treatment
effect.
1The regions are: EU, UK, US.
2The sectors are: CD, CS, INDU, FINA, HC, ITTE, ENGY, MATR, UTIL.
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5.1 General results
In this section we review the results of the analysis without taking into account the sector or region
the company is a part of. In order to evaluate for each company the effect of the Carbon Disclosure
Project on the carbon emissions, we have calculated the following statistics: treatment effect3,
average treatment effect4, pre-treatment root mean squared prediction error (RMSPE)5, RMSPE-
ratio6. Moreover we constructed individual path and gaps plots7 for each company and applied the
in-space placebo test which allowed us not only to calculate the RMSPE-ratio p-value8, but also to
construct the placebo effect graph9 and estimate the placebo p-value10.
Table 5.1 gives the summary results of the analysis for all companies regardless the sector or
geographic location. In total, out of the 73 companies that participate in the Carbon Disclosure
Project, we have observed 6 treated companies with extremely large CO2 emissions per employee
(large values were also detected for other predictor variables). Their pre-treatment RMSPE was
higher than 200. This very large pre-treatment RMSPE indicates a problem of extreme value ob-
servations, and so there was no combination of units in the sample that could reproduce the time
series of the potential outcome prior the treatment. Thus, we did not find any matching synthetic
control for them, and the six firms were removed from our analysis.
The rest of the companies performed well, and their pre-treatment RMSPE was lower than 10.
This relatively low pre-treatment RMSPE shows good matching results between the treated firm
and its synthetic control. Out of the remaining 67 companies, 48 companies revealed decrease of
CO2 emissions per employee after signing to the CDP. That is, we observe negative values of the
treatment effect for most of the post-treatment periods, and the average treatment effect was lower
than zero. This result would suggest a 72% success rate of the program before the test.
Number of companies
73
-6 Extreme
67 Treated
 19 No effect
48 Decline in CO2
(72%) Success in decrease of CO2 per employee
Source: Author’s elaboration.
Table 5.1: Summary results
Table 5.3 presents overall results after the tests, and table 5.4 shows detailed inference test
results for all companies with a positive average treatment effect. In order to decide on the degree
3Defined in equation (4.3).
4Defined in equation (2.11) with aˆ1t defined in equation (4.3), t1 = To+1 and t2 = T .
5Defined in equation (2.13) with t1 and t2 are equal to 1 and T0.
6Defined in equation (2.14).
7See annex A.5.
8Defined in equation (2.15).
9See annex A.5.
10Defined in equation (2.12).
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of the pertinence of the average treatment effect, we based ourself on the value of the treatment
effect, the pre-treatment RMSPE, the RMSPE-ratio, the RMSPE-ratio p-value, and the pseudo p-
value. In table 5.2 we summarise the threshold values of the mentioned statistics, which categorise
the treatment effects in four degrees of significance, that is: no treatment effect, small not significant
treatment effect, low significant treatment effect, and highly significant effect. The threshold values
were based on a subjective decision with respect to our case.
Sign Average treatment RMSPE RMSPE-ratio RMSPE-ratio Placebo
effect p-value p-value
(-) No treatment effect < 0 < 10 < 1.1 x x
(+) Small treatment effect but not significant < 0 < 10 > 1.1 x > 0.4
(*) Low significant treatment effect < 0 < 10 > 1.1 x < 0.4
(**) Highly significant treatment effect < 0 < 10 > 10 < 0.2 < 0.3
Source: Author’s elaboration.
Table 5.2: Treatment effect signs’ explications
As presented in the table 5.3, out of the 48 companies with evident decline in CO2 emissions
per employee, 10 have RMSPE-ratios lower than 1.1. This means that their CO2 emissions per
employee were no different from before the company signed to the CDP. Thus for these companies,
we cannot approve the improvement in carbon performance despite the decrease in emissions
during the post-treatment period. This result leaves us with 38 companies showing a positive
change in the post-treatment period.
Out of the 38 companies, about 77% have relatively small pseudo p-value, which indicates a
significant improvement from the pre-treatment period. The remaining 7 companies are considered
as having the not significant treatment effect. The rest of the 21 companies have relatively small
RMSPE-ratios and are characterised with high RMSPE-ratios p-values indicating no significant im-
provement from the pre-treatment period with respect to the other placebo-treated companies. For
these 21 companies we could not approve with placebo tests and RMSPE-ratios a significant and
positive treatment effect, so we classify them as “low significant”. On the other side, 10 companies
outperform the other ones in the values of the tests. They all have relatively high RMSPE-ratio with
respect to the rest of the firms. This high ratio shows a large decrease in CO2 emissions per em-
ployee. The results are supported by both low placebo and RMSPE p-values for all ten companies,
showing that other placebo-treated companies did not perform as well as the treated companies
under investigation.
Total 48 companies with decrease in CO2 emissions per employee
( ) 10 without significant change with respect to pre-treatment period
(+) 7 with at least 10% decrease of CO2 with respect to the pre-treatment period
(⇤) 21 with at least 10% decrease of CO2 with respect to the pre-treatment period and significant placebo test results
(⇤⇤) 10 with at least 100% decrease of CO2 with respect to the pre-treatment period,
and highly significant placebo test and RMSPE test results
Source: Author’s elaboration.
Table 5.3: Summary of significant treatment effects
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Region Sector Name Tr.effect RMSPE RMSPE-ratio RMSPE-ratio Placebo
p-value p-value
European Union CD Gtech Spa  0.41  0.73 0.83 1.00 0.43
CD Nokian Renkaat  2.88⇤⇤ 0.49 6.24 0.23 0.08
CD Valeo Sa  2.10⇤ 0.25 3.77 0.54 0.23
CS Greencore Group  6.14⇤ 2.57 2.65 0.64 0.09
CS Jeronimo Martins  0.56+ 0.10 4.77 0.41 0.55
CS Koninklijke Phil  2.85⇤ 2.44 1.44 0.82 0.08
INDU Atlantia Spa  4.18⇤⇤ 0.45 11.59 0.26 0.07
INDU Centrotec Sustai  0.76  2.97 0.25 1.00 0.31
INDU DCC Plc  1.07+ 0.37 4.75 0.47 0.81
INDU Flsmidth Co  2.13⇤ 1.24 1.77 0.79 0.11
INDU Kobenhavns Lufth  3.59⇤ 1.62 2.22 0.47 0.05
INDU Kone Oyjb  1.09⇤ 0.04 2.30 0.74 0.36
INDU Obrascon Huarte  3.72⇤⇤ 0.33 14.57 0.21 0.06
HC William Demant  2.29⇤ 1.09 2.10 0.60 0.20
ITTE Dassault System  0.82⇤ 0.14 6.55 0.21 0.38
ITTE Seagate Technolo  8.18⇤ 1.22 7.96 0.42 0.09
ITTE Vaisala Oyja Sh  1.09+ 0.56 2.45 0.78 0.45
FINA Banco Com Portr  0.43+ 0.41 1.24 0.70 0.54
FINA Generali Assic  0.34  0.56 0.88 0.90 0.54
ENGY Saipem Spa  0.14+ 0.02 9.35 0.57 0.57
UTIL Enagas Sa  0.41  0.66 1.10 1.00 0.45
United Kingdom CD Debenhams Plc  0.72⇤ 0.16 5.47 0.46 0.28
CD Dignity Plc  0.62  0.36 0.61 0.62 0.52
CS Mcbride Plc  4.47⇤⇤ 0.03 23.03 0.11 0.15
INDU Serco Group  1.57⇤⇤ 0.08 19.19 0.10 0.18
HC BTG Plc  12.43⇤ 9.57 1.30 0.50 0.11
HC Synergy Health  3.28⇤ 2.21 2.34 0.40 0.12
ITTE Computacenter Pl  0.39  0.38 1.06 0.92 0.77
ITTE Pace Plc  1.15+ 1.15 1.33 0.78 0.67
FINA Savills Plc  1.66  4.25 0.80 0.90 0.54
United States CD Leggett & Platt  14.15⇤ 8.53 1.84 0.84 0.08
CD Lowe’s Cos Inc  0.93  3.24 1.06 1.00 0.41
CD Vf Corp  0.68  0.87 1.04 0.92 0.36
CS Constellationa  4.87⇤⇤ 0.62 14.13 0.18 0.07
CS Estee Lauder  0.61⇤⇤ 0.14 15.71 0.06 0.35
CS Hershey CO  7.32⇤ 4.87 1.61 0.82 0.06
CS Philip Morris  4.12⇤ 1.73 2.41 0.64 0.15
INDU ABM Industries  0.24⇤ 0.05 6.67 0.11 0.50
HC Actavis Plc  2.53⇤⇤ 0.19 14.87 0.10 0.16
HC Celgene Corp  4.16⇤⇤ 0.36 12.26 0.20 0.17
ITTE Akamai Technolog  9.17⇤ 5.56 2.18 0.56 0.07
ITTE Broadcom Corpa  1.02⇤ 0.02 8.95 0.47 0.23
ITTE Cognizant Techa  1.95⇤ 0.23 8.48 0.60 0.10
ITTE Microchip Tech  17.25⇤⇤ 0.45 50.18 0.14 0.13
ITTE Western Digital  1.15⇤ 1.00 1.97 0.83 0.17
MATR Cliffs Natural R  6.05  1.02 0.76 0.50 0.36
ENGY Noble Energy Inc  6.16⇤ 0.98 6.83 0.50 0.08
UTIL Quest Diagnostic  0.02+ 0.02 2.24 0.57 0.50
Source: Author’s elaboration.
Table 5.4: Placebo tests results
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5.2 Results by region
In this section, we analyse the results with respect to the regions the companies are from. Table 5.5
shows the summary results distributed by region. Once the extreme values are removed, the data
contain 28 observations from the European Union, 14 from the United Kingdom and 25 from the
United States. There is no effect for 7 firms from EU, 5 firms from UK, and 7 firms from US, which
gives about a 70% success rate in decrease of CO2 emissions per employee. The highest rate is
75% for EU, 72% for US, and 64% for UK. As we can observe, the success rate decreases with the
number of firms in the respective samples. Thus, before the placebo test, we can not conclude that
one region performs better than the other in term of the success of the Carbon Disclosure Project.
EU UK US
29 16 28
 1  2  3 Extreme
28 14 25 Treated
 7  5  7 No effect
21 9 18 Decline in CO2
(75%) (64%) (72%) Success in decrease of CO2 per employee
Source: Author’s elaboration.
Table 5.5: Summary results by region
The table 5.4 presents the results of the placebo tests per company and region. The summary
of significant treatment effects by region is presented in the table 5.6. We remark that for the
European Union there is a 14% of the companies without significant change after the CDP comes
into force, for the United Kingdom it is 19%, and for the United States 16% of companies. Taking into
account only the companies with significant change with respect to the pre-treatment period11, the
analysis reveals it for 57% of companies from EU, 31% from UK, and 83% from US. The remaining
7 companies from the three regions show a low decrease in the CO2 emissions per employee but
is considered as not significant.
So far we can say that the United States indicate better performance. This is also proven by
the ratio of the companies that outperform the other ones in the values of the tests. Meaning that
they have a large decrease in CO2 emissions per employee (relatively high RMSPE-ratio, and low
placebo and RMSPE p-values, with respect to the rest of the firms). These companies are classified
as highly significant and 27% of the US companies are concerned, versus 14% of EU and 13% of
UK companies. Note, that if UK would have been considered in EU region, the CDP would have the
same success. But as it is not, we consider the United States as a slightly outperforming region.
5.2.1 Interpretation of companies from different regions from information technol-
ogy and telecommunication sector
The figure 5.1 presents the path plot and the synthetic matching and permutation tests for four
companies from information technology and telecommunication sector. These companies are Mi-
crochip Tech, Seagate Technolo, Pace Plc, Computacenter Pl, and they are from US, EU, and last
11The significant improvement from the pre-treatment period is indicated by a relatively small pseudo p-value,
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EU UK US
Total 21 9 18 companies with decrease in CO2 emissions per employee
( ) 4 3 3 without significant change with respect to pre-treatment period
(+) 5 1 1 with at least 10% decrease of CO2 with respect to the pre-treatment period
(⇤) 9 3 9 with at least 10% decrease of CO2 with respect to the pre-treatment period
and significant placebo test results
(⇤⇤) 3 2 5 with at least 100% decrease of CO2 with respect to the pre-treatment period,
and highly significant placebo test and RMSPE test results
Source: Author’s elaboration.
Table 5.6: Summary of significant treatment effects by region
two from UK respectively. Note, that the same tables for the rest of the companies from the three
regions are presented in the annexe A.5 (figures A.13 – A.24), and can be interpreted in the same
way. More precisely, the first graph is showing a company with highly significant treatment effect,
the second line is for a firm with low significant treatment effect, the third company represents small
but not significant treatment effect, and the last line is for a firm with no treatment effect.
The first column of figure 5.1 shows the graphs of the gaps of the CO2 emissions per employee
for four treated companies and their synthetic controls. The almost parallel lines in pre-treatment
period (before the vertical line), for Microchip Tech and Computacenter Pl, indicate a good match
between the treated company and its synthetic control with respect to the CO2 emissions per
employee. This result is approved by small pre-treatment RMSPE. Pace Plc and Computacenter Pl
has a relatively bigger gap, which is also reflected in relatively higher RMSPE. Note that the scale
of the CO2 emissions per employee is different for the four companies, which can also visually
influence the perception. But in all ways, the match is relatively good for the four companies.
The gap between the treated and synthetic control in post-treatment period indicates treatment
effect: the bigger the gap, the larger the effect. We observe positive treatment effects, supported
by high RMSPE-ratios, indicating large decreases in CO2 emissions per employee in the post-
treatment period, for the first two companies. Moreover, we detect quite small RMSPE-ratios for
the third and fourth companies.
The second column of figure 5.1 shows the treated units and their relative placebo-treated units.
For the first two companies, we can see all placebo-treated units sitting above the treated units
under investigation. This means that the positive treatment effect of the treated unit is not random.
The results for the first two companies are approved by low placebo and RMSPE p-values, this
means that rest of the placebo-treated companies did not do as well as the treated companies
under investigation. We could almost consider the second company as a highly significant, as the
pseudo p-value is very small, but the RMSPE-ratio p-value is above the threshold. The last two
companies have relatively low RMSPE-ratios and high p-values, which approve the not significant
results.
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Figure 5.1: Synthetic matching and permutation tests for companies from information technology and
telecommunications’ sector and from United States, European Union, and two from United King-
dom respectively
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5.3 Results by sector
In this section we present the analysis with respect to the sectors, which are: financials (FINA),
health care (HC), information technology and telecommunication (ITTE), consumer discretionary
(CD), consumer staples (CS), industrials (INDU), energy (ENGY), materials (MATR), utilities (UTIL).
All the sectors have a different number of companies in the sample, which might bring an obstacle
in the interpretation of the results. We first analyse the three groups of sectors, as explained below,
and then we take each sector individually and give more details.
5.3.1 Analysis by group of emitters
As already mentioned in the previous chapter, in order to make the comparison between the sec-
tors more plausible, we divide them into three big groups: light, medium, and large carbon dioxide
emitters. The first group, the light emitters, contains the financial, the health care, and the informa-
tion technology and telecommunication sectors. The group of medium CO2 emitters contains the
consumer discretionary, the consumer staples, and the industrial sectors. And the last group, the
heavy emitters, contains the energy, the material, and the utility sectors.
First of all, we analyse the summary results by sector before the tests which are presented in
the table 5.7. Individually, the success in the decline of the CO2 emissions varies between 20 to
100%. But as already mentioned, each sector contains different numbers of observations, and each
group as well. After exclusion of the extreme values, the light emitters contains 21 companies, the
middle emitters, which are the biggest group, comprise 35 companies, and the big emitters group
contains 11 firms only. Success in the decrease of CO2 per employee is the highest for the light
emitters, being equal to 87% of companies achieving the decline in emissions. On the second
range is the middle emitters group with 74% of success in the decrease. And finally the last group,
with 51% success, belongs to the heavy emitters. So far, before the tests, the light emitters seems
to outperform the other sectors.
Light emitters Medium emitters Heavy emitters
FINA HC ITTE CD CS INDU ENGY MATR UTIL
3 7 12 10 12 18 3 5 3
0 0 -1 -1 -1 -3 0 0 0 Extreme
3 7 11 9 11 15 3 5 3 Treated
0 -2 -1 -1 -3 -6 -1 -4 -1 No effect
3 5 10 8 8 9 2 1 2 Decline in CO2
(100%) (71%) (91%) (89%) (73%) (60%) (67%) (20%) (67%) Success in decrease of CO2 per employee
Source: Author’s elaboration.
Table 5.7: Summary results by sector
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The significant treatment effects by sector are presented in the table 5.8, which is a summary
of the placebo tests per company presented in table 5.4. Within the three groups the light emit-
ters contain 25% of companies without significant change after the CDP comes into force, for the
medium emitters it is 20%, and for the heavy emitters 33% of companies.
Taking into account only the companies with a significant change with respect to the pre-
treatment period, significant treatment effect shows 73% of companies from the low emitters sector,
90% from the middle emitters, and only 25% from high emitters sector. The remaining 9 companies
show a low decrease in the CO2 emissions per employee but is considered as not significant.
So far, the light and middle emitters indicate quite a good performance, with slightly better
results for the middle-class emitters. Heavy emitters show very poor performance. That is, this
last group proves low significant treatment effects for only one out of 11 treated companies. At the
end, the highly significant treatment effect, with a large decrease in CO2 emissions per employee
(relatively high RMSPE-ratio, and low placebo and RMSPE p-values, with respect to the rest of the
firms), concerns 28% of the middle emitters and 16% of light emitters. Thus, the middle emitters
group proves to be having slightly better performance.
Light emitters Medium emitters Heavy emitters
FINA HC ITTE CD CS INDU ENGY MATR UTIL
Total 3 5 10 8 8 9 2 1 2 companies with decrease in CO2 emis-
sions per employee
( ) 2 0 1 4 0 1 0 1 1 without significant change with respect to
pre-treatment period
(+) 1 0 2 0 1 1 1 0 1 with at least 10% decrease of CO2 with re-
spect to the pre-treatment period
(⇤) 0 3 6 3 4 4 1 0 0 with at least 10% decrease of CO2 with re-
spect to the pre-treatment period and sig-
nificant placebo test results
(⇤⇤) 0 2 1 1 3 3 0 0 0 with at least 100% decrease of CO2 with
respect to the pre-treatment period, and
highly significant placebo test and RMSPE
test results
Source: Author’s elaboration.
Table 5.8: Summary of significant treatment effects by sector
5.3.2 Low carbon dioxide emitters
The first group of the three sectors with low carbon emissions that we are going to examine con-
tains the ITTE, the HC, and the FINA sectors. Theses sectors are characterised by relatively low
emissions and quite small values of the loss functions and RMSPE-ratios. The following section
presents closer analysis of each firm.
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Information Technology and Telecommunication sector
Information Technology and Telecommunication sector include 12 treated and 18 controls units. We
observed one extremely large treated company with the pre-intervention RMSPE equal to 30, which
is much higher than the rest of the companies from the same sector. The company with the extreme
values was not considered for further analysis. The rest of the companies performed relatively
well and their pre-intervention RMSPE’s were lower than 6, with the majority of them having the
pre-intervention RMSPE lower than 1. Out of the remaining 11 companies, 10 companies show
decrease of CO2 emissions per employee over the post-intervention period. And our statistical
inferences put into evidence the positive significant treatment effect for 7 companies.
Interpretation of the results from the ITTE sector is already partially done in the previous section
5.2.1, where we picked four companies from different regions and compared them with respect to
the significance of the treatment effect. That is why we keep the description of the results of this
sector short.
Computacenter Pl and Pace Plc show relatively poor performance. Their low RMSPE-ratios
prove no significant improvement from the pre-treatment period, which is also approved by high
p-values. Vaisala Oyja Sh has higher RMSPE-ratio, which means an improvement from the pre-
treatment period, but unfortunately, the high p-values also give no significant treatment effects as
for the two previous companies.
Dassault System, Seagate Technolo, Akamai Technolog, Broadcom Corpa, Cognizant Techa,
and Western Digital are approved low significant. All of them have relatively high RMSPE-ratio,
low pseudo p-value, but relatively high RMSPE-ratio p-value. On the other side, Microchip Tech
outperforms other companies from its sector. The firm has high average treatment effect, very low
RMSPE, highest RMSPE-ratio, and low both p-values. This company show significant treatment
effect.
Health care sector
The health care sector contains 7 treated and 9 control units. Out of the 7 companies, 5 companies
show decrease of CO2 emissions per employee over the post-intervention period. And all of them
are significant.
In comparison to other companies in the HC sector, William Demant, BTG Plc, and Synergy
Health have relatively low RMSPE-ratios, proving not a great improvement compare to the pre-
treatment period. On the other side, they do have low pseudo p-values, which approve a significant
treatment effect. Thus we classify these three companies as low significant.
On the other side, Actavis Plc and Celgene Corp largely outperform other companies from the
same sector in the values of the tests and are classified as highly significant. They have large
RMSPE-ratios, indicating large decreases in CO2 emissions per employee in the post-intervention
period. The lowest possible pseudo p-values indicate that the positive treatment effect of the treated
unit is not random. The high significant treatment effect is also approved by low placebo and
RMSPE p-values, which means that other placebo-treated companies did not perform as well as
the treated companies under investigation.
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Financial sector
The financial sector, including 3 treated companies and 9 potential controls, performed relatively
bad compare to the other sectors. For the three companies that were having a decrease in the
CO2 emissions per employee in the post-treatment period, none of the treatment effects is proven
to be significant.
5.3.3 Medium Carbon Dioxide emitters
The second group of the three sectors with medium carbon emissions comprises the CD, the CS,
and the INDU sectors. These sectors are characterised by medium emissions compared to the
other sectors, and relatively small values of the loss functions and the highest significant ratio of
the treatment effect. In the following sections, we debrief the results of each firm.
Consumer Discretionary sector
Our data, restricted to the consumer discretionary sector, contain 10 treated and 12 control com-
panies. We observed one extremely large treated company with pre-intervention RMSPE equal
to 290 and for which we did not find a matching synthetic control. We have removed it from our
analysis. The rest of the companies performed relatively well and got the pre-intervention RMSPE
lower than 10, with the majority of them lower than 1. Out of the remaining 9 companies, 8 show
decrease of CO2 emissions per employee over the post-intervention period. And our statistical
inferences put into evidence the positive significant treatment effect for 4 companies.
In the table 5.4 we find the tests results for the eight companies with a positive average treat-
ment effect. Gtech Spa, Dignity Plc, Lowe’s Cos Inc, and Vf Corp show no improvement from the
pre-treatment period, justify by low RMSPE-ratio and high RMSPE-ratio p-value. Thus, we reject
the hypothesis of significant treatment effect for these four companies.
Valeo Sa, Debenhams Plc, and Leggett & Platt show low significant treatment effects. We
observe relatively high RMSPE-ratios. Although for the Leggett & Platt the RMSPE-ratio p-value
is quite high due to relatively high pre-treatment RMSPE. For the three companies we have low
pseudo p-values which also confirm the low significant treatment effect.
Nokian Renkaat outperforms other companies in the sector and is classified as highly sig-
nificant. In the annexe, the second firm of the figure A.13 presents the synthetic matching and
permutation tests for this company. There is almost perfect match between the treated company
and its synthetic control with respect to the CO2 emissions per employee. This result is confirmed
by small pre-intervention RMSPE. We observe positive treatment effects, supported by high RM-
SPE-ratios. All placebo-treated units are sitting above the treated units under investigation, and
having both low placebo and RMSPE p-values. As a consequence, there is a significant positive
treatment effect for Nokian Renkaat.
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Consumer Staples sector
Our data, restricted to the consumer staples sector, contains 12 treated and 16 control companies.
We observed one extremely large treated company with relatively high pre-intervention RMSPE
that was higher than 10 and we did not find a matching synthetic control. As the rest of the compa-
nies in the sector has the RMSPE lower than 5, we have considered this observation as extreme
and removed it from our analysis. Out of the remaining 11 companies, 8 show decrease in CO2
emissions per employee over the post-intervention period. And our statistical inferences put into
evidence the positive significant treatment effect for 7 companies, including 3 highly significant
effects.
In the table 5.4, we find the statistical inference results for the eight companies with a positive
average treatment effect. Only Jeronimo Martins shows quite a poor performance and no signif-
icant treatment effect. This is especially proven by the path plot and the placebo gaps plot (top
graphs) on the figure A.14. Although all the statistics are relatively good for the company, we ob-
serve decreasing and then increasing gaps over the post-treatment period, which shows no effect
of the treatment despite the good RMSPE’s measures.
Grencore Group, Koninkljke Phil, Hershey CO, Philip Morris show low significant positive treat-
ment effect. Compare to the other three companies, with highly significant treatment effect, they
have relatively low RMSPE-ratios and relatively high RMSPE-ratio p-values. On the other side, the
four companies have low pseudo p-values which confirm significant treatment effect.
Mcbride Plc, Constellationa, and Estee Lauder outperform the other companies in the values
of the tests, and are classified as highly significant. The first column of figure 5.2 shows the
graphs of the gaps of the CO2 emissions per employee for three treated companies and their
synthetic controls. The path graphs indicate a good match between the treated company and its
synthetic control with respect to the CO2 emissions per employee. This result is confirmed by small
pre-treatment RMSPE for the three companies. The big gaps between the treated and synthetic
control in post-treatment period indicate large treatment effects. These positive treatment effects
are supported by high RMSPE-ratios, indicating large decreases in CO2 emissions per employee
in the post-treatment period. On the placebo gaps graphs, during the post-treatment period, almost
all placebo-treated units sit above the treated units under investigation. Thus the positive treatment
effects of the treated units are not random. The results are affirmed by low placebo and RMSPE
p-values. This means that the rest of the placebo-treated companies did not do as well as the
treated companies under investigation.
Industrial sector
Our data, restricted to the industrial sector, contains 18 treated and 18 control companies. We ob-
served 3 extremely large treated companies for which we did not find a matching synthetic control.
Their pre-intervention RMSPEs were higher than 180. We have removed these cases from our
analysis. The rest of the companies performed relatively well and got a pre-intervention RMSPE
lower than 3. Out of the remaining 15 companies, 9 companies show decrease of CO2 emissions
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Figure 5.2: Synthetic matching and permutation tests for Mcbride Plc, Constellationa, and Estee Lauder
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per employee over the post-intervention period. And our statistical inferences put into evidence a
positive significant treatment effect for only 7 companies, including 3 highly significant treatment
effects.
In the table 5.4, we find the test results for the nine companies with a positive average treatment
effect. Centrotec Sustai shows very poor RMSPE-ratio and its p-value prove no improvement from
the pre-treatment period. Moreover, DCC ’s high pseudo p-value rejects the hypothesis of significant
treatment effect, despite the small RMSPE and relatively high RMSPE-ratio.
ABM Industries shows a very small decrease in CO2 emissions per employee, although with
a poor pseudo p-value. We decided to classify it as a significant treatment, as it has relatively
high RMSPE-ratio and the related p-value is the lowest possible. Flsmith & CO, Kobenhavns Lufth
and Kone Oyjb show relatively good decreases in their CO2 emissions per employee, but have
relatively small RMSPE-ratios, with high p-values indicating not a so great improvement from the
pre-treatment period. On the other side, the low pseudo p-values prove no random effects. For
these companies, we could confirm with placebo tests low significant and positive treatment effects.
On the other side, Atlantia S.p.A., Obracson Huarte and Serco Group outperform the other
companies, and are classified as highly significant. In the annexe A.5 we present the figures of
the synthetic matching and permutation tests for these three companies. We see a good match
between the treated company and its synthetic control with respect to the CO2 emissions per
employee. This result is confirmed by small pre-intervention RMSPEs for all three companies. We
observe positive treatment effects, supported by high RMSPE-ratios, indicating large decreases
in CO2 emissions per employee in the post-intervention period for the three companies. We can
also observe almost all placebo-treated units sitting above the treated units under investigation.
This means that the positive treatment effect of the treated unit is not random. The results are
affirmed by both low placebo and RMSPE p-values for all three companies, showing that other
placebo-treated companies did not perform as well as the treated companies under investigation.
5.3.4 High Carbon Dioxide emitters
The last group of the three sectors with high carbon emissions includes the ENGY, the MATR, and
the UTIL sectors. The high CO2 emitters are specific by very large greenhouse gas emissions.
Moreover, the firms have relatively low number of employees, which leads to elevated values of the
outcome variable. Another observation is the heterogeneity of the companies in the donor pool.
These two arguments might be the reason for very high values of the loss function for the firms in
these sectors that is an other of the characteristics of the group.
Note that for the three sectors the second model having the GHG as the outcome variable12,
was a bit more suited. This model gave relatively small values of the loss functions, but also always
confirmed the results of the GHG_EMP model. Thus we kept the main model (GHG_EMP) for the
analysis.
12Cf. section 4.3.1, presenting the alternative model.
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As already mentioned, our data, restricted to the high CO2 emitters, include energy, materials,
and utility sectors. The data contain 11 treated and between 9 to 14 control companies (depending
on respective sector). The companies performed relatively well in the matching process and got
pre-intervention RMSPEs lower than 1.213. Out of the 11 companies 5 show decrease of CO2
emissions per employee over the post-intervention period. And our statistical inferences put into
evidence the positive significant treatment effect for one company.
In the table 5.4, we find the statistical inference test results for the five companies with a positive
average treatment effect. Four of them, Saipem Spa, Enagas Sa, Cliffs Natural R, and Quest
Diagnostic, show very poor performance and no significant treatment effect. They have either low
RMSPE-ratios or relatively high p-values, which reject the hypothesis of significant treatment effect.
On the other side, Noble Enrgy Inc outperforms other companies from the group and shows a
low significant treatment effect. The firm has high RMSPE-ratio and low pseudo p-values, which
prove no random treatment effect. For this company, we could affirm with placebo test low signifi-
cant and positive treatment effect.
5.4 Conclusion
The objective of our study was to assess the pertinence of green policy introduction at the business
level. In particular, we intended to evaluate whether signing up to the Carbon Disclosure Project,
has a positive effect on companies’ emissions. We used the synthetic control approach that allowed
us to calculate the treatment effect for each of the companies under investigation, and perform
statistical inferences at the same time. The conclusions about the suitability of the synthetic control
method to study our problematic and the general observations about the method will be presented
in the main conclusion. In this section, we make the statements on the three research questions.
First research question
“Is there a positive impact of the Carbon Disclosure Project on the participating firms?”
In total, out of the 73 companies that participate in the Carbon Disclosure Project, we have ob-
served 6 companies with extremely large carbon emissions. These 6 companies were considered
as outliers, and we did not include them for further analysis. Out of the remaining 67 companies,
48 revealed decrease of CO2 emissions per employee after signing to the CDP. The placebo tests
and the RMSPE indicators confirm low significant treatment effect for 21 companies and highly
significant treatment effect for 10 companies. The remaining firms are considered either as having
no treatment effects or showing no significant improvement.
13In order to make the results comparable to other sectors we lower the RMSPE by dividing the outcome variable
(GHG_EMP) by 10.
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Second research question
“Is there a difference of the impact on the international level, between European Union, United
Kingdom, United States?”
The data distributed per regions, without the extreme values, contains 29 companies from the
European Union, 16 from the United Kingdom, and 25 from the United States. We observe no effect
for 7 firms from EU, 5 firms from UK, and 7 firms from US. Out of all companies with decreasing
CO2 emissions per employee after signing for the CDP program, we notice a significant change with
respect to the pre-treatment period for 12, 5, and 14 companies from EU, UK, and US respectively.
Which gives the highest success rate of 83% companies with the decreasing CO2 emissions per
employee for the United States.
Third research question
“Is there a difference in the impact between the sectors of activities?”
After exclusion of the extreme values, the data distributed per sectors contains 21 companies
from the light emitters group, 35 companies from the middle emitters, which are the biggest group,
and 11 firms only from the big carbon emitters group. The light emitters show the decrease in the
CO2 emissions per employee for 18 firms after the CDP entered into force, the middle emitters
group show the decrease for 25 firms and the heavy emitters for 5 firms. This gives the highest
success rate of 87% of companies achieving a decline in carbon emissions per employee to the
light emitter. After the placebo tests, within the three groups, the light and middle emitters indicated
much better performance than the heavy emitters which show low significant treatment effects for
only one out of 11 treated companies. Significant treatment effects were revealed for 12 companies
from the light emitters group and 18 from the medium carbon emitters group. Which gives a very
close success rate of the program, 67% and 77% for the respective groups. Although, the medium
emitters show slightly better performance in term of highly significant treatment effects. Concerning
the individual sectors, we observed the highest success rates of the program after the placebo tests
for the four following sectors: HC, ITTE, CS, and INDU.
Final conclusion
In conclusion, we found a decrease in CO2 emissions per employee after the company starts to
report to the Carbon Disclosure Project in about 70% of cases. So generally, there is a positive
effect of the CDP on the firms’ carbon performance. Moreover, the statistical inferences confirmed
the significant treatment effect for 31 out of 48 companies that revealed decrease of CO2 emissions
per employee after signing to the CDP. Out of the three regions, United States seams to slightly
outperform the other regions in the success of the program. And concerning the sectors, the
middle emitters group shows a bit better performance in term of significant treatment effects. A
final remark is that we observe significant and positive treatment effects for only half of the treated
firms. This could be due to the fact that other non-participating companies are also under another
strong institutional regulation of CO2 emissions.
Conclusion
In our work, we covered different subjects. In the first chapter, we did a short literature review and
introduced the main elements of the program evaluation methods. The second chapter covered the
subject of the synthetic control method, which to our knowledge was not yet presented in one review
in such an extend. The third chapter was dedicated to the environmental problematic. The fourth
and fifth chapters covered the empirical part of our study. The chapter four set up the objectives
of our study, and we presented the research questions, data and model implementation. And
the chapter five showed the estimations and results and gave the answers to the three research
questions.
The primary purpose of our study was to assess the effect of the CDP on the companies’
emissions. To do so, we made use of the synthetic control methods that allowed us to generate the
treatment effect for each of the studied companies, and perform statistical inferences. Moreover, for
our analysis, we built a unique database containing high-quality data on the firm’s characteristics,
including the carbon dioxide emissions and other environmental indicators.
We have chosen the synthetic control method for different reasons. First of all, it allows re-
searchers to analyse phenomena that occur in a limited population or that apply to only a small
number of units. In our case, these units are firms, which is a situation perfectly suited to our prob-
lematic. Additionally, this method allows performing statistical inference analysis and supporting
the results quantitatively. Several conclusions concerning the suitability of the method to our study
have to be done.
First of all, using the synthetic control method allowed us to run individual company analysis.
Which means that we did not have to use some general average measures per sector or country
to estimate the treatment effects. For each firm, we could assess the impact of the program and
make the statistical inferences, based on the specific company characteristics.
Second, we had to be careful while interpreting the results, because the size of the treatment
effect was very proportionate to the size of the emissions. It means that in most of the cases,
lower the emissions are, lower the size of the treatment effect is and vice versa. Though, the
scope of the treatment effect was not the only measure showing the success of the program due
to the heterogeneity of the companies. One could think that if we would have some normalisation
of the quantitative characteristics of the firms, we could get more comparable firms in the pool.
But we argue against the normalisation as it would not reflect the reality of the firms’ behaviours.
So, we need different measurements to quantify the treatment. It was very important in our case,
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to always look at all aspects of the analysis and measures that the SCM proposed. That is, we
have to consider the size of the emissions and other firm’s characteristics, the matchings, the loss
functions, the graphs, the p-values, the RMSPEs indicators, or the ratios.
Third, we concluded that the model was very sensitive to the outliers. In our case, extreme
values occurred by significant greenhouse gas emissions and relatively small number of employ-
ees, as well as relatively large values of other firms characteristics. The outliers had relatively large
values of the loss functions, and we could not find matching control units. Consequently, we had
to exclude the outliers from the analysis, as we could not give any appropriate interpretation of the
results.
Fourth, we could approve that the model gave us a good quality match on the predictor vari-
ables. Also, the first goal of the method was always to make a good match between the outcome
variables of the treated unit and its synthetic control. That is if there would be a big heterogeneity
with respect to the CO2 emissions per employee between the treated unit and the units in donor
pool, more weights would be given to the special predictors than to the rest of the predictors. We
also observed that the match between the treated unit and its synthetic control was mostly much
better that the match between the treated company and the average values of the predictors in the
donor pool.
Fifth, sometimes the low number of observations in the donor pool, especially when there was
a quite big heterogeneity between the observations in the donor pool on the treated unit, leads to
high values of the loss functions under the random assignment.
Sixth, we noted that the value of the pre-treatment RMSPE is very individual and changes
dramatically from one sector to other, that is why other synthetic control measurements helped
to remain objective and give the not biased interpretation of the results. Moreover, the observa-
tions with relatively high values of the treatment effects have relatively low RMSPE-ratios, and the
observations with relatively low RMSPE got relatively high RMSPE-ratios.
And finally, while doing the placebo tests, we observed that in the same sector of activities, that
had the same donor pool, the synthetic control units for the placebo-treated companies remained
mostly the same while changing the treated unit. This was another proof of the robustness of our
model.
As already mentioned, the primary objective of our study was to assess the pertinence of
green policy introduction at the business level. More precisely, we intended to evaluate whether
participating in the Carbon Disclosure Project, as one of the binding reporting standards, has a
positive effect on the firm’s emissions. We also focussed on three different geographic regions,
which are the European Union, the United Kingdom, and the United States. Furthermore, we
compare the results between various sectors of activities.
In conclusion, we found that out of the 67 companies evaluated over 5 years and covering 9
sectors, even if the size of the effect varies on a case by case basis, the majority of the companies
showed a positive effect of the CDP on the firms’ environmental behaviour. Moreover, by the
statistical inferences, we confirmed the significant treatment effect for half of the companies. Out
of the three regions, even though the United States slightly outperformed the other regions in the
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success of the program, we did not find a big significant difference between the three regions (US,
UK and EU). We could observe that the three studied regions are under strong regulation of CO2
emissions, amplified by large impact of the international agreements. This was also reflected in the
quite good environmental performance of the other non-participating companies. Concerning the
sectors of activities, inferior performance was shown by the high CO2 emitters. On the other side,
the light and medium carbon emitters gave a very satisfying success rate of the program, with the
middle emitters group showing slightly better performance in terms of significant treatment effects.
During our analysis, we encounter two issues. The first issue we faced concerned some ap-
proximated data for the greenhouse gas emissions. In most of the cases, we could solve the
problem during the estimations. Thanks to the other firm’s characteristics we could reestimate the
emissions and make them more trustable. The second problem was related to a relatively short
pre-treatment period to estimate the synthetic control units and a relatively short post-treatment
period to evaluate the treatment effects. Keeping in mind that we would probably achieve higher
quality estimation with a longer observation period, the use of the synthetic control method allows
the estimation of the treatment effect in the case when only a few observations at the time are
available. So we should not worry too much about the size of the observation period in our case.
We confirm that this method was well suited to our study, and could be used for further similar
researches, as to analyse the introduction of other green policies or evaluation of disclosure meth-
ods. We could analyse whether the CDP firms achieved their target CO2 emissions. For this, the
researcher should get extra information on what the target emission was. One could also collect
data for more years or other regions and do an extensive study to prove the veracity of our results.
Concerning the synthetic control method, we think that there could be some improvements done
on the problematic of the outliers and estimations of the synthetic control units.
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A.1 Basics behind matching and difference-in-differences methods
In this section, we present the basic idea behind matching and difference-in-differences (DID) meth-
ods. Note, that we have already introduced matching and difference-in-differences methods in
section 1.2 as one of the methods that estimate the treatment effect under or without unconfound-
edness. Since these two methods are used in the synthetic control method, the main method that
we use in the empirical part to estimate the treatment effect and that will be presented in chapter
2, we would like to explain a bit more about the two methods in order to give some better under-
standing of chapter 2.
A.1.1 Matching methods
While estimating the treatment effect, we would like to compare the treated and control groups that
are as similar as possible. Matching is one of the methods that helps us to find similar individuals.
This method is used in two cases. In the first case, outcome variable isn’t yet available, and the
matching is used to select the subjects to follow up. In the second case, the outcome variable is
already available, and the matching is used to estimate the causal effect and reduce selection bias
in the estimate of the treatment effect.
Matching methods is performed in two steps. First, we have to determine the measure of
distance (“closeness”) to use in matching and then use the distance to execute the matching. In
this section, we briefly present these two stages, and for more information see Stuart (2010), which
is an excellent review of the matching methods.
Distance measures
The first estimation stage, determination of the measure of distance to be used in the matching, is
proceeded in two steps. Firstly we choose the covariates to be included while relying on the strong
ignorability assumption. Then secondly we combine the covariates into the distance measures,
that is, measures of similarity between two individuals. Different distance measures exist. The
most known are exact measure, Mahalanobis, propensity score or linear propensity score.
Here we present the four primary ways to define the distance zi j between individuals i and j.
1. Exact distance
zi j =
8<:0 if Ci =Cj,• if Ci 6=Cj.
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2. Mahalanobis distance
zi j = (Ci Cj)0S 1(Ci Cj),
where S is the variance covariance matrix ofC (covariates) in the full control or treated group.
3. Distance based on propensity score
zi j =
  ei  e j   ,
where ek is the propensity score for individual k (see Rosenbaum and Rubin (1985)).
4. Distance based on linear propensity score
zi j =
  logit(ei)  logit(e j)   .
We have to point out that little is known about the optimal number of matches, or about data-
dependent ways of choosing it. And that the most common distance metric used in practice to find
the matches is the Mahalanobis metric, but there is also some very interesting alternative metrics
that depend on the correlation between covariate, treatment assignment, and outcomes.
Matching methods
Once the distance measure has been selected, the following step is to use that distance to execute
the matching. A spectrum of matching methods exists. One of the most common ones is the
nearest neighbour matching method. The nearest neighbour matching includes methods as optimal
matching, ratio matching and matching with or without replacement. Another class of methods
includes sub-classifications, full matching and weighting.
Note that the matching methods are not themselves methods for estimating causal effects. After
the matching has created treated and control groups with adequate balance, we can move to the
outcome analysis stage. Depending on the choice of the matching methods, this stage involves,
for example, the regression methods, propensity score methods, DID, and many others, depending
on the choice of the matching methods.
A.1.2 Difference-in-differences methods
As we presented before, matching is one of the methods that controls for observed confounding
vectors and minimises the selection bias. If important confounders are unobserved, we can get the
causal effect by using instrumental variables. Another way to deal with unobserved confounders
is to use panel data and the fixed effects methods, or it’s extended version of the difference-in-
differences method or fixed effect with lagged dependent variable presented in this section.
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Fixed effect model
In the observational study, while constructing the treatment effect, we face the problem of heteroge-
neous treated and control units. Many of the factors that make the difference will not be observable,
and so we face the standard omitted variable bias (OVB) problem, as we now define.
Definition A.1 (Omitted variable bias).
OVB occurs when we incorrectly left out one or more important control variables when the
model is created. The bias occurs when the model compensates for the missing factor by over or
underestimating the effect of one of the other factors.
Individual level panel data is a powerful tool for estimating treatment effect and deal with the
OVB. To estimate the treatment effect we can use the fixed effect strategy that requires panel data,
that is, repeated observations on the same individuals. This means that we have n individuals
and T time periods. Let i = 1, ...,n be an individual, who decides whether to participate in the
program and t = 1, ...,T a period of time. Furthermore, the fixed effect model contains the following
variables: Yit , potential outcome of individual i at the time period t, Dit , causal exposure variable for
individual i at time period t, Cit , time varying and observed covariates and Ai, unobserved but fixed
confounders.
We are interested in the causal effect estimation, which is the difference between the treated
and control outcome variables. Because of the fundamental problem of causal inferences we have
to estimate the potential outcome for the control group. We suppose that E[YNit | Ai,Cit , t,Dit ] =
E[YNit | Ai,Cit , t] and so we can define the expected potential outcome of the controls as follow:
E[YNit | Ai,Cit , t] = a+lt +A0ip+C0itq . (A.1)
Assuming that the causal effect of the treated is additive and constant we have the following
expected potential outcome of the treated:
E[Y Iit | Ai,Cit , t] = E[YNit | Ai,Cit , t]+d . (A.2)
The equations (A.1), (A.2) imply:
E[Yit | Ai,Cit , t] = a+lt +dDit +A0ip+C0itq ,
where d is the causal effect of interest.
Putting all together, this implies the following regression equation, which is the fixed-effect
model:
Yit = ai+lt +dDit +C0itq + eit ,
where eit = YNit  E[YNit | Ai,Cit , t] and ai = a+A0ip . If we estimate this model with simple ordinary
least squares without including individual fixed effects, ai will be correlated with Dit and so the Dit
will be correlated with the error term and this will lead to biased ordinary least squares estimates. In
practice, there are two ways to estimate the fixed effects model: within estimator or first differencing,
presented in following equations:
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1. Within estimator:
Yit   Y¯i = lt   l¯ +d (Dit   D¯i)  (Cit  C¯i)0q +(eit   e¯i).
2. First differencing:
DYit = Dlt +dDDit  DC0itq +Deit ,
where prefix D denotes the change from one period to the next one, for exemple DYit =
Yit  Yit 1.
Both methods drop out the ai, and therefore the error term and the regressor would no longer
be correlated. With two periods, the two methods are algebraically the same, but otherwise not.
Both methods should work, but with first differencing, we introduce serial correlation of the error
terms. Therefore within estimator would be more likely the better option.
Difference-in-differences
As we already mentioned, the fixed effect strategy requires panel data. But if only the aggregate
data are available, the option is to use the difference-in-differences methods, a version of fixed-
effect estimation using aggregate data. Since the work by Ashenfelter and Card (1985), the use of
difference-in-differences methods has become quite widespread.
The simplest setting of the DID model is one where the outcome is observed for units that are
observed in one of two groups, and in one of two time periods. Only units in one of the two groups
are exposed to treatment in the second time period. None of the units is exposed to the treatment in
the first period, and units from the control group are never exposed to the treatment. The average
gain over time in the control group is subtracted from the gain over time in the treatment group.
Imbens and Wooldridge (2008, p. 64) states: “This double differencing removes biases in second
period comparisons between the treatment and control group that could be the result of permanent
differences between those groups, as well as biases from comparisons over time in the treatment
group that could be the result of time trends unrelated to the treatment.”
Let i be the individual that belongs to the group gi 2 N, I (where group N is the control and I is
the treatment), and is observed in time period ti 2 0,1. Then we can define the expected potential
outcome for the controls as follows:
E[YNi | g, t] = gg+lt ,
where gg is time invariant group effect and lt time effect that is common across groups.
Let Dgt be the causal exposure variable for group g at time t. Assuming that E[Y Ii  YNi | g, t] = d
is the treatment effect, in the standard DID model we can write the outcome for individual i in the
absence of intervention, YNi as:
YNi = gg+lt +dDgt + ei,
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where the term ei represents unobservable characteristics of the individuals. Then the standard
DID estimands of the treatment effect is equal to:
ddid = E[Y Ii | Di = 1] E[YNi | Di = 0]
= (E[Yi | gi = I, ti = 1] E[Yi | gi = I, ti = 0])
 (E[Yi | gi = N, ti = 1] E[Yi | gi = N, ti = 0]).
In other words, to get the DID estimands of the treatment effect, the population average difference
over time in the control group is subtracted from the population average difference over time in
the treatment group to remove biases associated with a common time trend underrated to the
intervention. Common time trend under non-treatment is the key assumption for any DID strategy.
It is the outcome in treatment and control group that would follows the same time trend in the
absence of the treatment. Note, that this does not mean that they have the same mean of the
outcome. Common trend assumption is difficult to verify but one often uses pre-treatment data to
show that the trend are the same.
To conclude this chapter, we have to mention different important remarks concerning the DID
model. The first remark is that the two periods and two groups problem can be easily extended to
the multiple periods and multiple groups.
Second, we can also estimate the difference-in-differences estimator in a regression framework.
Angrist and Pischke (2008) defend the regression framework and presents following advantages:
it’s easy to calculate standard errors, to control for other variables which may reduce the residual
variance, easy to include multiple periods, to study treatments with different treatment intensity.
Third, one can use lagged dependent variables over h14 periods of time, Yit h, in the esti-
mation so the conditional independence assumption become: E[YNit | Ai,Yit h,Cit , t,Dit ] = E[YNit |
Ai,Yit h,Cit , t], and the term Yit h is introduced in the modelling.
A final remark is that in some cases, treatment and potential control groups do not follow parallel
trends and so the standard DID methods would lead to biased estimates. Abadie and Gardeazabal
(2003) pioneered a synthetic control method when estimating the effects of the terrorist conflict in
the Basque Country using a combination of other Spanish regions as a comparison group. The
basic idea behind the synthetic control is that a combination of units often provides a better com-
parison for the unit exposed to the intervention than any single unit alone. The synthetic control
method is presented in chapter 2.
14In this case, h> 1, otherwise one gets the unconfoundedness case for matching.
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A.2 Sectors descriptions
The description is extracted from Carbon Diclosure Project (CDP) (2014a).
Energy Sector: The GICS Energy Sector comprises companies whose businesses are dominated
by either of the following activities: The construction or provision of oil rigs, drilling equipment
and other energy related service and equipment, including seismic data collection. Companies
engaged in the exploration, production, marketing, refining and/or transportation of oil and gas
products.
Materials Sector: The GICS Materials Sector encompasses a wide range of commodity-related
manufacturing industries. Included in this sector are companies that manufacture chemicals, con-
struction materials, glass, paper, forest products and related packaging products and metals, min-
erals and mining companies, including producers of steel.
Industrials Sector: The GICS Industrials Sector includes companies whose businesses are domi-
nated by one of the following activities: The manufacture and distribution of capital goods, includ-
ing aerospace & defence, construction, engineering & building products, electrical equipment and
industrial machinery. The provision of commercial services and supplies, including printing, em-
ployment, environmental and office services. The provision of transportation services, including
airlines, couriers, marine, road & rail and transportation infrastructure.
Consumer Discretionary Sector: The GICS Consumer Discretionary Sector encompasses those in-
dustries that tend to be the most sensitive to economic cycles. Its manufacturing segment includes
automotive, household durable goods, textiles & apparel and leisure equipment. The services seg-
ment includes hotels, restaurants and other leisure facilities, media production and services and
consumer retailing.
Consumer Staples Sector: The GICS Consumer Staples Sector comprises companies whose busi-
nesses are less sensitive to economic cycles. It includes manufacturers and distributors of food,
beverages and tobacco and producers of non-durable household goods and personal products.
It also includes food & drug retailing companies as well as hypermarkets and consumer super-
centers.
Health Care Sector: The GICS Health Care Sector encompasses two main industry groups. The
first includes companies who manufacture health care equipment and supplies or provide health
care related services, including distributors of health care products, providers of basic health-care
services and owners and operators of health care facilities and organisations. The second regroups
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companies primarily involved in the research, development, production and marketing of pharma-
ceuticals and biotechnology products.
Financials Sector: The GICS Financial Sector contains companies involved in activities such as
banking, mortgage finance, consumer finance, specialised finance, investment banking and bro-
kerage, asset management and custody, corporate lending, insurance, financial investment and
real estate, including REITs.
Information Technology Sector: The GICS Information Technology Sector covers the following gen-
eral areas: First, Technology Software & Services, including companies that primarily develop soft-
ware in various fields such as the Internet, applications, systems, database management and/or
home entertainment and companies that provide information technology consulting and services
as well as data processing and outsourced services; second, Technology Hardware & Equipment,
including manufacturers and distributors of communications equipment, computers & peripher-
als, electronic equipment and related instruments, and third, Semiconductors and Semiconductor
Equipment Manufacturers.
Telecommunications Services Sector: The GICS Telecommunications Services Sector contains
companies that provide communications services primarily through a fixed-line, cellular, wireless,
high bandwidth and/or fiber optic cable network.
Utilities Sector: The GICS Utilities Sector encompasses those companies considered electric, gas
or water utilities or companies that operate as independent producers and/or distributors of power.
This sector includes both nuclear and non-nuclear facilities.
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A.3 Data descriptives
Variables Description
ID Company’s identification number (numeric);
NAME Company’s name (nominal);
CDP_IN Indicator variable defining if the company is reporting to the CDP (0: not
reporting, 1: reporting) (numeric);
CDP_YEAR The year the company started to report between 2003 – 2013, is NA if the
company does not report (numeric);
COUNTRY Company’s headquarter (nominal);
SECTOR Company’s sector (nominal);
INDUSTRY_SECTOR Company’s industry (nominal);
SUB_INDUSTRY Company’s sub-industry (nominal);
CLIMAT_CDP The year the company started to report to the CDP Climat change
program, concerns only the period between 2003 – 2013, is NA if the
company does not report (numeric);
WATER_CDP The year the company started to report to the CDP Water program,
concerns only the period between 2003 – 2013, is NA if the company does
not report (numeric);
SUPPLY_CHAIN_CDP The year the company started to report to the CDP Supply chain program,
concerns only the period between 2003 – 2013, is NA if the company does
not report (numeric);
FOREST_CDP The year the company started to report to the CDP Forest program,
concerns only the period between 2003 – 2013, is NA if the company does
not report (numeric);
GHG05   GHG13 Company’s greenhouse gas emissions in metric tons for the years 2005 –
2013 (numeric);
S05   S13 Source of the reported company’s greenhouse gas for the years 2005 –
2013;
R05   R013 Company’s revenue in mio CHF for the years 2005 – 2013 (numeric);
GP05   GP13 Company’s gross profit in mio CHF for the years 2005 – 2013 (numeric);
COGS05   COGS13 Company’s cost of goods sold in mio CHF for the years 2005 – 2013
(numeric);
FA05   FA13 Company’s fixed assets in mio CHF for the years 2005 – 2013 (numeric);
EMP05   EMP13 Company’s number of employees for the years 2005 – 2013 (numeric);
P05   P13 Company’s share price in CHF for the years 2005 – 2013 (numeric);
RI05   RI13 Company’s return on investment in CHF for the years 2005 – 2013
(numeric);
KL05   KL13 Company’s capital-labor ratio for the years 2005 – 2013 (numeric);
GHG_EMP05   GHG_EMP13 Company’s greenhouse gas emissions in metric tons per employee for the
years 2005 – 2013 (numeric);
Source: Author’s elaboration.
Table A.1: Variables in the transversal database
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[1] "ABM INDUSTRIES" "ACS" "ACTAVIS PLC" "AECOM TECHNOLOGY"
[5] "AGCO CORP" "AGGREKO PLC" "AKAMAI TECHNOLOG" "ALASKA AIR GROUP"
[9] "ALBEMARLE CORP" "AMEC FOSTER WHEE" "ANTOFAGASTA PLC" "AP MOELLERB"
[13] "AQUA AMERICA INC" "ATLANTIA SPA" "AVON RUBBER" "BANCO COM PORTR"
[17] "BAVARIAN NORDIC" "BLOOMSBURY PUBL" "BOOKER GROUP PLC" "BROADCOM CORPA"
[21] "BTG PLC" "CABOT CORP" "CAMPBELL SOUP CO" "CARDINAL HEALTH"
[25] "CARILLION PLC" "CELGENE CORP" "CENTROTEC SUSTAI" "CHEMRING GROUP"
[29] "CHIME COMMUNICAT" "CINEWORLD GROUP" "CLIFFS NATURAL R" "COGNIZANT TECHA"
[33] "COMPUTACENTER PL" "CONSTELLATIONA" "CR BARD INC" "CREDIT AGRICOLE"
[37] "DASSAULT SYSTEME" "DCC PLC" "DEBENHAMS PLC" "DELTA AIR LI"
[41] "DIGNITY PLC" "DLH A/S" "DRESSERNRAND GRO" "ENAGAS SA"
[45] "ENCE ENERGIA Y C" "ERAMET" "ESTEE LAUDER" "FALCK RENEWABLES"
[49] "FIAT CHRYSLER AU" "FIDESSA GROUP PL" "FISHER (JAMES)" "FLOWERS FOODS"
[53] "FLSMIDTH & CO" "FLUIDRA SA" "FRIGOGLASS SAIC" "FROMAGERIES BEL"
[57] "FUTURE PLC" "GENERALI ASSIC" "GREENCORE GROUP" "GREIF INCCL A"
[61] "GTECH SPA" "HANSTEEN HOLDING" "HARLEYNDAVIDSON" "HELLENIC PETRO"
[65] "HELLENIC TELECOM" "HERSHEY CO/THE" "HORMEL FOODS CRP" "HOWDEN JOINERY G"
[69] "HUNTSMAN CORP" "IHS INCNCLASS A" "INTERCONTINENTAL" "JARDINE LLOYD TH"
[73] "JERONIMO MARTINS" "JETBLUE AIRWAYS" "KBR INC" "KOBENHAVNS LUFTH"
[77] "KONE OYJB" "KONINKLIJKE PHIL" "KRKA" "LEGGETT & PLATT"
[81] "LENNOX INTL INC" "LIBERTY GLOBALNA" "LOWE’S COS INC" "MACERICH CO"
[85] "MARVELL TECH GRP" "MCBRIDE PLC" "MELIA HOTELS INT" "MERCIALYS"
[89] "MICROCHIP TECH" "MOHAWK INDS" "MOSAIC CO/THE" "NOBLE ENERGY INC"
[93] "NOKIAN RENKAAT" "OBRASCON HUARTE" "ODET" "OMV PETROM SA"
[97] "OSHKOSH CORP" "PACE PLC" "PATRIZIA IMMOBIL" "PHILIP MORRIS IN"
[101] "PROSEGUR" "PVH CORP" "PZ CUSSONS PLC" "QUEST DIAGNOSTIC"
[105] "RAISIO OYJNV" "RENREDE ENERGET" "RESTAURANT GROUP" "SACYR SA"
[109] "SAIPEM SPA" "SAVILLS PLC" "SCHNITZER STEEL" "SEAGATE TECHNOLO"
[113] "SECHE ENVIRONNEM" "SENIOR PLC" "SERCO GROUP" "SL GREEN REALTY"
[117] "SONAE" "SOUTHWEST AIR" "SUNPOWER CORP" "SYNERGY HEALTH P"
[121] "TESORO CORP" "TIMBERLAND BANCORP INC" "TULLETT PREBON P" "TUPPERWARE BRAND"
[125] "ULTRA ELECTRONIC" "VAISALA OYJA SH" "VALEO SA" "VESUVIUS PLC"
[129] "VF CORP" "VOPAK" "WATERS CORP" "WESTERN DIGITAL"
[133] "WILLIAM DEMANT" "XAAR PLC" "ZODIAC AEROSPACE"
Source: Author’s elaboration.
Table A.2: Company’s names
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ID2 YEAR NAME
100 2009 AP MOELLERB
CDP COUNTRY SECTOR
1 Denmark Industrials
INDUSTRY_SECTOR SUB_INDUSTRY CLIMAT_CDP
Marine Marine 1
WATER_CDP SUPPLY_CHAIN_CDP FOREST_CDP
0 0 0
GHG S R
40488998 CSR 52777
GP COGS FA
43178 9598 77102
EMP P RI
115386 1412 1039
KL GHG_EMP
668213 732
Source: Author’s elaboration.
Table A.3: One observation from the data
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CDP_YEAR
n missing unique
142 0 3
2009 (42, 30%), 2010 (34, 24%), N (66, 46%)
COUNTRY
n missing unique
135 0 14
Denmark Finland France Germany Greece Ireland Italy Netherlands Portugal
Frequency 6 3 9 2 3 3 6 2 4
% 4 2 7 1 2 2 4 1 3
Romania Slovenia Spain UK US
Frequency 1 1 8 34 53
% 1 1 6 25 39
INDUSTRY_SECTOR
n missing unique
135 0 57
SUB_INDUSTRY
n missing unique
135 0 85
CLIMAT_CDP
n missing unique
135 0 4
2009 (41, 30%), 2010 (30, 22%), 2011 (1, 1%), NA (63, 47%)
WATER_CDP
n missing unique
135 0 5
2010 (3, 2%), 2011 (3, 2%), 2012 (6, 4%), 2013 (2, 1%), NA (121, 90%)
SUPPLY_CHAIN_CDP
n missing unique
135 0 5
2010 (6, 4%), 2011 (7, 5%), 2012 (8, 6%), 2013 (5, 4%), NA (109, 82%)
FOREST_CDP
n missing unique
135 0 3
2012 (4, 3%), 2013 (1, 1%), NA (130, 96%)
Source: Author’s elaboration.
Table A.4: Descriptive statistics for different variables - Transversal database
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CD CS ENGY FINA HC INDU IT MATR TC UTIL Sum
Denmark 0 0 0 0 2 3 0 1 0 0 6
Finland 1 0 0 0 0 1 1 0 0 0 3
France 1 1 0 2 0 3 1 1 0 0 9
Germany 0 0 0 1 0 1 0 0 0 0 2
Greece 0 1 1 0 0 0 0 0 1 0 3
Ireland 0 1 0 0 0 1 1 0 0 0 3
Italy 2 0 1 1 0 1 0 0 0 1 6
Netherlands 0 1 1 0 0 0 0 0 0 0 2
Portugal 0 2 0 1 0 0 0 0 0 1 4
Romania 0 0 1 0 0 0 0 0 0 0 1
Slovenia 0 0 0 0 1 0 0 0 0 0 1
Spain 1 0 0 0 0 5 0 1 0 1 8
UK 10 3 1 4 2 9 4 1 0 0 34
US 7 7 3 3 5 12 6 7 0 3 53
Sum 22 16 8 12 10 36 13 11 1 6 135
Source: Author’s elaboration.
Table A.5: Cross-table country and sector for all countries
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CD CS ENGY FINA HC INDU IT MATR TC UTIL Sum
Denmark 0 0 0 0 1 3 0 1 0 0 5
Finland 1 0 0 0 0 1 1 0 0 0 3
France 1 0 0 0 0 0 1 0 0 0 2
Germany 0 0 0 0 0 1 0 0 0 0 1
Greece 0 0 0 0 0 0 0 0 1 0 1
Ireland 0 1 0 0 0 1 1 0 0 0 3
Italy 1 0 1 1 0 1 0 0 0 0 4
Netherlands 0 1 1 0 0 0 0 0 0 0 2
Portugal 0 2 0 1 0 0 0 0 0 1 4
Romania 0 0 0 0 0 0 0 0 0 0 0
Slovenia 0 0 0 0 0 0 0 0 0 0 0
Spain 1 0 0 0 0 2 0 0 0 1 4
UK 3 2 0 1 2 5 2 1 0 0 16
US 3 6 1 0 4 4 6 3 0 1 28
Sum 10 12 3 3 7 18 11 5 1 3 73
Source: Author’s elaboration.
Table A.6: Cross-table country and sector for participating countries
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CD CS ENGY FINA HC INDU IT MATR TC UTIL Sum
Denmark 0 0 0 0 1 0 0 0 0 0 1
Finland 0 0 0 0 0 0 0 0 0 0 0
France 0 1 0 2 0 3 0 1 0 0 7
Germany 0 0 0 1 0 0 0 0 0 0 1
Greece 0 1 1 0 0 0 0 0 0 0 2
Ireland 0 0 0 0 0 0 0 0 0 0 0
Italy 1 0 0 0 0 0 0 0 0 1 2
Netherlands 0 0 0 0 0 0 0 0 0 0 0
Portugal 0 0 0 0 0 0 0 0 0 0 0
Romania 0 0 1 0 0 0 0 0 0 0 1
Slovenia 0 0 0 0 1 0 0 0 0 0 1
Spain 0 0 0 0 0 3 0 1 0 0 4
UK 7 1 1 3 0 4 2 0 0 0 18
US 4 1 2 3 1 8 0 4 0 2 25
Sum 12 4 5 9 3 18 2 6 0 3 62
Source: Author’s elaboration.
Table A.7: Crosstable country and sector for non-participating countries
Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 824508 246841 1043881 22000 3245900 90
R 9001 3286 14776 298 58642 90
COGS 5989 2262 9870 126 38400 90
EMP 35907 18368 44806 2270 166000 90
KL 221375 179196 221042 29618 1199210 90
GHG_EMP 49 11 93 4 359 90
Non-CDP companies
GHG 545089 71000 1073052 302 4383000 108
R 9306 1861 22192 120 103000 108
COGS 7105 767 19015 59 88012 108
EMP 25064 7411 52145 292 225587 108
KL 165449 90748 231528 13338 996569 108
GHG_EMP 15 11 17 1 76 108
Source: Author’s elaboration.
Table A.8: Summary statistics (panel data on 9 years) sector “Consumer Discretionary”
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Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 501042 295647 460431 51954 2612602 108
R 9918 7207 10384 1080 44026 108
COGS 5589 3977 6052 639 28996 108
EMP 32757 19200 34732 4120 159226 108
KL 170534 1436941 98215 52855 424754 108
GHG_EMP 22 15 18 2 77 108
Non-CDP companies
GHG 189811 50298 146295 22563 444211 36
R 2827 2756 1997 159 7168 36
COGS 2195 1513 2012 149 6956 36
EMP 8398 8650 2152 4209 11832 36
KL 185208 134771 365228 36629 2274356 36
GHG_EMP 21 16 15 5 50 36
Source: Author’s elaboration.
Table A.9: Summary statistics (panel data on 9 years) sector “Consumer Staples”
Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 1387853 1343336 89113 279000 294419 27
R 6182 3509 5741 1059 16475 27
COGS 1940 1458 1593 352 5024 27
EMP 13768 3707 16508 1171 48607 27
KL 3397249 1382298 3744035 258198 9525704 27
GHG_EMP 553 92 729 31 2049 27
Non-CDP companies
GHG 2773680 2499053 2571238 29941 8939025 45
R 9405 6737 9430 207 34850 45
COGS 8294 4430 8951 167 32044 45
EMP 9530 5400 11700 742 49553 45
KL 712564 355264 705425 57822 26980143 45
GHG_EMP 589 621 524 5 1848 45
Source: Author’s elaboration.
Table A.10: Summary statistics (panel data on 9 years) sector “Energy”
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Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 55468 65739 41432 1910 122680 27
R 2825 1045 3344 99 9991 27
COGS 2713 986 3276 66 9771 27
EMP 39273 22001 27380 14516 85368 27
KL 4510915 5823547 3403289 4252 9419665 27
GHG_EMP 2 1 2 0.1 4 27
Non-CDP companies
GHG 82312 12021 169343 228 594287 81
R 5332 728 13448 27 49073 81
COGS 3277 323 8406 4 33597 81
EMP 10470 1045 25517 6 89172 81
KL 10649346 3215802 14127956 11145 58158299 81
GHG_EMP 72 16 100 0.2 485 81
Source: Author’s elaboration.
Table A.11: Summary statistics (panel data on 9 years) sector “Financial”
Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 87714 33083 121162 2226 381000 63
R 15825 1626 34869 86 108000 63
COGS 14145 358 33434 53 103000 63
EMP 8775 5000 11881 67 55000 63
KL 140775 128260 77657 55557 509709 63
GHG_EMP 12 11 9 1 42 63
Non-CDP companies
GHG 51346 42722 43863 4188 152132 27
R 1340 1377 1077 15 2835 27
COGS 520 515 406 14 1107 27
EMP 6405 7975 4722 224 13000 27
KL 204261 220762 132395 45626 559912 27
GHG_EMP 12 15 6 3 26 27
Source: Author’s elaboration.
Table A.12: Summary statistics (panel data on 9 years) sector “Health Care”
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Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 6111641 144091 12874994 14609 56739464 162
R 9771 4832 13837 98 66400 162
COGS 5521 3265 7179 93 41117 162
EMP 35632 13901 41887 788 164750 162
KL 315720 102529 448624 1376 2173789 162
GHG_EMP 316 14 1040 1 7431 162
Non-CDP companies
GHG 607549 110822 1199739 3138 5988837 162
R 4317 3748 3223 105 13137 162
COGS 3260 2229 2964 37 12314 162
EMP 20851 14059 25326 718 154514 162
KL 133214 67774 161174 2370 605604 162
GHG_EMP 70 8 143 0.2 546 162
Source: Author’s elaboration.
Table A.13: Summary statistics (panel data on 9 years) sector “Industrial”
Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 220468 59276 347331 1998 1300000 63
R 4348 3037 3774 307 14454 63
COGS 2625 1581 2862 69 11304 63
EMP 22755 7939 32510 595 171400 63
KL 167638 108208 175311 8273 763078 63
GHG_EMP 14 7 17 1 101 63
Non-CDP companies
GHG 4254 3872 1346 2421 6079 27
R 219 181 133 70 411 27
COGS 167 116 128 36 348 27
EMP 854 640 565 260 738 27
KL 133900 160258 61515 65079 227824 27
GHG_EMP 6 6 3 3 10 27
Source: Author’s elaboration.
Table A.14: Summary statistics (panel data on 9 years) sector “Information technology and telecomunication”
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Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 276568 265309 68213 190056 4770009 27
R 3147 1272 3085 564 8090 27
COGS 1558 324 2027 0.2 4764 27
EMP 14581 1031 19748 584 43500 27
KL 4796959 6907469 4422537 1603 11384492 27
GHG_EMP 217 269 161 6 434 27
Non-CDP companies
GHG 2682301 222132 3682312 43188 9842151 27
R 222436 681 320146 127 695000 27
COGS 13159 562 24469 85 77726 27
EMP 1028 1330 663 140 1896 27
KL 2604853 2561552 2092489 262914 77724328 27
GHG_EMP 2131 1542 2116 23 6030 27
Source: Author’s elaboration.
Table A.15: Summary statistics (panel data on 9 years) sector “Utilities”
Variables Mean Median Std. Dev. Min. Max. N
CDP companies
GHG 3474314 3677795 3675338 3715 9320000 45
R 4167 3229 2844 358 11518 45
COGS 2819 2295 2128 319 8424 45
EMP 4886 4370 2153 473 8500 45
KL 836972 762177 533283 38346 1689423 45
GHG_EMP 643 516 485 2 1745 45
Non-CDP companies
GHG 2310130 1330000 1829647 432121 6650000 54
R 4218 3157 3214 795 13310 54
COGS 3346 2764 2778 317 11296 54
EMP 7871 6252 5163 1048 15741 54
KL 531435 489851 338972 130739 1592713 54
GHG_EMP 322 305 134 77 590 54
Source: Author’s elaboration.
Table A.16: Summary statistics (panel data on 9 years) sector “Materials”
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A.4 Results of the synthetic control analysis in R
# 2.1. Run the synth command to identify optimal weights (see Remarque Synth)
> synth(dataprep.out)
X1, X0, Z1, Z0 all come directly from dataprep object.
****************
searching for synthetic control unit
****************
****************
****************
MSPE (LOSS W): 0.00017517
MSPE (LOSS V): 0.02834802
solution.v:
3.58464e-05 0.0003637101 0.0001761632 0.3505531 0.0002139565 0.0004261314
7.57813e-05 0.04520849 0.1585999 0.07461483 0.1847113 0.1850208
solution.w:
0.0007608 0.000728132 0.1799323 0.1262085 0.5895293 0.0009608754 0.001070103
0.0001224718 0.0001216348 0.01529448 0.001251224 0.08402018
Source: Author’s elaboration.
Figure A.3: Results of the function synth() for company “DEBENHAMS”
# 2.2 Compute the gaps
> print(gaps)
403
2005 0.122113871
2006 0.008454128
2007 0.112171278
2008 -0.292961475
2009 0.193088601
2010 -1.006822614
2011 -0.569185343
2012 -0.642107052
2013 -1.563949296
Source: Author’s elaboration.
Figure A.4: Treated effects for company “DEBENHAMS”
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# 2.3.1 Summary tables
print(synth.tables)
$tab.w
w.weights unit.names unit.numbers
218 0.001 BLOOMSBURY PUBL 218
308 0.001 CHIME COMMUNICAT 308
321 0.180 CINEWORLD GROUP 321
517 0.126 FIAT CHRYSLER AU 517
548 0.590 FUTURE PLC 548
612 0.001 HARLEYNDAVIDSON 612
649 0.001 HOWDEN JOINERY G 649
816 0.000 LIBERTY GLOBALNA 816
908 0.000 MOHAWK INDS 908
1071 0.015 PVH CORP 1071
1101 0.001 RESTAURANT GROUP 1101
1357 0.084 TUPPERWARE BRAND 1357
Source: Author’s elaboration.
Figure A.5: Optimal weights for synthetic control of the company “DEBENHAMS”
$tab.v
v.weights
R 0
GP 0
COGS 0
EMP 0.351
KL 0
GHG 0
P 0
RI 0.045
special.GHG_EMP.2005 0.159
special.GHG_EMP.2006 0.075
special.GHG_EMP.2007 0.185
special.GHG_EMP.2008 0.185
Source: Author’s elaboration.
Figure A.6: Predictors’ weight for synthetic control of the company “DEBENHAMS”
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$tab.pred
Treated Synthetic Sample Mean
R 3937.198 11243.009 9840.471
GP 678.554 1900.564 2308.367
COGS 3258.644 9342.444 7532.098
EMP 25486.500 25461.808 24038.583
KL 67365.037 47608.478 150835.855
GHG 169126.500 422328.595 529772.146
P 2.998 5.797 23.716
RI 159.790 207.718 3312.377
special.GHG_EMP.2005 7.463 7.341 15.127
special.GHG_EMP.2006 7.585 7.577 15.247
special.GHG_EMP.2007 6.131 6.019 14.563
special.GHG_EMP.2008 5.563 5.856 15.190
Source: Author’s elaboration.
Figure A.7: Treated effects for company “DEBENHAMS”
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Source: Author’s elaboration.
Figure A.8: Path and gaps plots of the company “DEBENHAMS”
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# Placebo gaps data
> placebo.data$p.gaps.data
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
2005 0.122113871 -0.33512984 -0.03639431 -0.3815492 1.3447303 0.5622978
2006 0.008454128 -0.47886195 0.05727377 0.9695022 0.6068070 0.6274852
2007 0.112171278 -0.02825890 0.06382242 0.2505468 0.6491470 -1.0602120
2008 -0.292961475 0.03281298 -0.09399626 -0.6967589 -2.1600912 -0.5091866
2009 0.193088601 -0.53104800 0.01796652 -2.1931031 -6.4480451 1.0924287
2010 -1.006822614 -0.44126672 -0.02317348 -4.0523202 1.1051677 0.8451190
2011 -0.569185343 0.30961872 -0.71778532 -5.3838476 0.2886103 1.3469621
2012 -0.642107052 -0.06300761 -0.41391257 -3.4817202 1.0201325 1.3928916
2013 -1.563949296 0.17105217 -0.77996239 -4.2087497 -0.9745326 2.3055472
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
2005 -0.79894967 0.5692431 0.2752905 32.01991 1.9529418 0.31578787
2006 1.66657408 -1.5961107 0.4004502 30.88229 -0.4065026 0.08040454
2007 0.13773359 1.2040084 -1.6492399 33.42222 -0.4442271 -0.33832431
2008 -0.80014317 -0.1448424 0.8038444 37.62800 -1.2460007 -0.08440156
2009 -0.09466666 -2.9341117 -1.9460788 41.99778 -2.1682149 0.90352103
2010 3.88725178 -7.5758652 -4.3482746 49.41503 -3.2704115 -1.35019130
2011 8.23899475 -5.4681568 -4.4435783 49.01530 -7.7956705 -1.28135540
2012 10.09665081 -4.5172050 -2.3199739 35.68888 -7.8415892 -1.23536835
2013 6.75387436 -7.1411257 -14.3701678 56.58550 -6.9832405 -0.33079648
TUPPERWARE BRAND
2005 -0.9447216
2006 0.5073607
2007 0.8437779
2008 -0.3512600
2009 0.5136837
2010 -1.1743715
2011 -0.3497365
2012 1.1479265
2013 0.8116233
Source: Author’s elaboration.
Figure A.9: In-space placebo treated effects, exemple of the company “DEBENHAMS”
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# 3.2 MSPE Pre-Treatment, Post-Treatment, MSPE ration
> mse.f(wdf, data = p.gaps.data, unit = tr.id, period = t.p)
$mse.pre
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
2.834802e-02 8.587401e-02 4.378357e-03 4.084403e-01 1.815975e+00 5.233092e-01
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
1.018747e+00 1.085556e+00 9.005758e-01 1.127975e+03 1.432270e+00 5.694346e-02
TUPPERWARE BRAND
4.963146e-01
$mse.post
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
0.8466372 0.1211642 0.2591481 16.0105530 8.9744724 2.1955257
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
46.1115798 33.4608600 50.8648211 2216.7548921 37.2850791 1.1833599
TUPPERWARE BRAND
0.7483605
$mse.ratio
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
29.865828 1.410953 59.188436 39.199252 4.941958 4.195465
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
45.263019 30.823717 56.480334 1.965251 26.032151 20.781316
TUPPERWARE BRAND
1.507835
$rmse.pre
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
0.16836871 0.29304267 0.06616915 0.63909332 1.34758119 0.72340117
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
1.00933014 1.04190002 0.94898671 33.58534419 1.19677500 0.23862828
TUPPERWARE BRAND
0.70449599
$rmse.post
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
0.9201289 0.3480864 0.5090659 4.0013189 2.9957424 1.4817306
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
6.7905508 5.7845363 7.1319577 47.0824266 6.1061509 1.0878235
TUPPERWARE BRAND
0.8650783
$rmse.ratio
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
5.464964 1.187835 7.693402 6.260931 2.223051 2.048283
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
6.727780 5.551911 7.515340 1.401874 5.102171 4.558653
TUPPERWARE BRAND
1.227939
$m.pr.tr.effect
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
-0.012555550 -0.202359428 -0.002323594 0.035435232 0.110148276 -0.094903921
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
0.051303706 0.008074591 -0.042413701 33.488104199 -0.035947140 -0.006633365
TUPPERWARE BRAND
0.013789244
$m.tr.effect
DEBENHAMS PLC BLOOMSBURY PUBL CHIME COMMUNICAT CINEWORLD GROUP FIAT CHRYSLER AU FUTURE PLC
-0.7177951 -0.1109303 -0.3833734 -3.8639482 -1.0017334 1.3965897
HARLEYNDAVIDSON HOWDEN JOINERY G LIBERTY GLOBALNA MOHAWK INDS PVH CORP RESTAURANT GROUP
5.7764210 -5.5272929 -5.4856147 46.5405005 -5.6118253 -0.6588381
TUPPERWARE BRAND
0.1898251
Source: Author’s elaboration.
Figure A.10: Root mean squared prediction errors and related statistics in-space placebo, exemple of the
company “DEBENHAMS”
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Figure A.11: Placebo plot of the company “DEBENHAMS”
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Figure A.12: Placebo plots of the company “DEBENHAMS” (with different root mean squared prediction
error exclusion rules)
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A.5 Results of the synthetic control analysis
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Figure A.13: Synthetic matching and permutation tests Gtech, Nokian, Valeo, Greencore
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Figure A.14: Synthetic matching and permutation tests Jeronimo, Koninklijke, Atlantia, Centrotec
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Source: Author’s elaboration.
Figure A.15: Synthetic matching and permutation tests Dcc, FlSmidth, Kobenhavns, Kone
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Source: Author’s elaboration.
Figure A.16: Synthetic matching and permutation tests Obrascon, William, Dassault, Seagate
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Source: Author’s elaboration.
Figure A.17: Synthetic matching and permutation tests Vaisala, Banco, Generali, Saipem
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Source: Author’s elaboration.
Figure A.18: Synthetic matching and permutation tests Enagas, Debenhams, Dignity, McBride
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Figure A.19: Synthetic matching and permutation tests Serco, Btg, Synergy, Computacenter
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Source: Author’s elaboration.
Figure A.20: Synthetic matching and permutation tests Pace, Savills, Leggett, Lowescos
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Source: Author’s elaboration.
Figure A.21: Synthetic matching and permutation tests VfCorp, Constallationa, EsteeLauder, Hershey
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Source: Author’s elaboration.
Figure A.22: Synthetic matching and permutation tests Philipmorris, Abm, Actavis, Celgene
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Figure A.23: Synthetic matching and permutation tests Akamai, Broadcom, Cognizant, Microhip
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Figure A.24: Synthetic matching and permutation tests Western, Cliffs, Noble, Quest
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# ==============================================================================
#
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#
#
# Applied S t a t i s t i c s and Modell ing
# Department of I n f o rma t i c s
# Un ive r s i t y of Fr ibourg ( Swi t ze r l and )
#
#
# AUTHOR:
#
# Adela Wyncoll
# Department of I n f o rma t i c s
# Un ive r s i t y of Fr ibourg ( Swi t ze r l and )
# Bd de P e r o l l e s 90
# CH 1700 Fr ibourg
#
# EMAIL:
#
# Adela . Turkova@UniFr . ch
#
# PROJECT:
#
# PhD Thes i s Syn t h e t i c Cont ro l Approach L ib ra ry
#
# PROGRAMME:
#
# Mylib . r
#
# OBJECTIVE:
#
# Fonc t ions ad hoc :
#
#
# ==============================================================================
#
# sp . pr . f SPECIAL PREDICTORS
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n sp . pr . f c r e a t e s a l i s t of the s p e c i a l p r e d i c t o r s to be used
# in the f unc t i o n da t ap rep ( )
#
# USAGE
sp . pr . f  function (moddata , u n i t = t r . id , yr1 = 2005 , yr2 = 2005 , yr3 = 2008 ,
yr4 = 2009 , va l1 = 1 , va l2 = 2 , v2 = "GHG_EMP" , stat =
"mean" ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# u n i t : Uni t number , by d e f a u l t t r e a tmen t i d e n t i f i e r t r . i d
# v2 : Var i ab l e to be genera ted , eg . "GHG_EMP"
# s t a t : S t a t i s t i c to be genera ted , eg . "mean"
# yr1 : 1 s t va lue of the the f i r s t year vec t o r
# yr2 : 1 s t va lue of the the second year vec t o r
# yr3 : Las t va lue of the the f i r s t year vec t o r
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# yr4 : Las t va lue of the the second year vec t o r
# va l1 : Value of the f i l t e r v a r i a b l e , by d e f a u l t s e t to 1
# va l2 : Value of the f i l t e r v a r i a b l e , by d e f a u l t s e t to 2
#
# VALUES
#
# time : Values to be gene ra t ed . One or more un i t of t imes as
# vec to r , e . g . 2005:2009. Depending on he t r e a tmen t year . By
# d e f a u l t we s p e c i f i e d t h a t the f i r s t year i s 2005 and the l a s t
# 2008 or 2009
# sp . pr : L i s t of the s p e c i a l p r e d i c t o r s , eg .
# l i s t ( l i s t ( "GHG_EMP" , 2005 , "mean " ) ,
# l i s t ( "GHG_EMP" , 2006 , "mean " ) ,
# l i s t ( "GHG_EMP" , 2007 , "mean " ) ,
# l i s t ( "GHG_EMP" , 2008 , "mean " )
# )
time  year . vec . f (moddata , un i t , yr1 , yr2 , yr3 , yr4 )
sp . pr  vector ( " l i s t " , length ( time ) )
for ( i i n 1 : length ( time ) ) {
sp . pr [ [ i ] ]  l i s t ( v2 , time [ i ] , stat )
}
return ( sp . pr )
}
# ==============================================================================
#
# year . vec . f YEAR VECTOR
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n year . vec . f c r e a t e s a vec t o r t h a t d e f i n e the t ime vec t o r t h a t
# i s s p e c i f i c to the t r e a tmen t v a r i a b l e w. r . t t he t r e a tmen t year
#
# USAGE
year . vec . f  function (moddata , u n i t = t r . id , yr1 ,
yr2 , yr3 , yr4 , v1 = "CDP" , va l1 = 1 , va l2 = 2) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# u n i t : Uni t number , by d e f a u l t t r e a tmen t i d e n t i f i e r t r . i d
# v1 : F i l t e r v a r i a b l e t h a t s p e c i f y the t r e a tmen t year
# yr1 : 1 s t va lue of the the f i r s t year vec t o r
# yr2 : 1 s t va lue of the the second year vec t o r
# yr3 : Las t va lue of the the f i r s t year vec t o r
# yr4 : Las t va lue of the the second year vec t o r
# va l1 : Value of the f i l t e r v a r i a b l e , by d e f a u l t s e t to 1
# va l2 : Value of the f i l t e r v a r i a b l e , by d e f a u l t s e t to 2
#
# VALUES
#
# year . vec : Values to be gene ra t ed . One or more un i t of t imes as vec to r ,
# e . g . 2005:2009 , or a l s o j u s t a s c a l a r 2008:2008. Depending on
# the t r e a tmen t v a r i a b l e and needed year
#
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# NOTE
#
# This f unc t i o n i s most ly used to s p e c i f y the t ime or year v e c t o r s
# to be used as arguments in d i f f e r e n t f u n c t i o n s . In our case , we
# de f i n e by d e f a u l t va l1 and va l2 equa l to 1 ( t r e a t e d in 2009) ,
# 2 ( t r e a t e d in 2009)
i f (unique (moddata [ is . element (moddata$ID2 , u n i t ) , v1 ] ) == val1 )
{ year . vec  c ( yr1 : yr3 ) }
i f (unique (moddata [ is . element (moddata$ID2 , u n i t ) , v1 ] ) == val2 )
{ year . vec  c ( yr2 : yr4 ) }
return ( year . vec )
}
# ==============================================================================
#
# un i t . par . f PARAMETRES OF THE UNIT
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n un i t . par . f g ives the va lues of the pa rame te r s f o r the
# un i t of i n t e r e s t
#
# USAGE
un i t . par . f  function (moddata , u n i t = t r . id , v3 = "NAME" ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# u n i t : Uni t number , by d e f a u l t t r e a tmen t i d e n t i f i e r t r . i d
# v3 : The v a r i a b l e t h a t g ives us the va lue to be found
#
# VALUES
#
# un i t . par : Values to be genera ted , e . g . t he name of the company
#
# NOTE
#
# This f unc t i o n i s most ly used to s p e c i f y the name of the company
# as an argument in o t h e r f u n c t i o n s
un i t . par  unique (moddata [ is . element (moddata$ID2 , u n i t ) , v3 ] )
return ( u n i t . par )
}
# ==============================================================================
#
# da t ap rep . arg DATAPREP ARGUMENTS
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n da t ap rep . arg c r e a t e s a l i s t of arguments to be used in the
# f unc t i o n da t ap rep
#
# USAGE
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dataprep . arg  function ( ) {
# VALUES
#
# mypar : L i s t of arguments to be used
#
# NOTE
#
# This f unc t i o n doesn ’ t c on t a i n s any arguments as i t s e l f i t
# c r e a t e s a l i s t of arguments . Before we can implement the
# f unc t i o n da taprep , a l l t he arguments has to be s p e c i f i e d in the
# environment
mypar1  a l i s t ( p r ed i c t o r s = pr ,
p r ed i c t o r s . op = pr . op ,
dependent = dep ,
u n i t . var iable = u . v ,
time . var iable = t . v ,
spec ia l . p r ed i c t o r s = sp . pr ,
time . p r ed i c t o r s . p r i o r = t . pr . p ,
time . optimize . ssr = t . op . ssr ,
u n i t .names . var iable = u . n . v ,
time . plot = t . p )
mypar2  a l i s t ( t rea tment . i d e n t i f i e r = t r . id ,
con t r o l s . i d e n t i f i e r = c . i d )
mypar  c ( a l i s t ( foo = data . frame ( wdf ) ) , mypar1 , mypar2 )
return (mypar )
}
# ==============================================================================
#
# gaps . f GAPS
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n gaps . f c a l c u l a t e s the gaps of the ou tpu t v a r i a b l e between the
# t r e a t e d un i t and i t s s y n t h e t i c c o n t r o l
#
# USAGE
gaps . f  function ( dataprep . out , synth . out ) {
# ARGUMENTS
#
# da t ap rep . out : Output of the f unc t i o n da t ap rep
# synth . out : Output of the f unc t i o n syn th
# Y1plot : Values of the ou tpu t v a r i a b l e of the t r e a t e d un i t
# Y1plot : Values of the ou tpu t v a r i a b l e of the c on t r o l u n i t
# s o l u t i o n .w : Values of the w weights
#
# VALUES
#
# gaps : The pe r iod by pe r iod d i s c r e p a n c i e s between the t r e a t e d un i t and
# i t s s y n t h e t i c c o n t r o l u n i t
#
# NOTE
#
# The ou tpu t from synth can be f l e x i b l y combined with the ou tpu t
# from da t ap rep to compute o t h e r q u a n t i t i e s of i n t e r e s t . In o rde r to
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# ge t t h i s va lues , we need to have f i r s t t he syn th ou tpu t
gaps  dataprep . out$Y1plot ( dataprep . out$Y0plot %*% synth . out$ so l u t i o n .w)
return ( gaps )
}
# ==============================================================================
#
# path . p l o t . f PATH PLOTS
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n gaps . p l o t . f g ives summary " pa th " p l o t s
#
# USAGE
path . plot . f  function (moddata , u n i t = t r . id , yr1 = 2009 , yr2 = 2010 ,
yr3 = 2009 , yr4 = 2010 , dataprep . out , synth . out ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# u n i t : Uni t number , by d e f a u l t i t i s t r e a tmen t i d e n t i f i e r t r . i d
# yr1 : 1 s t va lue of the the f i r s t year vec t o r
# yr2 : 1 s t va lue of the the second year vec t o r
# yr3 : Las t va lue of the the f i r s t year vec t o r
# yr4 : Las t va lue of the the second year vec t o r
# da t ap rep . out : Output of the f unc t i o n da t ap rep
# synth . out : Output of the f unc t i o n syn th
#
# VALUES
#
# path . p l o t : Gives the summary p l o t s f o r outcome t r a j e c t o r i e s of the t r e a t e d
# and the s y n t h e t i c c o n t r o l u n i t
#
# NOTE
#
# We use the f un c t i o n s t r . year to s e t the t r e a tmen t year , and
# t r . name to s e t the t r e a tmen t u n i t name . For more i n f o rma t i on s
# see f unc t i o n pa th . p l o t or gaps . p l o t . The l a b e l s a re a l r e ady
# s e t . For the t r . year we want to have only a s c a l a r equa l to
# 2009 or 2009 , t h a t ’ s why we put as va lues yr1 = 2008 ,
# yr2 = 2009 , yr3 = 2008 , yr4 = 2009
t r . year  year . vec . f (moddata , un i t , yr1 , yr2 , yr3 , yr4 )
t r . name  un i t . par . f (moddata , u n i t )
path . plot  path . plot ( synth . res = synth . out , dataprep . res = dataprep . out ,
t r . i n take = t r . year ,
Ylab = c ( "CO2 emissions per employee " ) ,
Xlab = c ( " Year " ) ,
Legend = c ( t r . name, " Syn the t i c company " ) ,
Main = c ( " Path p l o t " , t r . name)
)
}
# ==============================================================================
#
# gaps . p l o t . f GAPS PLOTS
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#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n gaps . p l o t . f g ives summary " gaps " p l o t s
#
# USAGE
gaps . plot . f  function (moddata , u n i t = t r . id , yr1 = 2009 , yr2 = 2010 ,
yr3 = 2009 , yr4 = 2010 , dataprep . out , synth . out ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# p l o t : Defined which p l o t we want . E i t h e r gaps . p l t ( " gaps " ) , or
# pa th . p l o t ( " pa th " )
# un i t : Uni t number , by d e f a u l t i t i s t r e a tmen t i d e n t i f i e r t r . i d
# yr1 : 1 s t va lue of the the f i r s t year vec t o r
# yr2 : 1 s t va lue of the the second year vec t o r
# yr3 : Las t va lue of the the f i r s t year vec t o r
# yr4 : Las t va lue of the the second year vec t o r
# da t ap rep . out : Output of the f unc t i o n da t ap rep
# synth . out : Output of the f unc t i o n syn th
#
# VALUES
#
# gaps . p l o t : Gives the summary p l o t s f o r outcome t r a j e c t o r i e s gaps of the
# t r e a t e d and the s y n t h e t i c c o n t r o l ( t r e a t e d s y n t h e t i c )
#
# NOTE
#
# We use the f un c t i o n s t r . year to s e t the t r e a tmen t year , and
# t r . name to s e t the t r e a tmen t u n i t name . For more i n f o rma t i on s
# see f unc t i o n pa th . p l o t or gaps . p l o t . The l a b e l s a re a l r e ady
# s e t . For the t r . year we want to have only a s c a l a r equa l to
# 2009 or 2009 , t h a t ’ s why we put as va lues yr1 = 2008 ,
# yr2 = 2009 , yr3 = 2008 , yr4 = 2009
t r . year  year . vec . f (moddata , un i t , yr1 , yr2 , yr3 , yr4 )
t r . name  un i t . par . f (moddata , u n i t )
gaps . plot  gaps . plot ( synth . res = synth . out , dataprep . res = dataprep . out ,
t r . i n take = t r . year ,
Ylab = c ( "Gap in CO2 emissions per employee " ) ,
Xlab = c ( " Year " ) ,
Main = c ( "Gaps p l o t " , t r . name)
)
}
# ==============================================================================
#
# p . vec . par . f PLACEBO VECTOR OF PARAMETRES
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n p . vec . par . f g ives the vec t o r of va lue s of the pa rame te r s f o r
# the un i t of i n t e r e s t , which w i l l be used in the placebo t e s t s
#
# USAGE
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p . vec . par . f  function (moddata , u n i t _1 = t r . id , u n i t _2 = c . id ,
v4 = "NAME" ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# u n i t _1 : Unit number of the t r e a t e d un i t , by d e f a u l t i t i s t he
# t r e a tmen t i d e n t i f i e r t r . i d
# un i t _2 : Unit number of the c on t r o l un i t s , by d e f a u l t i t i s t he c on t r o l
# i d e n t i f i e r t r . i d
# v4 : The parameter t h a t g ives us the va lue to be found
#
# VALUES
#
# p . vec . par : Values to be genera ted , e . g . t he name of the companies
#
# NOTE
#
# This f unc t i o n i s most ly used to s p e c i f y the names or id ’ s of
# the t r e a t e d and con t r o l companies f o r the placebo t e s t s
# company as an argument in o t h e r f u n c t i o n s
p . vec . par  c ( u n i t . par . f (moddata , u n i t = un i t _1 , v4 ) ,
u n i t . par . f (moddata , u n i t = un i t _2 , v4 ) )
return ( p . vec . par )
}
# ==============================================================================
#
# placebo . da t a . f PLACEBO DATA
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n placebo . da t a . f produce the placebo data , as p lacebo gaps and
# placebo
#
# USAGE
placebo . data . f  function (moddata , p . vec . name, p . vec . id , per iod = t . p ) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# pe r iod : Time p l o t value , eg . t . p  2005:2013
# p . vec . name : Vectors of the names of " p lacebo " t r e a t e d u n i t s
# p . vec . id : Vectors of the id numbers of " p lacebo " t r e a t e d u n i t s
#
#
# VALUES
#
# p . gaps . da t a : I s the mat r ix t h a t s t o r e s the va lues of the gaps of a l l t he
# " placebo " t r e a t e d u n i t s
# p . syn th . t ab : Gives a l i s t of the syn th . t a b l e s f o r a l l " p lacebo " t r e a t e d
# u n i t s
# da t ap rep . out : P repare the da t a f o r the f unc t i on synth , see a l s o
# da t ap rep . arg f unc t i o n
# synth . out : Gives the r e s u l t of the s y n t h e t i c c o n t r o l methods , see
# a l s o the f unc t i o n synth
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#
# NOTE
#
# This f unc t i o n produce the mat r ix of the placebo gaps and
# synth . t a be s f o r a l l t he t r e a t e d ann con t r o l u n i t s . In o rde r to ge t
# the r e s u l t s , t he f unc t i o n formals ( da t ap rep )  da t ap rep . arg ( ) has
# to be a l r e ady run be fo re
# Crea te the " s t o r e " mat r ix and snyth . t a b l e . l i s t v e c t o r
s to re  matrix (NA, length ( per iod ) , length ( p . vec .name) )
colnames ( s to re )  p . vec .name
p . synth . tab . l i s t  vector (mode = " l i s t " , length ( p . vec .name) )
names ( p . synth . tab . l i s t )  p . vec .name
# Run the bug
for ( i i n 1 : length ( p . vec .name) ) {
# Redef ine t r . id , c . i d in the mypar ob j e c t ( see da t ap rep . arg ) , t o t ake the
# va lues from the g loba l environment
t r . i d < p . vec . i d [ i ]
c . i d < p . vec . i d [ i ]
# Run synth
dataprep . out  dataprep ( )
synth . out  synth ( dataprep . out )
synth . t ab les  synth . tab ( dataprep . res = dataprep . out ,
synth . res = synth . out )
# S to re gaps and synth . t a b l e s
s to re [ , i ]  gaps . f ( dataprep . out , synth . out )
p . synth . tab . l i s t [ i ]  l i s t ( synth . t ab les )
}
# Get the da t a
data  s to re
rownames ( data )  per iod
# Get the p . syn th . t ab
p . synth . tab  p . synth . tab . l i s t
# Redef ine the va lue of the t r . i d in the g l oba l environment
t r . i d < p . vec . i d [ 1 ]
return ( l i s t ( p . gaps . data = data , p . synth . tab = p . synth . tab ) )
}
# ==============================================================================
#
# mse . f MSPE
#
# ==============================================================================
#
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# DESCRIPTION
#
# The f unc t i o n mse . f c r e a t e s a l i s t of d i f f e r e n t mean squared p r e d i c t i o n e r r o r
# (MSPE)
#
# USAGE
mse . f  function (moddata , data = p . gaps . data , u n i t = t r . id , per iod = t . p ,
pyr1 = 2008 , pyr2 = 2009 , pyr3 = 2008 , pyr4 = 2009 ,
t y r 1 = 2009 , t y r 2 = 2010 , t y r 3 = 2009 , t y r 4 = 2010) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# da t a : The mat r ix con t a i n i ng the da t a of " p lacebo " gaps f o r a l l
# " p lacebo " t e s t e d un i t s , see f un c t i on gap . t e s t . da t a . f
# u n i t : Uni t number , by d e f a u l t t r e a tmen t i d e n t i f i e r t r . i d
# pe r iod : Time p l o t value , by d e f a u l t t . p  2005:2013
# pyr : Pre t r e a tmen t year , f o r more see year . vec . f f un c t i on
# t y r : Treatment year , f o r more see year . vec . f f un c t i on
#
# VALUES
#
# pr . year : Las t pre t r e a tmen t year
# t r . year : Treatment year
# gap . end . pre : Gives the l a s t p r e t r e a tmen t year and i t ’ s p o s i t i o n in the
# vec t o r
# t r e a t . s t a r t : Gives the l a s t p r e t r e a tmen t year and i t ’ s p o s i t i o n in the
# vec t o r
# mse . pre : Vector of the p r e t r e a tmen t MSPE
# mse . pos t : Vector of the post t r e a tmen t MSPE ( i n c l ud i ng the t r e a tmen t
# year )
# mse . r a t i o : Vector of the MSPE r a t i o s (mse . pos t /mse . pre )
# rmse . pre : Vector of the p r e t r e a tmen t RMSPE
# rmse . pos t : Vector of the post t r e a tmen t RMSPE ( i n c l ud i ng the t r e a tmen t
# year )
# rmse . r a t i o : Vector of the RMSPE r a t i o s (mse . pos t /mse . pre )
# m. t r . e f f e c t : Average t r e a tmen t e f f e c t over a l l t r e a tmen t yea r s
# m. pr . t r . e f f e c t : Average pre t r e a tmen t e f f e c t over a l l pre t r e a tmen t yea r s
# company . mse : True t r e a t e d company MSPE
# NOTE
# This f unc t i o n g ives us the l i s t of d i f f e r e n t MSPE. They w i l l be
# used to do more placebo ana ly s e s
# Set bounds in gaps da t a
gap . s ta r t  1
gap .end  length ( per iod )
pr . year  year . vec . f (moddata , un i t , yr1 = pyr1 , yr2 = pyr2 , yr3 = pyr3 ,
yr4 = pyr4 )
t r . year  year . vec . f (moddata , un i t , yr1 = ty r1 , yr2 = ty r2 , yr3 = ty r3 ,
yr4 = t y r 4 )
gap .end . pre  which ( rownames ( data ) == pr . year )
t r e a t . s ta r t  which ( rownames ( data ) == t r . year )
# Get d i f f e r e n t MSPE
mse . pre  apply ( data [ gap . s ta r t : gap .end . pre , ] ^ 2 , 2 , mean)
mse . post  apply ( data [ t r e a t . s ta r t : gap .end , ] ^ 2 , 2 , mean)
mse . r a t i o  (mse . post ) / (mse . pre )
rmse . pre  (mse . pre ) ^0.5
rmse . post  (mse . post ) ^0.5
rmse . r a t i o  (mse . post ) ^0.5 / (mse . pre ) ^0.5
m. t r . e f f e c t  apply ( data [ t r e a t . s ta r t : gap .end , ] , 2 , mean)
173
m. pr . t r . e f f e c t  apply ( data [ gap . s ta r t : gap .end . pre , ] , 2 , mean)
company .mse  as . numeric (mse . pre [ 1 ] )
return ( l i s t (mse . pre = mse . pre , mse . post = mse . post , mse . r a t i o =mse . r a t i o ,
rmse . pre = rmse . pre , rmse . post = rmse . post , rmse . r a t i o = rmse . r a t i o ,
m. pr . t r . e f f e c t = m. pr . t r . e f f e c t , m. t r . e f f e c t = m. t r . e f f e c t , company .mse =
company .mse) )
}
# ==============================================================================
#
# p . syn th . p l o t . f PLACEBO SYNTH PLOT
#
# ==============================================================================
#
# DESCRIPTION
#
# The f unc t i o n p . syn th . p l o t . f g ives summary gaps p lo t , t h a t r e p r e s e n t the " t r u e "
# t r e a t e d un i t and the " placebo " ( c o n t r o l ) t r e a t e d u n i t e s
# USAGE
p . synth . plot . f  function (moddata , mse , x , data = p . gaps . data ,
u n i t = t r . id , per iod = t . p , c1 , c2 , pyr1 = 2008 ,
pyr2 = 2009 , pyr3 = 2008 , pyr4 = 2009 , t y r 1 = 2009 ,
t y r 2 = 2010 , t y r 3 = 2009 , t y r 4 = 2010) {
# ARGUMENTS
#
# moddata : Data t h a t c on t a i n s the u n i t of i n t e r e s t
# mse : Values of the f unc t i o n mse . f
# x : Values to be excluded from the gap . t e s t . data ,
# usua ly x  5 *mse$company . mse
# da t a : The mat r ix con t a i n i ng the da t a of " p lacebo " gaps and synth . t a b l e s
# f o r a l l " p lacebo " t e s t e d un i t s , see f un c t i on gap . t e s t . da t a . f
# u n i t : Uni t number , by d e f a u l t t r e a tmen t i d e n t i f i e r t r . i d
# pe r iod : Time p l o t value , by d e f a u l t t . p  2005:2013
# c1 : F i r s t va lue t h a t de te rmines the y l eng t h of the graph ( eg . 1 0 )
# c2 : Second va lue t h a t de te rmines the y l eng t h of the graph ( eg . 10)
# pyr : Pre t r e a tmen t year , f o r more see year . vec . f f un c t i on
# t y r : Treatment year , f o r more see year . vec . f f un c t i on
#
# VALUES
#
# pr . year : Las t pre t r e a tmen t year
# t r . year : Treatment year
# gap . end . pre : Gives the l a s t p r e t r e a tmen t year and i t ’ s p o s i t i o n in the
# vec t o r
# t r e a t . s t a r t : Gives the l a s t p r e t r e a tmen t year and i t ’ s p o s i t i o n in the
# vec t o r
# t r . name : Name of the t r e a t e d un i t
# da t a . p l o t : New data , c on t a i n i ng the excluded values , see argument x
# p l o t : Gives the placebo e f f e c t f i g u r e with a l l t he u n i t s
#
# NOTE
# This f unc t i o n needs the s p e c i f i c c1 and c2 va lues f o r each un i t
# Set bounds in gaps da t a
gap . s ta r t  1
gap .end  length ( per iod )
pr . year  year . vec . f (moddata , un i t , yr1 = pyr1 , yr2 = pyr2 , yr3 = pyr3 ,
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yr4 = pyr4 )
t r . year  year . vec . f (moddata , un i t , yr1 = ty r1 , yr2 = ty r2 , yr3 = ty r3 ,
yr4 = t y r 4 )
gap .end . pre  which ( rownames ( data ) == pr . year )
t r e a t . s ta r t  which ( rownames ( data ) == t r . year )
# Set t r e a t e d name and year
t r . name  un i t . par . f (moddata , u n i t )
# Exclude companies with x t imes h ighe r MSPE than the t r e a t e d
data . plot  data [ ,mse$mse . pre < x ]
Cex . set  .75
# P lo t
plot ( per iod , data . plot [ gap . s ta r t : gap .end ,
which (colnames ( data . plot ) == t r . name) ] ,
y l im = c ( c1 , c2 ) , # to be de f ined CASE BY CASE
x lab = " Year " ,
x l im = c ( per iod [ 1 ] , per iod [ length ( per iod ) ] ) ,
y lab = "Gap in CO2 emissions per employee " ,
main = c ( " Placebo gaps f o r " , t r . name) ,
type = " l " , lwd = 2 , col = " b lack " ,
xaxs = " i " , yaxs = " i " )
# Add l i n e s f o r c o n t r o l s t a t e s
for ( i i n 1 : ncol ( data . plot ) ) {
l ines ( per iod , data . plot [ gap . s ta r t : gap .end , i ] , col=" gray " )
}
# Add t r e a t e d company l i n e
l ines ( per iod , data . plot [ gap . s ta r t : gap .end ,
which (colnames ( data . plot ) == t r . name) ] ,
lwd = 2 , col = " b lack " )
# Add g r i d
abline ( v = t r . year , l t y = " dot ted " , lwd = 2)
abline ( h = 0 , l t y = " dashed " , lwd = 2)
legend ( " bo t tomr igh t " , legend = c ( t r . name, " Cont ro l un i t s " ) ,
l t y = c ( 1 ,1 ) , col = c ( " b lack " , " gray " ) , lwd=c ( 2 ,1 ) , cex = .8 )
# arrows (1967 , 1 . 5 , 1968.5 , 1 . 5 , co l = " b lack " , l eng t h = .1 )
# t e x t (1961 .5 , 1 . 5 , " Ter ror i sm Onset " , cex=Cex . s e t )
abline ( v = per iod [ 1 ] )
abline ( v = per iod [ length ( per iod ) ] )
abline ( h = c1 ) # to be de f ined CASE BY CASE
abline ( h = c2 ) # to be de f ined CASE BY CASE
}
Script B.1: My library
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# ==============================================================================
#
# . oooo . . oooo . o . oooo . ooo . . oo . . oo .
# ‘P ) 88b d88 ( "8 ‘P ) 88b ‘888P"Y88bP"Y88b
# . oP"888 ‘"Y88b . . oP"888 888 888 888
# d8 ( 888 o . ) 88b d8 ( 888 888 888 888
# ‘Y888""8o 8""888P’ ‘Y888""8o o888o o888o o888o
#
#
# Applied S t a t i s t i c s and Modell ing
# Department of I n f o rma t i c s
# Un ive r s i t y of Fr ibourg ( Swi t ze r l and )
#
#
# AUTHOR:
#
# Adela Wyncoll
# Department of I n f o rma t i c s
# Un ive r s i t y of Fr ibourg ( Swi t ze r l and )
# Bd de P é r o l l e s 90
# CH 1700 Fr ibourg
#
# EMAIL:
#
# Adela . Turkova@UniFr . ch
#
# PROJECT:
#
# PhD Thes i s Syn t h e t i c Cont ro l Approach
#
# DATE:
#
# Apr i l 2016
#
# PROGRAMME:
#
# Synth_CD. r
#
# OBJECTIVE:
#
# Apply s y n t h e t i c c o n t r o l method to the CD Indus t ry , model dep  GHG_EMP
#
# DATA:
#
# Type : Qu a l i t a t i v e and q u a n t i t a t i v e da t a
#
# F i l e s : Panel_Companies_Data_New. csv
#
# N. obs . : 1215 (135 u n i t s )
#
# N. v a r i a b l e s : 23
#
# N. pe r i od s : Da ta se t c on t a i n s i n fo rma t i on from 2005 2013 (9 pe r i od s )
#
# T i t l e : Syn t h e t i c Cont ro l Method App l i c a t i on
#
# Source : Pe r sona l work , Package ’ Synth ’ (2015) ,
# Synth : An R Package f o r Syn t h e t i c Cont ro l Methods (2011)
#
# Desc r i p t i on : Data base con t a i n i ng d i v e r s v a r i a b l e s used f o r the
# ana ly s e s
#
# Va r i ab l e s :
#
# ID2 : Company i d e n t i f i c a t i o n number ( d i g i t a l ) ;
176 Appendix B. Scripts
# YEAR : Year ( d i g i t a l ) ;
# NAME : Company sho r t name ( nominal ) ;
# CDP : I s the company r e p o r t i n g to the CDP
# ( 0 : not r epo r t i ng , 1 : in 2009; 2 : in 2010) ( d i g i t a l ) ;
# COUNTRY : Headquar te r ( nominal ) ;
# SECTOR : Sec to r ( nominal ) ;
# INDUSTRY_SECTOR : I ndu s t r y ( nominal ) ;
# SUB_INDUSTRY : Sub indus t ry ( nominal ) ;
# CLIMAT_CDP : I s the company r e p o r t i n g to the Climate change program
# ( 0 : No; 1 : Yes ) ( b inomia l ) ;
# WATER_CDP : I s the company r e p o r t i n g to the Water program
# ( 0 : No; 1 : Yes ) ( b inomia l ) ;
# SUPPLY_CHAIN_CDP: I s the company r e p o r t i n g to the Supply cha in program
# To i d e n t i f y the year the company s t a r t e d to r epo r t ,
# rem i f 1 on 2005 = r epo r t e d in 2003 , 2004 or 2005
# ( 0 : No; 1 : Yes ) ( b inomia l ) ;
# FOREST_CDP : I s the company r e p o r t i n g to the Fo r e s t program
# To i d e n t i f y the year the company s t a r t e d to r epo r t ,
# rem . i f 1 on 2005 = r epo r t e d in 2003 , 2004 or 2005
# ( 0 : No; 1 : Yes ) ( b inomia l ) ;
# GHG : Company ’ s CO2 emiss ions in me t r i c tons ( d i g i t a l )
# S : Source of the r e po r t e d company ’ s greenhouse gas or CO2
# emiss ions ( nominal )
# R : Company ’ s revenue in mio ( d i g i t a l )
# GP : Company ’ s g ros s p r o f i t i n mio ( d i g i t a l )
# COGS : Company ’ s co s t of goods so ld in mio ( d i g i t a l )
# FA : Company ’ s f i x ed a s s e t s in mio ( d i g i t a l )
# EMP : Company ’ s number of employees ( d i g i t a l )
# P : Company ’ s sha re p r i c e ( d i g i t a l )
# RI : Company ’ s r e t u r n on inves tmen t ( d i g i t a l )
# KL : Company ’ s c a p i t a l l a bo r r a t i o ( d i g i t a l )
# GHG_EMP : Company ’ s CO2 emiss ions in mt per employee ( d i g i t a l )
#
# REFERENCES:
#
# Hainmueller , J . and Diamond , A. (2014) Package ’ Synth ’ .
#
# Abadie , A. and Gardeazabal , J . (2003) Economic Costs of Con f l i c t : A Case
# Study of the Basque Country American Economic Review 93 (1 ) 113 132 .
#
# Abadie , A. , Diamond , A. , Hainmueller , J . (2011) . Synth : An R Package f o r
# Syn t h e t i c Cont ro l Methods in Comparative Case S tud i e s . J ou rna l of
# S t a t i s t i c a l Sof tware 42 (13 ) 1 1 7 .
#
# Wyncoll , A. , The e f f e c t of f i rms r e p o r t i n g to the Carbon d i s c l o s u r e
# p r o j e c t on t h e i r CO2 emiss ions . An emp i r i c a l s tudy based on the s y n t h e t i c
# c on t r o l approach .
#
# COMMENTS:
#
# REMARKS: Abadie and Gardeazabal (2003) use 13 p r e d i c t o r s v a r i a b l e s f o r each
# region , the v a r i a b l e s a re : 1964 1969 averages f o r g ros s t o t a l
# inves tmen t ( i n v e s t ) ; 1964 1969 schoo l ing v a r i a b l e s ; 1961 1969
# average f o r s i x i n d u s t r i a l s e c t o r sha r e s as a pe rcen t age of t o t a l
# p roduc t i on ; 1960 1969 averages f o r r e a l GDP per c a p i t a ; 1969
# popu l a t i on den s i t y .
#
#
# ==============================================================================
# I n i t i a l i s a t i o n
# ==============
# Chemins d ’ accès aux do s s i e r s de données
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ddpath  " /Volumes / D i r e c t o r i e s / TurkovaA /My Documents /PhD Thesis / Data / "
# Chemins d ’ accès aux do s s i e r s de t r a v a i l
wdpath  " /Volumes / D i r e c t o r i e s / TurkovaA /My Documents /PhD Thesis / Data / "
# Chemins d ’ accès à mes f on c t i o n s ad hoc
j dpa th  " /Volumes / D i r e c t o r i e s / TurkovaA /My Documents /PhD Thesis / jobs / "
# Fixe l e d o s s i e r de t r a v a i l e t de données
setwd ( wdpath )
# My l i b r a i r i e s
# =============
source ( f i l e ( paste ( jdpath , " Myl ib . r " , sep=" " ) , encoding=" l a t i n 1 " ) )
# L i b r a i r i e s
# ==========
l i b ra ry ( Synth ) # use s y n t h e t i c c o n t r o l method
l i b ra ry ( Hmisc ) # con ten t s , desc r ibe , l abe l , summarize
# Remarques Snyth : The synth command i d e n t i f i e s op t imal weights . The
# op t im i s a t i o n method may be ( " Nelder Mead ’ , ’BFGS’ , ’CG’ ,
# ’L BFGS B’ , ’ nlm ’ , ’ nlminb ’ , ’ spg ’ , and ’ ucminf " ) , t he d e f a u l t
# method i s c ( " Nelder Mead" , "BFGS" )
# ==============================================================================
#
# Data
#
# ==============================================================================
# 1 .1 Data
# ========
# Groupe of t r e a t e d ( P a r t i c i p a t i n g 2009 / 2010) and c o n t r o l s (Non P a r t i c i p a t i n g )
wdf  read . csv2 ( f i l e ( paste ( ddpath , " Panel_Companies_Data_New. csv " , sep=" " ) ,
encoding=" l a t i n 1 " ) , header=T , sep=" , " , dec=" . " ,
na . s t r i n g s ="NA" )
head ( wdf )
# 1 .2 Data P r e p a r a t i o n s
# =====================
# 1 . 2 . 1 Transform the v a r i a b l e NAME from f a c t o r to c h a r a c t e r
wdf$NAME as . character ( wdf$NAME)
# 1 . 2 . 2 General va lue s of the arguments to be used in da t ap rep ( )
# P r e d i c t o r s
pr  c ( "R" , "GP" , "COGS" , "EMP" , "KL" , "GHG" , "P" , " RI " )
# P r e d i c t o r s . op
pr . op  "mean"
178 Appendix B. Scripts
# Dependent
dep  "GHG_EMP"
# Unit . v a r i a b l e
u . v  " ID2 "
# Time . v a r i a b l e
t . v  "YEAR"
# un i t . names . v a r i a b l e
u . n . v  "NAME"
# t ime . p l o t
t . p  2005:2013
# ==============================================================================
#
# 1 . CD ob . 403
#
# ==============================================================================
# CD s e c t o r ob s e r v a t i on :
# Year : 2009
# Comments : We have good pre t r e a tmen t f i t and l i t t l e p o s i t i v e t r e a tmen t e f f e c t .
# The p va lue i s 5 / 13 fo r rmse . r a t i o and the t o t a l p va lue i s 4 / 13 : ) In the
# placebo graphs the average p va lue i s 0.4822 compare to 0.244 ( be s t p va lue ) .
# ob . 908 i s an extreme va lue .
# 1 . Crea te ma t r i c e s from pane l da t a t h a t p rov ide i npu t s f o r syn th ( )
# ==================================================================
# 1 .1 Sp e c i f i c va lue s of the arguments to be used in da t ap rep ( )
# Treatment i d e n t i f i e r
t r . i d  403
# Con t ro l s i d e n t i f i e r
c . i d  c (218 , 308 , 321 , 517 , 548 , 612 , 649 , 816 , 908 , 1071 , 1101 , 1357)
# Spec i a l . p r e d i c t o r s
sp . pr  sp . pr . f ( wdf , u n i t = t r . id , v2 = "GHG_EMP" , stat = "mean" )
# t ime . p r e d i c t o r s . p r i o r
t . pr . p  year . vec . f ( wdf , u n i t = t r . id , yr1 = 2005 , yr2 = 2005 , yr3 = 2008 ,
yr4 = 2009)
# t ime . op t imize . s s r
t . op . ssr  t . pr . p
# 1 .2 Run da t ap rep to p repa re the arguments f o r the f unc t i on syn th
formals ( dataprep )  dataprep . arg ( )
dataprep . out_403  dataprep ( )
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# 2 . Run the s y n t h e t i c c o n t r o l ana l y s e s
# =====================================
# 2 . 1 . Run the synth command to i d e n t i f y op t imal weights ( see Remarque Synth )
synth . out_403  synth ( dataprep . out_403)
# 2 .2 Compute the gaps
gaps  gaps . f ( dataprep . out_403 , synth . out_403)
pr in t ( gaps )
# 2 .3 Summarise r e s u l t s
# 2 . 3 . 1 Summary t a b l e s
synth . t ab les  synth . tab ( dataprep . res = dataprep . out_403 , synth . res =
synth . out_403)
pr in t ( synth . t ab les )
# 2 . 3 . 2 Path p l o t and gaps p l o t
op  par ( mfrow = c ( 2 ,1 ) )
path . plot  path . plot . f ( wdf , u n i t = t r . id , yr1 = 2009 , yr2 = 2010 , yr3 = 2009 ,
yr4 = 2010 , dataprep . out_403 , synth . out_403)
gaps . plot  gaps . plot . f ( wdf , u n i t = t r . id , yr1 = 2009 , yr2 = 2010 , yr3 = 2009 ,
yr4 = 2010 , dataprep . out_403 , synth . out_403)
par ( op )
# 3 . Gaps Tes t
# ============
# Vectors of id ’ s and names
p . vec .name  p . vec . par . f ( wdf , v4 = "NAME" )
p . vec . i d  p . vec . par . f ( wdf , v4 = " ID2 " )
# 3 . 1 . 1 Vector of gaps and synth . t a b l e s
# Placebo da t a
placebo . data_403  placebo . data . f ( wdf , p . vec . name, p . vec . id , per iod = t . p )
# Placebo gaps da t a
p . gaps . data  placebo . data_403$p . gaps . data
# Placebo synth . t a b l e s
p . synth . tab  placebo . data_403$p . synth . tab
# 3 .2 MSPE Pre Treatment , Post Treatment , MSPE r a t i o n
mse_403  mse . f ( wdf , data = p . gaps . data , u n i t = t r . id , per iod = t . p )
# 3 .3 Figure
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# Values to be excluded from the gap . t e s t . data , usua ly x  5 *mse$company . mse
x  5 *mse_403$company .mse
# P lo t
p . synth . plot . f ( wdf , mse_403 , x , data = p . gaps . data , u n i t = t r . id , per iod = t . p ,
c1 = 2 , c2 = 2)
Script B.2: Synthetic control analysis customer discretionary sector
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